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Ovulation is a natural, recurrent injury involving sustained breakdown and remodelling of
extracellular matrix (ECM) proteins, as follicles grow, ovulate and luteinise during each
reproductive cycle. It is generally accepted that ovulation-associated tissue injury is the
end-product of an acute inflammatory cascade driven by gonadotrophins (follicle-
stimulating hormone (FSH) and luteinising hormone (LH)) and inflammatory mediators
that signal up-regulation of matrix metalloproteinase enzymes, which proteolytically
digest the follicle wall to allow oocyte release. The principle ECM component of the
basement membrane separating granulosa cells (GC) and theca cells (TC) in the follicle
wall is collagen IV. The terminal stage in mature collagen formation is cross-linkage of
collagen fibrils catalysed by lysyl oxidase (LOX). The pro-LOX protein encoded by LOX
mRNA is hydrolysed extracellularly to active LOX by bone-morphogenetic protein-1
(BMP-1), which also hydrolyses procollagens to mature forms of collagen. BMP-1 action
on pro-collagen is enhanced by procollagen C-proteinase enhancer (PCPE). This thesis
examines where and how expression of these collagen pathway component genes are
regulated at mRNA and protein levels throughout follicular development, asking in which
cell types are they expressed; are they developmentally (i.e. gonadotrophin) regulated;
and do local pro- and anti-inflammatory mechanisms influence their activity?
Quantitative RT-PCR analysis of total RNA from rat ovaries and in situ hybridisation
studies revealed presence of LOX, BMP-1 and PCPE mRNA in both GC and TC of rat
ovary. In immature follicles, LOX mRNA principally located to GC where its abundance
declined during gonadotrophin-induced follicular development. Conversely, BMP-1 and
PCPE mRNA were present at similar levels in GC and TC. No developmental regulation
was determined in isolated cells but visualisation by in situ hybridisation on whole
ovaries saw these genes associated with the theca layer declining as maturation occurred.
LOX and BMP-1 protein were located in both GC and TC layers. These results suggest a
two-cell mechanism of ECM formation involving GC LOX and TC BMP-1.
GC and TC isolated from rat ovarian follicles were cultured with development-associated
regulatory cues: FSH (GC), LH (TC) and TGF-P for immature follicles; LH, TGF-P and
IL-la for preovulatory follicles, in presence and absence of anti-inflammatory steroids
(progesterone or corticosterone), to determine how these factors affect collagen pathway
gene expression in vitro. Results established that components of ECM remodelling varied
viii
with the changing profile of ovarian regulators. In the immature follicle FSH in the GC,
LH in the TC and TGF-P in both cell types caused an overall increase in up-regulation of
collagen pathway activity to allow for follicle growth. Towards ovulation LH,
progesterone, IL-1 and a probable lack of TGF-P caused a cessation of active
remodelling. Then post-ovulation remodelling was resumed due to the positive influences
of TGF-P and corticosterone.
The classic anti-inflammatory glucocorticoid corticosterone, acts to minimise or prevent
fibrosis. Evidence from culture experiments showed corticosterone influenced collagen
pathway gene expression. Within glucocorticoid target tissues corticosterone formation is
amplified by 11 P-hydroxysteroid dehydrogenase (lipHSD) type 1 and suppressed by
11PHSD type 2. Both 11PHSD isoforms are known to be regulated at the level of gene
expression in the ovary. Immunolocalisation of lipHSD proteins in normal rat ovary
showed that lipHSDl increased as follicles developed, whereas llpHSD2 declined,
suggesting that active glucocorticoid becomes available to influence collagen deposition
and remodelling after ovulation. However, ovaries from mice null for the lipHSDl
gene, in which corticosterone cannot be locally activated, remained fertile and no changes
were seen in protein expression of LOX or BMP-1. Therefore other mechanisms may
rate-limit intra-ovarian glucocorticoid action during ovulation.
Finally, collagen pathway components are instrumental in forming stable collagen
structures and are believed to influence collagen IV networks. In the ovary collagen IV is
associated with the follicular basement membrane. But mice with partial disruptions of
COL4al did not show gross abnormalities in fertility or collagen pathway gene location.
This result suggests that the follicular basement membrane is a dynamic structure that can
accommodate partial disturbances without becoming dysfunctional.
The conclusion of this thesis is that there are changes in intrafolliclular ECM remodelling
driven by endocrine, paracrine and intracrine signals. Collagen pathway components are
key to this process and present targets for future studies of tissue injury and repair in ovary
and elsewhere in the body.
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1. Review of the Literature
1.1. Ovulation as an inflammatory event
The process of ovulation is described as an inflammatory reaction (Espey 1980; Espey
1994). This model states that the surge of luteinising hormone (LH) prior to ovulation
causes an inflammatory reaction within the preovulatory follicle that subsequently
results in the rupture of the healthy follicle and the release of the oocyte. Before
detailing ovulation as an inflammatory event, folliculogenesis will be briefly reviewed to
give an outline of non-inflammatory events in the ovary prior to ovulation, because if
these events do not occur ovulation cannot take place.
The ovary consists of follicles at different stages of development embedded in a
connective tissue matrix known as the stroma, as shown in Figure 1.1 A. The external
surface of the ovary is covered by a simple cuboidal epithelial layer of cells known as
the ovarian surface epithelium (OSE). Follicles are made up of granulosa cells and theca
cells, which are separated by a basement membrane (Fig. 1.1B). The theca layer is
vascular whereas the granulosa layer is avascular. The basement membrane prohibits
the invasion of vessels into the granulosa layer but allows passage of nutritional and
instructional substances between the two cell types and therefore ultimately to the
oocyte.
Figure 1.1. Collagen content and basement membrane location in the rat ovary. A. immature rat
ovary stained with Masson's Trichrome illustrating a population of preantral and antral follicles
within the stroma, scale bar 100pm. B, antral rat follicle showing the basement membrane
separating the granulosa and theca cells within the follicle, scale bar 50pm. Ovarian surface
epithelium (OSE), preantral follicle (PA), stroma (S), early antral follicle (EA), theca cells (TC),
oocytes (O), basement membrane (BM), cumulus oophorus complex (COC), antrum (A),
granulosa cells (GO).
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The follicles in the ovary are laid down before birth as primordial follicles, each
consisting of an oocyte (arrested at prophase I of meiosis) and a single layer of flattened
precursor granulosa cells. Primordial follicles are recruited throughout reproductive life
to grow and mature, either fully to result in ovulation and potential fertilisation or
incompletely to become atretic and degenerate.
1.1.1. Folliculogenesis
The process of follicle growth is known as folliculogenesis and involves endocrine
regulation from the hypothalamus and pituitary gland as well as paracrine signalling
within the ovary itself. Follicles mature (Fig 1.2A) from primordial through primary
(granulosa cells are cuboidal and the number of layers are increasing) and secondary
(increasing layers of granulosa cells surrounded by thecal cells recruited from the
stroma) to tertiary (when an antrum is formed) and onwards to become preovulatory
(Rajkovic et al. 2006). However the fate of most follicles is not ovulation but
degeneration. This maturation process of degeneration is known as atresia and is due to
programmed cell-death of somatic follicular cells and oocytes. The life-cycle of a
follicle is summarised in Fig. 1.2.
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Figure 1.2. The life-cycle of an ovarian follicle. A, illustration depicting follicular maturation:
1, primordial follicle; 2, primary follicle; 3, secondary follicle; 4, tertiary follicle; 5,
preovulatory follicle. B, graphical representation of the potential fates of a follicle during
maturation emphasising that the number of primordial follicles declines throughout
reproductive life until depletion. This conventional perception has recently been challenged
by the work of Jonathan Tilly (Johnson et at. 2004) suggesting that there is primordial
follicle renewal. Adapted from McGee and Hsueh (2000).
Folliculogenesis has two successive phases: gonadotrophin-independent (preantral)
followed by gonadotrophin-dependent (antral).
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1.1.1.1. Gonadotrophin-independent follicle growth
Primordial follicles are continuously recruited to grow as cohorts in the cortical stroma
and are activated to become primary follicles. The signals that stimulate activation are
not fully understood but possibly involve the removal of a local inhibitory factor (Suh et
al. 2002). At the preantral stage, paracrine factors cause the growth and differentiation
of oocytes, proliferation and cytodifferentiation of granulosa cells, and recruitment and
development of theca cells. The development of a thecal layer in the preantral follicle is
essential for any subsequent response of the follicle to LH (Magoffin 2005). Although
not well characterised, various growth and differentiation factors are assumed to work in
a series of paracrine feedback loops to orchestrate early follicle development and initiate
stages of development that eventually require the presence of FSH (Suh et al. 2002).
Mice null for the growth differentiation factor-9 (GDF-9) gene are unable to form a
theca layer, indicating that this growth/differentiation factor is important in theca
development (Dong et al. 1996). Whether such factors emanate from oocytes or
granulosa cells is uncertain but it can be concluded that paracrine communication
between both cells is an absolute requirement for normal folliculogenesis.
Once growth is initiated and 2-3 layers of granulosa cells have developed, the follicular
antrum starts to form (Suh et al. 2002). This cavity fills with follicular fluid comprised
of granulosa cell secretions and substances passing from plasma across the follicular
basement membrane. At this stage further growth and development becomes critically
dependent on stimulation by gonadotrophins.
1.1.1.2. Gonadotrophin-dependent follicle growth
Once antral development has started, follicle growth becomes gonadotrophin-dependent.
This is revealed by the phenotype of the follicle-stimulating hormone-(5 (FSHP)-null
mouse where folliculogenesis does not progress beyond preantral stages, likewise in the
luteinising hormone (LH) receptor null mouse, where follicles only reach early antral
stages (Kumar et al. 1997; Zhang et al. 2001). Follicles not in receipt of adequate
gonadotrophic support become atretic and degenerate.
The gonadotrophins are members of the glycoprotein hormone family that also includes
thyroid stimulating hormone. Each of these heterodimeric hormones shares a common
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a-subunit with a unique (3-subunit that confers individual receptor specificity. It is
gonadotrophin-releasing hormone (GnRH) produced by the hypothalamus that
stimulates release of FSH and LH from the anterior pituitary gland (Rajkovic et al.
2006). Negative and positive feedback loops along the hypothalamo-pituitary-gonadal
axis exist to regulate the release of these hormones.
FSH and LH act via their receptors (FSHR and LHR) on ovarian cells to promote follicle
maturation. In particular, FSH causes further granulosa cell proliferation and
differentiation. Preovulatory differentiation is signalled through increased aromatisation
of androgen to oestrogens and expression of the granulosa cell LHR. LH mainly causes
theca cells to produce androgens for aromatisation by granulosa cells and is eventually
necessary for ovulation to take place (Richards 1994). As well as FSH and LH, the
maturing follicle utilises locally-produced oestrogen to support granulosa cell
proliferation. Oestrogen biosynthesis requires two cell-types (granulosa and theca) and
two gonadotrophins (FSH and LH). This is described as the 'two-cell, two-

















Figure 1.3. The 'two-cell, two-
gonadotrophin' model of oestrogen
synthesis adapted from Magoffin
(2005). LH binds to its G protein-
coupled receptor on the theca cell
membrane and via cAMP signalling
stimulates the expression of
cholesterol side-chain cleavage
cytochrome P450 (CYP11A), 17a-
hydroxylase/C17_2o lyase cytochrome
P450 (CYP17) and 30-
hydroxysteroid dehydrogenase
(30HSD). This cascade results in
the synthesis of androstenedione
which passes across the basement
membrane to the granulosa cells.
FSH binds to its G protein-coupled
receptor and via cAMP causes the
expression of aromatase cytochrome
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In this classic model the granulosa and theca cells work together to regulate oestrogen
synthesis. The theca cells convert cholesterol to androgens following stimulation
signalled by LH through the G protein-coupled LHR on their cell surface. However,
theca cells cannot produce the aromatase enzyme cytochrome P450 (CYP19) needed to
convert androgen to oestrogen (Magoffin 2005). On the other hand the granulosa cells
cannot produce androgen due to the absence of 17a-hydroxylase/Ci7.2olyase cytochrome
P450 (CYP17) enzyme, which they can convert androgen to oestrogen since they
express CYP19, following FSH stimulation via the FSHR (Magoffin 2005). Hence
theca cells produce androgen in the form of androstenedione, which passes through the
basement membrane to the granulosa cells to be metabolised into oestrogen. LH
enhances the production of androgens both by increasing the number of LHR present on
theca cells and by increasing the expression of steroidogenic acute regulatory protein
(StAR) which aids cholesterol transport within the cell (Magoffin 2005). Oestrogen
production is limited by the amount of androgen available. Therefore the increased
amount of oestrogen secreted by the maturing follicle is coupled to the increased ability
of its theca cells to produce androgens, due to endocrine stimulation by LH and
paracrine stimulation by granulosa cell-derived inhibin (Hillier 1991). Oestrogens
created in the ovary also drive the proliferation and differentiation of steroidogenic
ovarian cells (Findlay et al. 2001)
As follicular oestrogen secretion continues to increase and plasma levels rise beyond a
critical threshold level, oestrogen exerts positive feedback action on the hypothalamus
and pituitary gland. This triggers the release of a surge of LH, which causes ovulation to
occur with release of the oocyte. The LH surge also causes the luteinisation of the
granulosa and theca cells of the preovulatory follicle (Richards 1994) to form the corpus
luteum, which is a highly vascularised endocrine gland that primarily produces
progesterone. The corpus luteum has one of two fates: it can either be maintained if
pregnancy occurs or if not it will regress and a new ovarian cycle will begin.
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1.1.2. Inflammation at ovulation
At ovulation the preovulatory follicles rupture to release oocytes for potential
fertilisation. This occurs through the LH surge triggering the secretion of proteases to
degrade the apical follicular wall. In addition to causing ovulation and luteinisation the
LH surge also initiates the progression of oocyte meiosis to metaphase II (where it is
arrested until fertilisation) and the down-regulation ofCYP17 (Magoffin 2005)
What is the evidence that ovulation is an inflammatory event? Classic inflammation is
characterised by: redness, heat, swelling, pain and organ dysfunction. Fig. 1.4 shows a
human ovary at ovulation. It can clearly be seen that the site of ovulation is red and
swollen.
Figure 1.4. The human ovary at ovulation.
Preovulatory follicle (PO), ovary (O). Source
www.oakbrookfertility.com/files/fertility.html
If non-steroidal anti-inflammatories are given during the first 80% of ovulation the
process will be stopped (Espey 1980). These drugs inhibit acute inflammation (unlike
steroidal anti-inflammatories that work on chronic conditions and have no effect on
inhibiting ovulation) (Espey 1994).
It is the LH surge that triggers these inflammatory changes around the preovulatory
follicle. The LH surge starts several hours prior to the physical act of follicle rupture
and oocyte release (the time span varies in different species). During this time physical
changes are occurring to the cells of the follicle and the surrounding tissue. There are
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five layers of cells that must be breached at ovulation; these are the OSE, the tunica
albuginea, the theca externa, the theca interna and the granulosa layer (Espey 1994).
These layers have associated collagenous ECM structures such as basement membranes
that must be broken down for ovulation to occur. The inflammation of ovulation
initiates protease activity that breaks down these tissue layers (Espey & Richards 2006).
As ovulation is imminent, the follicle wall becomes very thin due to degradation and the
follicle bulges from the surface of the ovary (Espey & Richards 2006). The LH surge
causes the fibroblasts in the collagenous tissues to be activated and proliferate leading to
the weakening of the follicle wall and eventual rupture of the follicle (Espey 1994).
Many genes involved in processes of inflammation in the body are evident in the process
of ovulation. Interleukin-1 (IL-1) is a pro-inflammatory cytokine and will induce
ovulation in the rat while IL-1 receptor antagonists (IL-1RA) will reduce the incidence
of ovulation (Brannstrom et al. 1993; Peterson et al. 1993) Leukocytes are recruited to
the follicle shortly after the LH surge and are regulated by IL-1 (Brannstrom & Enskog
2002). Ovarian perfusion in vitro with leukocytes taken from the peripheral circulation
increases the ovulation rate 3-fold (Brannstrom & Enskog 2002). Other cytokines
expressed at ovulation are IL-6, granulocyte-macrophage colony-stimulating factor
(GM-CSF) and tumour necrosis factor-alpha (TNF-a) (Brannstrom et al. 1994).
Prostagladins are also key mediators in inflammation and their production is regulated
by the LH-dependent cyclooxygenase-2 (COX-2) enzyme. Ovulation is prevented by
inhibition of prostaglandin biosynthesis by non-steroidal anti-inflammatories and
antisera to prostaglandin will also prevent follicle rupture (Sirois et al. 2004). Selective
COX-2 inhibitors prevent ovulation in mice, showing inhibition of prostaglandin
production is at the level of COX-2 (Sirois et al. 2004). The COX-2 null mouse fails to
ovulate (Lim et al. 1997) but this phenotype is rescued by the administration of
exogenous prostaglandin (Davis et al. 1999). All this evidence indicates that
inflammation is a key feature of ovulation.
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1.2. Anti-inflammatory mechanism of ovulation
Since ovulation is an inflammatory event, the ovary must be able to resolve this
inflammation before each new ovarian cycle begins.
Work in human OSE cells has shown that the active glucocorticoid, Cortisol, down-
regulates pro-inflammatory associated genes and up-regulates anti-inflammatory
regulators (Rae et al. 2004b). Progesterone also causes down regulation of pro¬
inflammatory induced genes in these cells but has no effect on anti-inflammatory
regulators (Rae et al. 2004b). This suggests that glucocorticoids with the assistance of
progesterone play a major role in inflammatory resolution.
1.2.1. Glucocorticoids
Glucocorticoids have many important functions emphasised by the fact that most cells in
the body possess receptors for these hormones. Glucocorticoids stimulate
gluconeogenesis which results in glucose formation from amino acids and lipids. They
also induce enzymes that metabolise these substrates from tissues and are involved in
glucose conservation. Active glucocorticoids are produced in acute periods of stress in
response to the 'fight-or-flight' mechanism. This burst of 'stress hormone' causes a
rapid increase in energy and immunity, heightened cognitive function, a lowering in pain
threshold and maintains homeostasis in the body; all of which lead to an increased
chance of survival in an adverse environment (Alberts et al. 1997). Glucocorticoids
have anti-inflammatory actions that are mediated through interaction with the
glucocorticoid receptor (GR) (Cato & Wade 1996). Anti-inflammatory glucocorticoids
inhibit the synthesis of prostaglandins and pro-inflammatory cytokines in the ovary
(Goppelt-Struebe 1997; Telleria et al. 1998). Glucocorticoids also have
immunosuppressive properties and these two properties have led to the use of
glucocorticoids in autoimmune and inflammatory diseases.
The fact that glucocorticoids have so many functions in the body highlights the
importance of understanding how they are regulated and influence different biological
processes.
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1.2.1.1. Glucocorticoid synthesis and regulation
1.2.1.1.1. The synthesis of glucocorticoids
Glucocorticoids are synthesised in the adrenal cortex from precursor cholesterol (Brook
& Marshall 2001). The synthesis and secretion of glucocorticoid by the adrenal gland is
stimulated by adrenocorticotrophic hormone (ACTH) from the pituitary gland (Brook &
Marshall 2001). ACTH causes an increase in the production of cholesterol side-chain
cleavage (CYP11A1) that converts cholesterol to pregnenolone (Fig. 1.5) (Brook &
Marshall 2001; Michael et al. 2003; Miller 1988). In the adrenal gland of most
mammals, pregnenolone can either be converted to 17a-hydroxypregnenolone via 17a-
hydroxylase (CYP17) or to progesterone via 3P-hydroxysteroid dehydrogenase (3pHSD)
(Fig. 1.5) (Brook & Marshall 2001). The exception to this is in the rodent, in which
CYP17 is not produced in the adrenals (Keeney et al. 1995). Therefore, in the rodent
adrenal pregnenolone is only converted to progesterone. Glucocorticoids are produced
from either progesterone or 17a-hydroxyprogesterone substrates via the enzymic
activities of 21-hydroxylase (CYP21) (Brook & Marshall 2001) and 11 fS-hydroxylase
(CYP11B1). Glucocorticoids principally circulate in human blood as 'active' Cortisol
and 'inactive' cortisone. As discussed below in the rodent, the active glucocorticoid is
corticosterone and the inactive form deoxycorticosterone. The difference between
human and rodent glucocorticoids is the absence of the hydroxyl groups at position C17
in the rodent, but the biological actions are the same (Michael et al. 2003).































Figure 1.5. Principal pathways of steroid biosynthesis. The steroid metabolism
conversion pathway. Precursor molecules are shown in grey, progestins in orange,
androgens in blue, oestrogens in purple, glucocorticoids in green and mineralocorticoids in
pink. Metabolising enzymes are shown against directional arrows. Adapted from source
www.mwcpharmacy.com/Hormone_Pathway.htm
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1.2.1.1.2. Regulation of glucocorticoid activity
A number of mechanisms regulate glucocorticoid formation and function. ACTH from
the pituitary gland acts directly on the adrenal gland to maintain blood levels of
glucocorticoids, which negatively feed back via the hypothalamic-pituitary-adrenal axis
to regulate ACTH release. Cortisol and corticosterone in the plasma bind with high
affinity to corticosteroid-binding globulin (CBG) and with low affinity to albumin,
which together regulate the bioavailability of glucocorticoids as well as transporting
these steroids around the body (Andersen 2002; Ho et al. 1999). In the human, CBG
binds 80% or more of the circulating Cortisol with albumin binding 14% and only 6%
circulating free (Lewis et al. 2005). In rodents, corticosterone usually circulates bound
to CBG whereas 11-dehydrocorticosterone circulates unbound (Kotelevtsev et al. 1997).
CBG protects glucocorticoids from degradation in the circulation. CBG-bound
glucocorticoid is not available to GR, thereby CBG helps determine the amount of
glucocorticoid circulating for action on target tissues.
At the tissue level, pre-receptor metabolism via cellular 11 P-hydroxysteroid
dehydrogenases (lipHSD) isoforms further regulates the bioavailability of
glucocorticoids to bind and activate GR. There gre two isoforms of the 11PHSD enzyme
produced by different genes; lipHSD type 1 (lipHSDl) and lipHSD type 2
(11PHSD2). They are biochemically different from one another and share only 30%
homology at the amino acid level (Kotelevtsev et al. 1997). Both 11 pHSDs are members
of the alcohol dehydrogenase superfamily (Penning 1997) and the mechanism by which
they regulate glucocorticoid activity is summarised in Figure 1.6. 1 lpHSDl functions
as either a dimer or a tetramer predominantly to produce active glucocorticoids by
NADPH-dependent reduction of the 11-keto-steroid (cortisone/11-
dehydrocorticosterone). lipHSDl is bidirectional and can also inactivate
glucocorticoids, the direction of conversion being dependent on the NADP(H) state of
the cell (Michael et al. 2003), and the low binding affinity of 1 lpHSDl for Cortisol or
corticosterone (Stewart & Mason 1995). In intact cells the main direction of conversion
catalysed by lipHSDl is from inactive to active. 11PHSD2 is a NAD+-dependent 11P-
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dehydrogenase and works only in a unidirectional manner to inactivate glucocorticoids
(Albiston et al. 1994). 11 {3HSD2 has a high binding affinity for Cortisol or corticosterone
(Stewart et al. 1994). Since 11(3HSD1 and 11 (3HSD2 essentially catalyse glucocorticoid







Figure 1.6. The glucocorticoid shuttle in the rodent. 11(3HSD1 mainly converts the
inactive glucocorticoid deoxycorticosterone to the active form corticosterone and 11PHSD2
inactivates corticosterone. Therefore relative presence determines availability of steroid to
act in target cells via the GR.
Actions of adrenal glucocorticoids and mineralocorticoids (which are involved in
regulating electrolytes and water balance) are transduced through intracellular receptors
that are members of the nuclear receptor family of ligand-dependent transcription factors
(Schaaf& Cidlowski 2003): GR and mineralocorticoid receptor (MR). GR mediates the
many different cellular functions associated with glucocorticoid action and selectively
binds glucocorticoids. Two isoforms ofGR exist: -a and -(3; of which GRa is the active
receptor (Pujols et al. 2004). MR mediates the actions of the mineralocorticoid
aldosterone, which is responsible for sodium resorption and electrolyte excretion. MR
and GR share a high degree of homology and have a similar binding affinity for
glucocorticoids and aldosterone. Therefore, a local level of regulation needs to be in
place to protect MR being engaged by glucocorticoid. The 11|3HSD isoforms serve this
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role. Thus in glucocorticoid target organs such as the liver 11 [1HSD1 provides active
glucocorticoids to stimulate the GR (Whorwood et al. 1992), whereas in
mineralocorticoid target organs such as the kidney and placenta 1 I [IIISD2 protects the
MR from being stimulated by glucocorticoids (Shimojo et al. 1997; Stewart & Mason
1995). This highlights the critical role of pre-receptor metabolism in glucocorticoid
action.
1.2.1.2. Glucocorticoids in the ovary
The ovary does not express 21-hydroxylase (CYP21) and therefore is unable to
synthesise glucocorticoids de novo (Omura & Morohashi 1995). However, this tissue
does possess a glucocorticoid shuttle. Ovary can be both glucocorticoid and
mineralocorticoid target organ depending on the levels of follicular activity (Tetsuka et
al. 1999b). Immature follicles are probably protected from the effects of circulating
glucocorticoids by 11(5HSD2 whilst ovulation-associated inflammation is thought to be
resolved by anti-inflammatory glucocorticoids generated by llpHSDl (Tetsuka et al.
1999b).
Glucocorticoids can be inhibited in ovarian cells by the actions of gonadotrophins and
steroids (Hsueh & Erickson 1978; Michael et al. 1993). The type of 11 (3HSD expression
in granulosa cells (hence potential for glucocorticoid activation) is dependent on their
degree of gonadotrophin-induced differentiation (Michael et al. 2003). Granulosa cells
that have not been exposed to the LH surge express both 11 [3HSD2 and MR (Tetsuka et
al. 1999b; Tetsuka et al. 1997). After the LH surge the expression of 11PHSD2
decreases and llpHSDl becomes the predominant isoform (Tetsuka et al. 1999b;
Tetsuka et al. 1997; Yong et al. 2000). There is also a decrease in the expression of MR
whereas GR expression being constitutive is relatively stable (Tetsuka et al. 1999b;
Tetsuka et al. 1997). This all contributes to a net increase in activation of the
glucocorticoids in the ovary as ovulation approaches. Yong et al (2000) showed that
theca cells from human periovulatory follicles could not convert cortisone to Cortisol but
immature theca cells could convert Cortisol to cortisone. 11PHSD2 protein has been
localised to human theca cells with immature cells having lower levels than more mature
Chapter 1 Review of Literature 15
cells (Ricketts et al. 1997). Therefore these cells presumably require protection from
glucocorticoid stimulation. By studying immature human granulosa cells in vitro it was
shown that hFSH caused an increase in the activity of 11PHSD1 in these cells and hLH
causes an increase in 11 |3HSD1 in periovulatory granulosa cells (Yong et al. 2000).
Free Cortisol levels in follicular fluid increase once the LH surge has occurred and
ovulation approaches, perhaps indicating disassociation from CBG (Harlow et al. 1997;
Yong et al. 2002). This could occur due to the excessive levels of progesterone present
in the follicular fluid at this time. Thus CBG has a higher affinity for progesterone than
Cortisol such that Cortisol is displaced when excess amounts of progesterone are present
(Andersen 2002). CBG may also be inactivated due to cleavage by proteolytic enzymes
that are active in the preovulatory follicle, which would also increase the free Cortisol
level (Hammond et al. 1990).
Intrafollicular changes in llpHSD isoform expression are not only regulated by
gonadotrophins but also by pro-inflammatory cytokines such as IL-1, in an
inflammatory cascade (Hillier 2003). Cultured rat granulosa cells show an increase in
11 (3HSD1 expression when stimulated with gonadotrophins (Tetsuka et al. 1999b). This
is increased further by the addition of IL-1 to the culture and attenuated by the presence
of IL-1RA (Tetsuka et al. 1999a). Also by studying human OSE cells, which are sites of
inflammation-associated damage at ovulation, an increase in the expression of 11 [3HSD1
was observed in response to IL-1 (Rae et al. 2004a; Rae et al. 2004b; Yong et al. 2002).
When Cortisol was also added to these cultures an enhanced IL-1-induced increase in
11 pHSD 1 was seen, while Cortisol alone had no effect (Rae et al. 2004b). This indicates
that human OSE cells in an inflammatory environment (created by the presence of IL-1)
will increase their own production of Cortisol to resolve inflammation.
All of this points to a local role for anti-inflammatory glucocorticoids at the time of
ovulation, principally due to up-regulate 1 1PHSD1.
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1.3. Collagen Pathway Biology
Collagens are major components of connective tissues that are subject to inflammatory
remodelling such as bone, tendon and ligament. However, collagens also have other
important biological roles such as regulating cell adhesion, differentiation, growth and
survival (Gelse et al. 2003). Through the receptor-like properties they possess, they also
serve as reservoirs for substances the body requires during growth and development.
Finally, the non-structural collagens can have roles in modulating tumorigenesis and
angiogenesis (Gelse et al. 2003). Therefore, collagens are essential components of any
functional tissue system, and it is important to understand how they are synthesised and
processed to accomplish their biological actions. Moreover, an understanding of normal
function should lead to a better appreciation of states of disease. However, since
collagen biology covers such a diverse field only a brief overview of the topic can be
given here. Key collagen pathway components relevant to this investigation are collagen
type IV, lysyl oxidase (LOX), bone morphogenetic protein-1 (BMP-1) and procollagen
C-proteinase enhancer protein (PCPE).
1.3.1. Collagen
Collagens are insoluble extracellular glycoproteins that are the most abundant proteins in
the body. To date at least 27 vertebrate collagens have been identified (Myllyhaiju &
Kivirikko 2004). Collagen polypeptide chains comprise Gly-Xaa-Yaa repeats in which
the Xaa and Yaa are usually proline and hydroxyproline, which limit the amount of
rotation of the collagen chains (Canty & Kadler 2005; Prockop & Kivirikko 1995).
Collagen forms a left-handed helix which combines with other primary polypeptide units
to form a right-handed elongated triple helix (Prockop & Kivirikko 1995). The member-
chains can be repeats or products of different collagen genes.
Collagens fall into 6 different categories; fibril-forming, basement membrane,
microfibrillar, anchoring, transmembrane and fibril-associated (Gelse et al. 2003).
(Only fibril-forming collagens and basement membranes will be discussed in this
review. For a review of the other types of collagen, refer to Gelse et al (2003). The
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different forms of collagen vary in their diversity and complexity due to additions of
non-collagen domains.
The most abundant collagens are the fibril-forming collagens that give bone and
cartilage their tensile strength. The fibril-forming collagens are types I-III, V and XI,
with type I being the most abundant and well-studied. Collagens have large helical
domains which confer strength to biological structures. Type I is an abundant,
ubiquitous collagen whereas the other fibrillar collagens are more tissue-specific
(Prockop & Kivirikko 1995). The importance of collagen type I is highlighted in
homozygous mice with deleted expression of COL1A1. These mice die in utero.
Moreover even though heterozygous mice survive, their bone strength is subnormal and
they have loss of hearing (Prockop & Kivirikko 1995).
The important collagen in basement membranes is type IV collagen, which forms the
flexible meshwork of these structures. Basement membranes form divisions between
cellular structures but also function to determine cell polarity and anchorage, forming
barriers or filters and templates for cell migration (Alberts et al. 1997).
1.3.1.1. Processing of collagen
Investigations into how collagens are processed have mostly focused on collagen type I
but similar mechanisms are believed to apply to other collagens, though one must
appreciate that significant differences may occur. Collagen type I is used as an example
in this text.
The box below summarises collagen biosynthesis, from transcription through to helix
formation.
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Box 1. Summary of key steps involved in collagen biosynthesis and maturation (adapted from
Gelse et al (2003) and Trackman (2005)).
1. Transcription and translation
| • regulation of collagen genes
2. Post-translational modifications
• hydroxylation (3- and 4-hydroxylases/lysyl hydroxylase) forms
intramolecular hydrogen bonds; intermolecular cross-links between
fibrils; create sites for carbohydrate attachment.
• Glucosylation and galactosylation
• Conformational folding (peptidyl-prolyl cis-trans
isomerase/chaperones)
• Disulphide bond formation (disulphide isomerase) forms inter- and
intra-bonds in procollagen.
3. Secretion
\ • Via secretory vesicles into the extracellular space
4. Cleavage
• Procollagen domain cleavage (Procollagen C-proteinase/
Procollagen N-proteinase)
5. Fibril formation
| • Spontaneous aggregations form ('self assembly')
6. Stabilisation
• Covalent cross-linkage (LOX) creates mechanical resilience.
From this summary, it can be seen that collagen protein is subject to many modifications
before it can fulfil its roles in the body. The foci of this investigation are the extracellular
modifications of collagen, in particular the proteins involved in its cleavage and
stabilisation.
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The triple helices of the fibril-collagens formed intracellularly are flanked by non-
col lagenous globular protein domains (Gelse et al. 2003), the C-propeptide and the N-
propeptide (Fig. 1.7), which keep procollagens in a soluble form until they are cleaved
after secretion from the cell. The propeptides are linked to the collagen helices by
telopeptides, which may be involved in forming covalent cross-links once the
procollagen has been processed or/and may link to other structures (Gelse et al. 2003).













Figure 1.7 The molecular structure of fibrillar procollagen. Adapted from (Gelse et al. 2003).
If prodomains are not removed, collagen cannot assemble into helices (Prockop et al.
1998). Procollagen undergoes two different point cleavages. The cleavage at the N-
terminus is accomplished by A Disintegrin and Metalloproteinase with Thrombospondin
I Motifs (ADAMTS) family members, while the C-terminus is cleaved by BMP-1
(Prockop et al. 1998). Removal of the C-terminal is critical for collagen assembly and is
therefore more efficient than N-terminal removal (Kadler et al. 1987).
1.3.1.1.1. Procollagen N-proteinase
The N-terminus of procollagen is cleaved by ADAMTS-2, -3, and -14. ADAMTS
proteins have zinc metalloproteinase domains that are required to cleave procollagens
and have a binding site for integrins (Colige et al. 1997). ADAMTS proteins are
activated through cleavage by furin, then go on to cleave the proforms of collagens I, II,
111 and V (Colige et al. 2005). All three of the ADAMTS proteins act on procollagens 1,
II and III, whilst ADAMTS-2 also acts on procollagen V (Colige et al. 2005). Each of
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these enzymes are expressed in a tissue-specific manner (Trackman 2005). Mice null
for ADAMTS-2 have brittle skin due to a lack of collagen type I cleavage and fibrils not
increasing in diameter, so tensile strength is lost (Porter et al. 2005). Presumably
ADAMTS-3 and -14 are not present in the skin as they do not compensate for the lack of
ADAMTS-2 (Li et al. 2001), confirming that different tissues require different members
of these procollagen N-proteinases for cleaving procollagen. Interestingly, female
ADAMTS-2 knockouts are fertile but males are sterile due to a lack of mature sperm (Li
et al. 2001). This perhaps indicates that these proteins have roles other than procollagen
cleavage or that fibrillar collagen is important in spermatogenesis. These proteinases
appear only to cleave procollagens that are in their native folded conformations
(Prockop et al. 1998).
1.3.1.2.2. Procollagen C-proteinase
Procollagen C-proteinase (PCP), also known as BMP-1, is fundamental for the assembly
of the ECM (Kessler et al.1990). The importance of BMP-1 is highlighted by the fact
that mice null for this gene die shortly after birth due to abnormal collagen
fibrillogenesis (Suzuki et al. 1996).
BMP-1 differs structurally from other BMPs. It is unrelated to TGF-[S, and is a member
of the astacin family of the zinc-requiring metalloproteinase endopeptidases (Li et al.
1996). Astacin proteins are important in early developmental decisions that coordinate
embryo development as well as embryonic hatching and dorsal-ventral patterning (Li et
al. 1996).
BMP-1 processes collagens and noncollagenous molecules of the ECM (Medeck et al,
2003). As shown in Fig. 1.8, BMP-1 cleaves the C-terminus of procollagens I, II, III, V
and XI. At the same time, the N-terminus is cleaved by procollagen N-proteinase thus
forming active collagens (Medeck et al. 2003). By removing the C-terminus of
procollagen, BMP-1 reduces the solubility of the peptide (Prockop & Kivirikko 1995),
thus allowing the collagen helix to form into an ordered unit (Trackman 2005). When
BMP-1 was inhibited in MC3T3-E1 cells collagen assembly was profoundly affected
(Pischon et al. 2005). The collagen in these cells had retained C-terminal domains,
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resulting in an increase in fibril diameter presumably due to improper alignment
(Pischon et al. 2004). BMP-1 also processes probiglycan, the y2 and a3 laminin chains,
chordin and prolysyl oxidase. These are all involved in ECM formation. Trackman
(2005) hypothesises that BMP-1 involvement in so many different aspects of ECM
maturation affords an economically sound strategy for fundamental control, which also









Procollagen C ► Collagen
Figure 1.8. BMP-1 action on the C-terminal of
procollagen, resulting in active collagen.
BMP-1 action on procollagens is enhanced by PCPE, a glycoprotein found in connective
tissues (Moschcovich et al. 2001 ). Three other BMP-1 related proteinases, mammalian
tolloid (mTLD), tolloid-like 1 (mTLL-1) and tolloid-like 2 (mTLL-2) also have
procollagen C-proteinase activity with varying substrate specificity (Uzel et al. 2001).
All members of the astacin family contain an N-terminal astacin-like metalloproteinase
domain, an epidermal growth factor (EGF)-like motif and C-terminal embryonic sea
urchin protein Uegf, BMP-1 (CUB) domains (Takahara et al. 1994). BMP-1 has three
CUB domains, with CUB2 and CUB3 being separated by an EGF-like domain (Hartigan
et al. 2003). Investigations into the structure of BMP-1 using domain-swapping
techniques show that for BMP-1 to be secreted the CUB1 domain is needed, positioned
next to the metalloproteinase domain. CUB3 and the EGF-like domain are not essential
for activity but CUB2 is necessary for BMP-1 C-proteinase function (Hartigan et al.
2003).
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1.3.1.2.2.1. Processing of BMP-1
BMP-1 is synthesised as an inactive proenzyme (Bond & Beynon 1995). Leighton and
Kadler (2003) have demonstrated that the prodomain is rapidly cleaved by furin-
like/paired basic proprotein convertases in the trans-Golgi network. This rapid
conversion may allow active BMP-1 to work efficiently in the local ECM. Regulation of
furin may be a control mechanism for assembly of the ECM (Leighton & Kadler 2003).
By inhibiting furin, BMP-1 was secreted in an inactive form, as demonstrated by the
lack of procollagen cleavage (Leighton & Kadler 2003). Therefore it is interesting that
the prodomain does not have to be cleaved for BMP-1 to be secreted from the cell
(Leighton & Kadler 2003). This may maintain the enzyme in an inactive form, so that it
is only cleaved when activation is required.
1.3.1.3.1. Procollagen C-Proteinase Enhancer
PCPE enhances BMP-1 action on procollagen and two PCPE proteins have been
identified: PCPE-1 and -2. Both are glycoproteins of the ECM that stimulate the
processing of the C-terminus of procollagens (Steiglitz et al. 2002; Moschcovich et al.
2001; Kessler & Adar 1989). The two PCPEs are comparable structurally (43%
homology) and have similar functions but it appears that PCPE-2 is not as widely
expressed as PCPE-1 (Steiglitz et al. 2002; Trackman 2005). Unless otherwise stated, it
is PCPE-1 that is referred to in the following text.
1.3.1.3.1.1. PCPE function on BMP-1
PCPE does not have inherent proteolytic activity (Kessler & Adar 1989; Moschcovich et
al. 2001), but it binds to C-propeptide domains of procollagens where it enhances the
proteolytic effect of BMP-1 (Fig 1.9) on procollagen up to 20-fold (Kessler & Adar
1989; Ricard-Blum et al. 2002). PCPE recognises not only the amino acid sequence of
BMP-1 but also its three-dimensional structure (Moali et al. 2005).
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BMP-1
Collagen
Figure 1.9. PCPE enhancement of the BMP-1 cleavage of
the C-terminal of procollagen.
PCPE has two CUB domains and a netrin (NTR)-like module (Banyai & Patthy 1999;
Takahara et al. 1994) arranged in a rod-like structure (Bernocco et al. 2003). To date,
the exact mechanism by which PCPE enhances BMP-l activity on procollagen is
unclear. It is postulated that it might be due to the CUB domains, as these domains can
mediate protein-protein interactions (Takahara et al. 1994). PCPE binds in a l: 1 ratio
with BMP-1 at the N-terminus of the molecule, although PCPE is not thought to enhance
BMP-1 activity directly (Moali et al. 2005; Ricard-Blum et al 2002). Structural studies
of PCPE show that it binds to both the BMP-1 and the procollagen molecule. It is also
proposed that PCPE causes a structural change in the C-terminus of procollagen to allow
BMP-1 to bind and cleave the pro-domain (Ricard-Blum et al. 2002) (Adar et al. 1986).
Because PCPE stimulates C-terminal processing of several procollagens it probably
shares a common recognition site on procollagens (Moali et al. 2005).
The NTR module may inhibit MMPs as it is homologous to tissue inhibitors of MMPs
(TIMPs) (Banyai & Patthy 1999) and fragments of C-terminal PCPE (CT-PCPE) (16.5
kDa) isolated from human brain tumour had characteristics of TIMPs (Mott el al. 2000).
The CT- PCPE fragments were shown to inhibit MMP-2 in solution with an IC50 value
of 560nM, which probably indicates that this is not its principal target (Mott et al. 2000).
Full-length PCPE did not have TIMP activity, nor did the 34kDa or 36kDa fragments
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that are thought to enhance BMP-1 (Hulmes et al. 1997; Mott el al. 2000), suggesting
that the C-terminus only has this function if cleaved from the rest of the protein. The
possible TIMP-like activity of PCPE suggests that this molecule may have multiple roles
in facilitating ECM maintenance and accumulation.
1.3.1.3.1.2. Other functions of PCPE
PCPE works in a 1:1 ratio with BMP-1 yet in fibroblasts it is expressed to a greater
degree than BMP-1 (Takahara et al. 1994). Also, investigations into the temporal
expression patterns of PCPE and BMP-1 in bone showed differences in their patterns of
expression, suggesting additional roles for PCPE (Scott et al. 1999). Matsui et al (2002)
postulated that PCPE may regulate protein synthesis in hepatic stellate cells (E1SC), as
the PCPE molecule has RNA-binding motifs in its sequence and reduced expression of
PCPE appeared to suppress the levels of both collagenous and non-collagenous
synthesised proteins. PCPE expression, elevated in Rat2 cells using a retroviral vector,
resulted in changes in cell morphology, contact inhibition and anchorage-independent
growth, indicating that PCPE may act as a tumour suppressor (Masuda et al. 1998;
Trackman 2005).
1.3.2. Collagen stability
Collagen is synthesised, processed, formed into helical structures and incorporated into
the ECM. It must then be stabilised and held in position so that it can serve its tensile
role. As previously stated, this is accomplished by: hydroxylases, glycosyltransferases
and an oxidase (Myllyharju & Kivirikko 2004).
The formation of stabilising covalent cross links between collagen fibrils is catalysed by
LOX through oxidative deamination of lysine residues in collagen and elastin fibrils
(Siegel 1976).
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1.3.2.1. Lysyl oxidase
LOX is a copper-dependent amine oxidase that catalyses critical post-translational
alteration needed to generate connective tissue matrices (Smith-Mungo & Kagan 1998).
It is also linked with the following: cancer cells (Kirschmann et al. 1999), healing
(Kagan et al. 1981), motility and migration of cells (Jo el al. 2004), and cell
differentiation (Omori et al. 2002). This array of functions indicates that LOX is a multi¬
functional protein. The LOX gene is highly conserved between mouse, rat and human,
showing that this gene has evolutionary importance (Chinoy et al. 2000).
1.3.2.1.1. Mechanism of LOX cross-linking
In the ECM, LOX catalyses the covalent cross-linking of elastin and collagen fibrils.
LOX substrate specificity could be low as the sequence surrounding lysine residues
present in collagen and elastin are very different. So too are their physical structures and
it has been shown that LOX will oxidise lysine peptides in an array of basic globular
proteins (Kagan et al. 1984), indicating that LOX has other potential roles other than to
covalently cross-link collagens. Cross-linking is achieved by oxidative deamination of
peptidyl lysine found in elastin and collagen to peptidyl a-aminoadipic-8-semialdehyde
(AAS) (Smith-Mungo & Kagan 1998). The stoichiometry of this reaction is shown in
Fig. 1.10A.


























Figure 1.10. The peptide cross-linking achieved by LOX. A, The
stoichiometry of the LOX catalysed reaction from a pepitidyl lysine to
a peptidyl AAS. B, the spontaneous formation of cross-links.
Adapted from Lucero and Kagan (2006).
This aldehyde spontaneously condenses with other amino groups or peptidyl aldehydes
forming the covalent cross-linkages between fibrils (Kagan et al. 1986). This is achieved
by condensation with an unmodified lysine forming the anhydrolysinonorleucine
(deLNL) cross-link and two AAS residues that form an alcohol condensation product
(ACP) (Fig. 1.10B). Therefore, LOX may be a controlling factor in ECM accretion and
stability, as a cross-linked matrix is less vulnerable to proteolysis. This is supported by
inhibiting LOX which retains collagen in its soluble and easily degradable form (Vater
et al. 1979).
LOX requires two co-factors to function: copper (Cu2+) and lysine tyrosylquinone
(LTQ), which is derived from tyrosine and lysine residues (Lucero & Kagan 2006). If
Cu2+ is not bound to LOX, the enzyme is inactive (Smith-Mungo & Kagan 1998). LTQ
is formed within the nascent LOX enzyme and links Lys 314 to Tyr 349 via a quinine
ring creating a transient electron sink in the catalytic mechanism of LOX (Lucero &
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Kagan 2006). LOX is classified kinetically as a "ping-pong" catalyst, as it carries out
amine oxidation in two kinetically distinct steps (Williamson & Kagan 1986). These
general steps are summarised below:
• RCH2NH2 + EriZoxidised ^ RCH==0 + EnZReduced
• EnZReduced + O2 + H2O EnZoxidised + H2O2 + NH3
The mechanism of LOX action in relation to the ping-pong catalytic mechanism is
summarised below in Box 2, to show how Cu2+ and LTQ are integral factors in
producing covalent cross-links (Lucero & Kagan 2006).
Box 2. Key stages in LOX catalysed cross-linkage of collagen fibrils
1. A Schiff base is formed with LTQ, which undergoes a rate-limiting general
base facilitated a-proton abstraction resulting in a reduction of LTQ.
2. Hydrolysis of the imine intermediate releases the reactive AAS product
(to form spontaneous cross-links) from the reduced LTQ.
3. The reduced enzyme is re-oxidised with the aid of Cu2+ (electron transfer)
forming and releasing H2O2.
4. The enzyme is then hydrolysed producing NH3 and the cycle is
completed as LTQ is regenerated.
It is thought that the oxygen-dependent reoxidation of this reaction could be rate limiting
for LOX catalysis (Shah et al. 1993).
Chapter 1 Review of Literature 28
1.3.2.1.2. Biological functions of LOX
As LOX causes covalent cross-linking of collagen and elastin, it is obviously important
in wound healing. In osteoblast cultures LOX increases dramatically just prior to
increasing collagen deposition (Trackman 2005). Studies into wound healing in
longitudinal injuries to the rat forebrain have shown that LOX is secreted
spatiotemporally by cells in the injury locus (Gilad et al. 2001). When the central
nervous system (CNS) is injured, scarring results from the deposition of collagen (Gilad
et al. 2001). If the amount of collagen present at an injury site is reduced, less scarring
occurs (Stichel & Muller 1998). Therefore as LOX causes collagen cross-linking it
would be reasonable to presume that inhibition of LOX would also reduce scarring.
This has been confirmed using P-aminoproprionitrile (BAPN) an irreversible inhibitor of
LOX to inhibit LOX in a unilateral spinal cord injury. This resulted in an increase in
healing and better functional recovery (Gilad & Gilad 2001). Also when atherosclerosis
was induced in rabbits by continual feeding of an atherogenic diet, LOX activity
measured in aortas increased detectably after 30d, and peaked at 90d (Kagan et al.
1981). Evidence that LOX activity is increased in the blood vessel walls and plaque-like
structures of people with Alzheimer's disease suggests that LOX is associated with the
ECM and may be instrumental in plaque formation (Gilad et al. 2005).
LOX has also been shown to be involved in fibrotic diseases (Smith-Mungo & Kagan
1998). LOX was greater in sclerodermatous (scaly) skin than in normal skin (Chanoki et
al. 1995) and was increased in the inflammatory oedematous stage (when mononuclear
cells are surrounding the collagen fibres of the fibrosis) rather than in the sclerotic stage
(when collagen becomes tightly packed) (Chanoki et al. 1995). LOX mRNA and
activity were also increased in synthetic liver fibrotic models compared to normal liver
(Wakasaki & Ooshima 1990).
Even though LOX is instrumental in the cross-linking of collagen and elastin, recent
research has shown that LOX may also have other functions, which are summarised
below.
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1.3.2.1.3. LOX and cancer
A role for LOX in cancer was first recognised when the murine LOX gene was shown to
be identical to the murine ras recision gene (rrg), which is a recognised tumour
suppressor (Contente et al. 1990). Ras induces DNA synthesis in the nuclei of inactive
cells to cause proliferation (Malumbres & Pellicer 1998). rrg regulates the expression of
ras by working through the ras signalling pathway (Contente et al. 1990). The mode of
regulation appears to be by suppression of ra.s-induced proliferation to prevent a
cancerous phenotype developing (Contente et al. 1990). Palamakumbura et al (2004)
have shown that it is the released LOX propeptide that is responsible for the effects on
ras, and not the active enzyme. BAPN does not have an inhibitory effect on these
actions of LOX indicating that this property of LOX is completely removed from the
enzyme acting on the ECM (Li et al. 2003). The rrg/LOX gene is expressed at lower
than normal levels in human malignant cell lines (Contente et al. 1990; Hamalainen et
al. 1995; Kenyon et al. 1991). In many cancers, the chromosome that LOX is located on
is deleted at high frequencies and the LOX promoter can be heavily methylated,
indicating two methods of down-regulating LOX in tumour cells (Kaneda et al. 2004;
Wieland et al. 1996). Recent work on microRNAs (miRNA) has show that the LOX
gene promoter contains a single miRNA binding site that is down-regulated in many
cancers, indicating another element of LOX control by cancer cells (Dalmay & Edwards
2006). LOX also has anti-mitogenic effects on basic fibroblast growth factor (bFGF) by
oxidising lysine residues, resulting in a loss of cell cycle progression and growth in
fibroblasts and tumour cell lines (Li et al. 2003). Other identified intracellular substrates
are histones. Therefore LOX could potentially influence histone-DNA interactions and
ultimately gene transcription (Giampuzzi et al. 2003). LOX may act to stop abnormal
growth of cells and could provide a possible anti-tumorigenic mechanism.
Consequently, it appears to be a key target for down-regulation by tumorigenic cells.
Reports of LOX in different types of tumours do not follow a consistent expression
pattern indicating that the stage/type of the cancer and/or the tissue of origin may
influence LOX expression. In general LOX appears to be down-regulated in carcinomas
but up-regulated in invasive metastasis (Bouez et al. 2006; Erler et al. 2006).
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Expression and activity of LOX in malignant cell lines were down-regulated and LOX
expression and protein location in breast and skin cancer tumours was observed only in
the areas surrounding the tumour (Bouez et al. 2006; Hamalainen et al. 1995; Peyrol et
al. 1997). In early tumour stages LOX expression may act as a defence mechanism to
contain the tumour in a cross-linked matrix and the lack of LOX in later stages of
tumour invasion may allow the tumour to metastasise (Peyrol et al. 1997).
LOX is up-regulated in metastatic breast cancer compared to primary cancer tissues (Jo
et al. 2004). LOX has recently been associated with hypoxia-induced metastatic
development from breast cancer tumours in mice, as the inhibition of LOX prevented the
formation of metastasis (Erler et al. 2006). Interestingly, inhibition of LOX had no effect
on the primary tumour. Erler et al (2006) also showed that LOX mRNA was up-
regulated by hypoxia-inducible factor-1 (HIF-1). It is proposed that LOX could be a
tumour-secreted factor needed to form a permissive niche for metastatic growth (Erler et
al. 2006). LOX is required for focal adhesion kinase activation, which is involved in
cell survival and proliferation, as well as fibronectin activation, a possible ligand that is
instrumental in permissive niche formation (Kaplan et al. 2005), and of course, LOX is
vital for ECM formation, which would provide a repository of substances needed for cell
survival (Erler et al. 2006).
Evidence implies that LOX is regulated by tumours depending on their environment of
demands, so established cancers down-regulate this gene in order to metastasise. Then
the break-away cancer cells use LOX to form a favourable environmental niche where
these cells can proliferate. It would be predicted that once metastatic cells become
established at a new site, LOX is down-regulated.
1.3.2.1.4. Other functions of LOX
As LOX catalyses cross-linking, it produces hydrogen peroxide (H202) and ammonia (Li
et al. 2000). LOX can also translocate to cells where it is proposed that it might act on
an unknown substrate to form H202 (Li et al. 2000). In vitro vascular smooth muscle
cells migrate towards the H202 produced by LOX (Li et al. 2000). Human monocytes
also migrate towards LOX (Lazarus et al. 1995). This could help explain the role of
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LOX in atherosclerosis, as smooth muscle cells and monocytes are seen to migrate
across the endothelium of blood vessels to contribute to plaque formation (Lusis 2000).
Atherosclerosis is viewed as a response to injury with a pro-inflammatory environment
being produced and the resultant plaques are formed via production of ECM (Lusis
2000). LOX mRNA in other cell systems has been shown to increase in response to pro¬
inflammatory mediators, indicating how this enzyme might be controlled in
atherosclerosis (Rae et al. 2004a; Trackman et al. 1998). So, LOX could be contributing
to ECM stabilisation and cell migration in this disease.
When LOX is inhibited in highly invasive cancer cell lines, a decrease in cell motility
and adhesion is observed (Jo et al. 2004). More detailed investigations have shown that
LOX causes changes in the actin filament polymerisation of cells (Jo et al. 2004). This
chemoattractant property of LOX could be important to other aspects of LOX function
such as when substances need to be attracted to a particular tissue during wound healing.
1.3.2.1.5. Processing dynamics of LOX
LOX is synthesised as a 46kDa preproenzyme. This (precursor) preproenzyme then
undergoes cleavage of a signal peptide and N-glycosylation to produce a proenyzme of
50kDa (Smith-Mungo & Kagan 1998). The proenzyme is cleaved to a 32 kDa active
enzyme in the extracellular space by the metalloproteinase BMP-1 (Trackman et al.
1992). BMP-1 cleaves pro-LOX at the Gly-Asp bond in the N-terminus (Cronshaw et
al. 1995). If BMP-1 is inhibited, LOX activity but not mRNA expression will be
inhibited (Pischon et al. 2005). LOX processing is summarised in Figure 1.11.












Lysine ► Allysine = essential for tensile
strength and mechanical
stability
Figure 1.11. LOX processing summarised. LOX mRNA is translated into a preproenzyme
that is processed intracellular to proLOX, which moves into the extracellular environment
where it is cleaved by BMP-1 to form active LOX. Active LOX causes the covalent cross-
linking of collagen and elastin.
As previously described in section 1.3.1.2.2, fibril-collagens are cleaved by BMP-1.
Subsequently these collagens can then be oxidised by LOX (Moschcovich et al. 2001;
Siegel 1974; Smith-Mungo & Kagan 1998). Therefore, BMP-1 has a dual function in
the formation of stable collagen through cleaving susceptible procollagen substrate and
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Figure 1.12. How BMP-1 and LOX process collagen, which results in covalent cross-
linking of collagen in the ECM.
As previously stated, other proteinases similar to BMP-l include mTLD, mTLL-1 and
mTLL-2. These proteinases have been shown to exhibit procollagen C-proteinase
activity and can process pro-LOX (Uzel et al. 2001). BMP-1 has been shown to be the
most efficient processor of pro-LOX (Uzel et al. 2001). Culturing fibroblasts from mice
null for either BMP-1 or mTLL-1 (the next most efficient proteinase after BMP-1) or
null for both genes showed that active LOX was present in wild-type and single nulls but
the double null had a 70% decline in LOX activity. This evidence suggests that these
enzymes are responsible for the majority of LOX activation in fibroblasts (Uzel et al.
2001).
1.3.2.1.6. The existence of a LOX-like family
A series of genes highly related to LOX exists, suggesting that there is a LOX family
(Smith-Mungo & Kagan 1998). These genes are LOX-like (LOXL), LOXL2, LOXL3
and LOXL4. LOX genes probably share a common ancestor as close homology exists
between exon regions (Molnar et al. 2003; Saux et al. 1999). These proteins have
domains characteristic of LOX in the carboxy terminus, including a copper-binding
domain, lysyl-tyrosyl-quinoneresidues and a cytokine receptor-like domain (Maki et al.
2001; Saux el al. 1999){Asuncion, 2001 #223}(Kim et al. 1995). However, the N-
terminal domains appear to differ, suggesting that they have different biological roles
(Borel et al. 2001).
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Null LOX mice develop to birth then die shortly after due to aortic aneurysms (Maki et
al. 2002). Embryonic lungs from these mice are developmentally abnormal (Maki et al.
2005). Collagen and elastin are present in these mice but presumably not extensively
cross-linked, since cardiovascular irregularities result (Maki et al. 2002). The fact that
these mice survive to birth may indicate that other members of the LOX family
contribute towards cross-linking but presumably this is not sufficient to ensure further
survival. This indicates that LOX is the main instigator of biological cross-linking
especially in the vasculature.
The different structures and patterns of expression of the members of the LOX family
suggest that each member has specific biological roles that may help to regulate ECM
remodelling. This is demonstrated by LOX and LOXL2 being expressed in different
locations and at different times in fetal reproductive tissues (Saux et al. 1999).
However, there is still much work remaining to determine the functions of these LOX-
like proteins.
1.3.3. Extracellular Matrix
The ECM is a highly dynamic structure which constantly renews itself where tissue
repair occurs and interactions among many different cell types take place (Bosman &
Stamenkovic 2003b). The ECM has many roles including influencing differentiation,
development, migration, cell behaviour, fluid dynamics and mechanical support of
tissues. (Meredith etal. 1993; Ortega & Werb 2002; Irving-Rodgers et al. 2002 Rodgers
et al. 2000; Rodgers et al. 2003). In addition, nutrients and hormones must traverse the
ECM to reach target cells. Regulation of cellular mechanisms by the ECM is in part
through its ability to bind growth factors (Taipale & Keski-Oja 1997). Bound growth
factors are kept in a latent state in the ECM and are activated when disassociated from
the matrix by proteolytic release, allowing for rapid availability of signalling messages
(Lyons et al. 1988).
The composition and structure of the ECM is organ-specific and thus provides an organ-
specific microenvironment (Brown et al. 2006; Rodgers et al. 2000). The ECM has two
principal forms: basement membrane and interstitial matrix or connective tissue. The
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basement membrane is a condensed layer of matrix adjacent to and providing support for
parenchymal epithelial cells (Bosman & Stamenkovic 2003a). The interstitial matrix is a
fibrillar network that surrounds cells, allowing their movement in discrete tissue zones
as well as providing structural support (Schwarzbauer 1999). Both these matrix layers
have a collagen scaffold but the two scaffolds differ in composition (as described below)
(Bosman & Stamenkovic 2003a). The collagen network provides a backbone to the
matrix, which also consists of adhesive glycoproteins and proteoglycans that interact
with cells via matrix receptors such as integrins (Bosman & Stamenkovic 2003a). When
the ECM undergoes remodelling new signals are produced between basement membrane
and surrounding cells (Ortega & Werb 2002).
1.3.3.1. Components necessary for a functional ECM
1.3.3.1.1. Interstitial matrix
The interstitial matrix primarily supports cells and allows substrates required by these
cells to pass among them. This matrix is composed of collagens, elastin, fibronectin,
glycosaminoglycans (GAGs), proteoglycans and integrins. Collagens give tensile
strength to the interstitial matrix and elastin gives the matrix flexibility (Alberts et al.
1997). The collagens of the interstitial matrix are mainly types I, II and III. Different
matrices are composed of different types of collagen that confer the required properties
on the specific matrices such as collagen type I and III in skin. Fibronectin, which is
involved in matrix adhesion as well as cell migration and differentiation, has rigid and
flexible domains and binds heparin sulphate, collagen, hyaluronic acid and fibronectin
(Johansson & Hook 1980). GAGs are unbranched polysaccharides including hyaluronan
and heparin sulphate (Alberts et al. 1997). Proteoglycans are highly glycosylated
proteins that can influence the diffusion of small molecules through the matrix due to
their size. Integrins are transmembrane glycoproteins that connect the matrix to the
cytoskeleton (Hynes 1987). The diversity of components alludes to the importance of
the interstitial matrix not only as a structural support but also in creating
microenvironments and contributing to the regulation of biological processes.
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1.3.3.1.2. Basement membranes
Basement membranes are specialised thin layers of ECM that are found in association
with endothelial cells, epithelial cells, muscle fibres, adipocytes and nerves (Erickson &
Couchman 2000; Ortega & Werb 2002). They are found throughout the body, usually
between epithelial cells and mesenchyme, consequently compartmentalising tissues
(Kalluri 2003).
The basement membrane contains members of several different protein families, the
main components being collagen type IV, laminin, nidogen or entactin and heparin
sulphate proteoglycans (the main one of which is perlecan). Basement membrane
specificity is regulated by the composition and variety of matrix receptors (Gelse et al.
2003). It has been proposed that there are two networks of basement membrane, one
composed of collagen IV and the other of laminin, and these two structures are linked by
entactin-1 (Timpl & Brown 1996). Collagen IV is a major component of the basement
membrane and is discussed in detail in the next section of this review.
Laminins form gel-like aggregates made up of three chains (a, P and y), and each of
these chain types comprises different sub-chains, which can form many different laminin
molecules contributing to the diversity of the basement membrane and accounting for
much of its complexity (Irving Rodgers & Rodgers 2005). Laminin is responsible for
the adhesion of adjacent cells to the basement membrane, and is involved in cell
migration and differentiation (Bosman & Stamenkovic 2003a). Mice null for the
laminin gamma-1 subunit die in utero at day 6.5 due to disorganisation of the basement
membrane resulting in an absence of gastrulation, showing that laminin is necessary for
the development of the basement membrane (Smyth et al. 1999). Laminins signal to
cells via integrins. They thereby act as mediators between the ECM and the cells.
Nidogen links laminin to type IV collagen and perlecan, thereby maintaining the
integrity of the basement membrane (Gelse et al. 2003; Timpl & Brown 1996).
1.3.3.1.2.1. The importance of collagen type IV
Collagen IV, the major collagen associated with basement membranes, is highly
conserved between vertebrates and invertebrates and functions in cell migration and
adhesion (Gelse et al. 2003; Gould et al. 2005). It also has roles in angiogenesis and
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structural roles in the vasculature (Gould et al. 2005). Collagen IV appears to bind many
basement membrane components and is therefore suggested to be an essential structural
component (Brauer & Keller 1989). Each collagen IV monomer consists of a triple
helix made from three collagen IV a-chains (Hudson et al. 1993). Collagen IV itself
consists of 6 polypeptide chains (al-a6), encoded by three pairs of genes: COL4A1 and
COL4A2, COL4A3 and COL4A4, COL4A5 and COL4A6. Each gene-pair is arranged
in close proximity, head-to-head, sharing a bidirectional promoter that coordinates their
transcription via downstream transcription elements, as shown in Fig. 1.13. (Pollner et
al. 1997).
COL4A2 •*!w[♦" COL4AI1
COL4A4 "*] ["*• COL4A3
—
COL4A6 Mf* COL4A51
Figure 1.13. The arrangement of the collagen IV a-chain genes and their
bidirectional promoters. Adapted from (Hudson et al. 1993).
The six a-chains assemble into three distinctive protomers a!ala2(lV), a3a4a5(IV) and
a5a5a6(lV) that form three separate networks: the al/a2(lV) arrangement which is
ubiquitous, a3a4a5(IV) and a structure formed from alala2(IV)/ a5a5a6(IV) (Borza et
al. 2002; Gelse et al. 2003). The two latter aggregations appear to occur later in
development where they replace the al/a2(lV) system in a tissue-specific manner (Gelse
et al. 2003). In adults, al(IV) and a2(lV) are found together in many different tissues
whereas the other four a chains are expressed in a more precise temporal and spatial
pattern (Fleischmajer et al. 1997; Miner & Sanes 1994). When mutations occur in
a3(IV) and a5(IV) characteristic phenotypes are seen in the tissues where these chains
are specifically expressed (Gelse et al. 2003).
The murine endodermal-derived M1536-B3 cells have been shown to make ECM in
vitro even though they lack collagen IV (Brauer & Keller 1989). The resulting basement
membrane is characteristically similar to collagen IV-containing basement membrane
suggesting that matrix can form without collagen IV in culture or that collagen IV does
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not provide the basic structural framework for basement membrane assemblage (Brauer
& Keller 1989). The al/a2(IV) aggregation is first detected at the 32-64 cell stage of
development in the mouse embryo giving the impression that it must be important in
early development. However, when the locus for COL4 al/a2 is inactivated, embryos
survive to E10.5 - 11.5 suggesting that while this network is not crucial to early
basement membrane formation it may have other functional and structural roles (Gelse
et al. 2003). Possibly, when these al/a2(IV)-chains are absent other a-chains take over
the roles of the missing a-chains to some extent. This has not been shown for al/a2(IV)
complexes but in male dogs mutant for a5(IV) where the a3a4a5(IV) complexes are not
formed and humans that lack the a3a4a5(IV) complex, fetal expression of al/a2(IV)
continues (Harvey et al. 1998; Kalluri et al. 1997). Embryonic lethality (or premature
death as seen in the a3(IV) null mouse (Cosgrove et al. 1996)) seen in COL4 a-chain
homozygous mutant mice implies that collagen IV chains work together in complex
ways and all are needed to function harmoniously. Certainly, all are needed as the
structural integrity of the embryo becomes more complex. All this suggests that COL4
is essential for the maintenance of the structure of the basement membrane but not the
formation.
1.3.3.1.2.2. Network formation
Each collagen IV a chain is made up of three distinct domains: a cysteine-rich N-
terminal 7S domain, a triple-helical domain that is found at the centre of the helix and a
highly conserved C-terminal non-collagenous globular domain (NCI) (Ortega & Werb
2002). The whole structure forms a flexible helix (Gelse et al. 2003). When NCI are
removed by enzymic digestion the folding ability of collagen IV is lost (Dolz et al.
1988)
The collagen IV network is formed by protomers interacting with each other to form a
mesh. Various interactions that can occur between the protomers are shown in Fig. 1.14.
These include NCI domains interacting with one another to form dimers and then with
7S domains to form tetramers (Boutaud et al. 2000). Additionally, supercoiling and
looping of protomers contributes to network formation (Hudson et al. 2003). The N-
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terminus can form disulphide bonds within and between molecules, which establish the
overall 'suprastructure' of the collagen IV network (Kalluri et al. 1997). The diverse
molecular associations made by collagen IV allow for the formation of diverse types of
basement membrane, consistent with their many tissue-specific roles throughout the
body.
Figure 1.14. Schematic representation of collagen IV 'suprastructure' and network (taken
from Hudson et al 2003). Each protomer helix consists of three a-chains, then NC1
domains link to form dimers and 7S domains link to form tetramers. Protomers also loop
and coil to form the collagen IV network.
The existence of six a-chains capable of forming triple helices creates the theoretical
potential for many different combinations of collagen IV helices to be formed into
networks. Yet in nature only three different combinations actually form and the reason
for this is unknown. Possibly, there is molecular specificity between the a-chains, such
that only three combinations can form. It has been shown that al(IV) and a2(IV) form
helices through recognition at NCI domains (Boutaud et al. 2000; Soder & Poschl
2004). Thus it is possible that the NCI domains define and limit the formation of
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2004). Thus it is possible that the NCI domains define and limit the formation of
particular collagen IV complexes. The NCI domain may also include intraprotomer and
interprotomer recognition sites necessary for helix and network specificity.
Alternatively, the spatiotemporal expression of particular genes within tissues could
dictate the composition of protomers that are formed. This could be because each type
of chain confers a distinctive strength potential and different tissues require basement
membranes with varying strengths. For example, in the COL4a5 null mouse the kidney
glomerular basement membrane lacks the a3a4a5(IV) complex, meaning that although
it still has the al/a2(IV) protomer the membrane is unable to handle the strain of
filtration, resulting in proteinuria (Hamano et al 2002).
Collagen IV protomers are also stabilised by undetermined covalent cross-links at the C-
and N- termini (Bailey et al 1984). These cross-links may be lysine aldehydes, pointing
towards the cross-links being similar to those in fibrillar collagens and hence possibly
being formed by LOX (Bailey et al. 1984). This is important as it has not conclusively
been proven that LOX is instrumental to collagen IV network formation. Collagen I, III
and IV in LOX null mice are histologically normal, but electron microscopic analysis
has revealed that the fibrillar collagens were dispersed and had shorter fibres compared
to the tightly bundled wild-type phenotype (Maki et al 2005). These authors did not
comment on basement membrane structure or location and no electron microscope
studies of basement membranes were undertaken. However, the lungs and
cardiovascular system in LOX-null mice are morphologically abnormal and
dysfunctional (Maki et al 2002; Maki et al 2005). Since, collagen IV is associated with
these tissues this phenotype may indicate the involvement of LOX in stabilising collagen
IV. However, this interpretation is potentially confounded by the fact that the fibrillar
collagens are also associated with these structures.
A possible binding site for LOX, similar to that in fibrillar collagen, has been identified
in collagen IV (Bailey et al 1993). The cross-link is reducible by mercaptoethanol
(Bailey et al 1984) as are cross-links created by LOX (Harris et al 1974). More recent
investigations into the NCI domain, which is essential for network formation as it forms
hexamers between helices, suggest that this region is stabilised by a covalent cross-link
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between methionine and lysine residues of opposing al and a2 chains. However, there
is much debate as to the nature of this link with some evidence suggesting that the cross¬
link is possibly a S-hydroxylysylmethionine (Than et al. 2005; Than et al. 2002;
Vanacore et al. 2005). Although deliberation on the nature of the cross-linkages of
collagen IV continues, the balance of the evidence to date suggests that LOX may be
involved. Certainly, no evidence has been provided to refute this possibility.
1.3.4. Intraovarian tissue remodelling
As discussed in section 1.1, the ovary is continually being subjected to a series of injury
and repair/remodelling episodes during the course of follicle growth and ovulation.
Therefore, collagen pathway biology must have a functional role in maintaining ovarian
tissue integrity and associated ECM remodelling. Processes controlling ovarian tissue
remodelling have been reviewed extensively by Ny et al (2002) and Curry & Osteen
(2003). These reviews summarise the roles of MMPs and the plasminogen activation
(PA) system in the ovary, which are beyond the scope of this literature survey. Instead,
the focus here is on formation and accumulation of ECM.
1.3.4.1. Ovarian ECM
1.3.4.1.1. Stroma
The ovarian stroma is an understudied tissue. The stromal matrix supports the resting
and growing follicle populations of the ovary as well as the ovarian vasculature, and
consists of collagen type I and III (Palotie et al. 1984; Paranko 1987). Theca cells are
recruited from unspecialised mesenchymal progenitor cells in the stroma, and once
differentiated these cells remain associated with the stroma (Magoffin 2005). Therefore
the stromal ECM may facilitate migration of theca precursors towards growing follicles.
This need only be over a short distance as evidence suggests theca cell recruitment is
controlled by granulosa cell secretions (Magoffin & Magarelli 1995).
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1.3.4.1.2. Follicular basement membrane
In the ovarian follicle, granulosa cells are supported by the follicular basement
membrane (also known as the basal lamina or lamina basalis) that separates them from
the surrounding theca interna (Rodgers et al. 2000). This basement membrane
influences granulosa cell proliferation and differentiation (Amsterdam et al. 1989).
Basement membranes are also found in the subendothelial theca cell layer (Rodgers et
al 2000). The focus of the following text is the basement membrane that separates the
granulosa and theca cells (Fig. 1.1).
In the healthy follicle, the basement membrane stops capillary invasion and entry of
white blood cells and nerves into the granulosa layer until ovulation when the basement
membrane is degraded (Rodgers et al. 2000). The basement membrane maintains the
polarity and specialisation of the granulosa cells and most probably adjusts its
composition in response to granulosa cell behaviour during follicle growth (Rodgers et
al. 2000). The semi-permeable follicular basement membrane also excludes large
molecular weight plasma proteins such as low density lipoproteins and molecules from
the antrum of the follicle (Andersen et al. 1976). Therefore, large molecules that are
synthesised by the granulosa cells and oocytes may be retained within the follicular fluid
(Rodgers et al. 2000). The molecular weight cut-off for the follicular basement
membrane is estimated to be 100-850 kDa (Andersen et al. 1976). Although it may
change throughout follicular development (Rodgers & Irving Rodgers 2002), this cut-off
is well beyond the size of most of the classic growth factors, which can almost certainly
move freely between the theca and granulosa cell layers. The proportion of
extracellular, large proteins in the follicular fluid increases as the follicle grows
(Andersen et al. 1976). This indicates that the movement of protein into the antrum is
governed by the follicular basement membrane. So, the basement membrane can act as
a barrier between the two main somatic follicular cell layers. However, since ECM can
also bind various growth factors it can act as a reservoir for instructional substances
needed by the different cell types at particular stages of follicular development (Rodgers
et al. 2000). For instance, the ECM binds and pools active TGF-J3, which is effectively
an ECM component (Gualandris et al. 2000).
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1.3.4.1.2.1. Early development of the follicular basement membrane
Even at very early stages of ovarian development, basement membranes are in evidence
as oogonial cords become separated from the ovarian stroma (Rodgers et al. 2003).
Then, as cords develop into primordial follicles the pregranulosa cells are also
surrounded by basement membrane (Irving Rodgers & Rodgers 2005). Eventually, as
growth of these follicles is initiated, the basement membrane expands to accommodate
later stages of follicle growth (Rodgers et al. 2003). Throughout, the basement
membrane can influence follicle growth by regulating substances that pass among theca
cells and granulosa cells, and beyond to the oocyte.
1.3.4.1.2.2. Basement membrane during follicular maturation
Cytoplasmic oocyte maturation occurs throughout follicular development and some of
the early changes occur in close contact with the primordial follicular basement
membrane (Oksjoki et al. 1999). Pre-ovulatory follicular development and post-
ovulatory development of the corpus luteum also intimately involve ECM (Oksjoki et al.
1999). As each stage occurs, the ECM undergoes extensive destruction, repair and
displacement, indicating that its role is instructional as well as structural (Woessner
1991). Studies have shown that the MMPs and their inhibitors, TIMPs, have
developmental-associated patterns of expression throughout folliculogenesis,
highlighting that formation and breakdown of ECM is precisely regulated (Duncan et al.
1998). In the mouse ovary during the oestrous cycle, different mRNA expression
patterns have been shown for type III, IV and VI collagens as well as for several small
proteoglycans (Oksjoki et al. 1999). This indicates that the destruction and construction
of the follicular ECM are influenced by cyclic changes and are a feature of normal
ovarian function.
Dormant primordial follicles contain a small, quiescent oocyte and a single layer of non-
replicating granulosa cells enclosed by the basement membrane (Irving-Rodgers &
Rodgers 2000). As previously stated (Section 1.1.1.1), follicular growth becomes
gonadotrophin-dependent once the antral cavity begins to form, which fills with fluid
composed in part from secretions of the granulosa cells (Hillier 1994). Extracellular
matrices have been shown to influence fluid movements within tissues that set up
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osmotic barriers can affect osmosis and filter soluble substances, both of which
properties would be important in the accumulation of follicular fluid and the nutritional
and instructional signals therein (Rodgers et al. 2003).
The granulosa cell layer expands as the follicle matures. As a general approximation, the
number of granulosa cells is four times that of the follicular surface area (Rodgers et al.
1999a). In rat and cow ovary, the composition of the follicular basement membrane has
been shown to change as development occurs (Frojdman et al. 1998; van Wezel et al.
1998). However, it has not yet been shown whether these changes are linked to changes
in the granulosa cells or to the permeability of the ECM. At ovulation the basement
membrane is degraded, allowing blood cells and inflammatory cells such as
macrophages to enter the granulosa cell compartment (Irving-Rodgers et al. 2002).
1.3.4.1.2.3. Basement membrane influences on cell morphology
It is thought that the follicular basement membrane influences the shape and function of
the granulosa cells (Huet et al. 2001). Differences have been observed between the
phenotypes of granulosa cells that are in direct contact with the basement membrane and
those that are situated in inner layers (Huet et al. 2001). Some follicles have basal cells
that are columnar in form, middle layers composed of rounded cells and antral granulosa
cells that are flattened, whilst other follicles have granulosa cells that are all rounded
(Irving-Rodgers & Rodgers 2000). The cell shape may reflect the proliferation status of
these cells as rounded basal granulosa cells have a greater rate of proliferation compared
to antral cells (Irving-Rodgers & Rodgers 2000; Jablonka-Shariff et al. 1994). These
differences within the follicle may be due to cellular location in relation to the basement
membrane.
Ultrastructural studies of bovine follicles reveal two main phenotypes. In healthy
preantral and antral follicles, the conventional single layer of basement membrane is
seen (Irving-Rodgers & Rodgers 2000). At the preantral stage the basement membrane
is enlarged and partially laminated. A loopy phenotype can also be observed in some
preantral follicles and antral follicles < 4mm in diameter (Irving-Rodgers & Rodgers
2000). However, is not seen in larger follicles (Irving-Rodgers & Rodgers 2000). When
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observed in antral follicles, the loopy phenotype was associated with columnar
granulosa cells, whereas normal basement membrane phenotype was observed in
connection with rounded granulosa cells (Irving-Rodgers & Rodgers 2000). The
basement membrane in preantral follicles was thicker than that of antral follicles, which
may reflect differences in the permeability of this layer as maturation occurs (Irving-
Rodgers & Rodgers 2000). The loopy phenotype suggests that cell shedding and,
therefore, cell replacement is occurring (Irving-Rodgers & Rodgers 2000). When
follicles with loopy and normal phenotypes were compared it was found that the normal
follicles were of a better 'quality' but a cause-effect relationship has not been established
(Irving Rodgers & Rodgers 2005).
A recent study of the bovine follicular matrix has highlighted a novel form of matrix
within the granulosa cell layer of antral/preovulatory follicles. Irving-Rodgers et al
(2004) term this the 'focimatrix' as it appears as aggregates of basement membrane in
between granulosa cells but its function is unclear. The role of focimatrix is unknown
but it is hypothesised to be important to the epithelio-mesenchymal transition of
granulosa cells through dispersing any positional cues being provided by the basement
membrane of the follicle (Irving Rodgers & Rodgers 2005).
1.3.4.1.2.4. Composition of the follicular basement membrane
The molecular components of the follicular basement membrane are believed to
originate primarily from granulosa cells (van Wezel et al. 1999). However, theca cells
also express several matrix components, which leaves the contribution of this issue open
to debate (van Wezel et al. 1999). The expression pattern of basement membrane
components in the ovary is summarised in Figure 1.15.
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Collagen IV a3 - a6
Perlecan + Nidogen
Laminins
Figure 1.15. Schematic diagram of the expression pattern of
basement membrane components in the ovary (adapted from Irving-
Rodgers and Rodgers 2005).
Laminins are localised to the basement membrane of all healthy follicles and in the theca
layers of antral follicles (van Wezel et al. 1998). All collagen IV a-chains are expressed
in primordial follicles (Rodgers et al. 1998). Therefore there is potential for all three
collagen IV helices (alala2(IV)/a3a4a5(lV)/a5a5a6(IV)) to be formed although to date
the complexes that actually exist have not been documented. As follicles increase in size
only al(IV) and a2(IV) become expressed (Rodgers et al. 1998). Expression of collagen
IV a3 through a6 declines, and perlecan and nidogen expression begins (Irving-Rodgers
et al. 2006). This switch occurs around the time of antrum formation, suggesting that the
presence of a3(IV),a4(IV) and a5(IV) opposes antral development. Alternatively the loss
of these a-chains may allow easier degradation of the basement membrane at ovulation,
as a3a4a5(IV) networks have a greater degree of protection from proteases due to heavy
cross-linking (Kalluri et al. 1997).
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1.3.4.2. Collagen biology in the ovary
So how is the collagenous composition of the follicular basement membrane regulated in
the ovary? Collagen synthesis and cross-linking catalysed by LOX are liable to be
critical, as are the activities of BMP-1 and PCPE (that to date have not been reported in
the ovary). This literature review concludes with an overview of what little data there
are describing LOX and ovarian function.
1.3.4.2.1. The role of LOX in remodeling of the ovary
Investigations into LOX in the ovary are very limited even though tissue remodelling
and repair are very important in this tissue due to follicular growth and ovulation. As
follicles grow their basement membranes and the surrounding stroma must
accommodate the increase in size. LOX mRNA is strongly expressed in preantral and
early antral granulosa cells (Harlow & Hillier 2002) and in situ hybridisation showed
LOX was most highly expressed in preantral/early antral follicles with much lower
expression in large preovulatory follicles (Slee et al. 2001).
At ovulation, localised tissue breakdown is necessary to release oocytes for potential
fertilisation. Each time ovulation occurs a natural wound develops that must be repaired
before the next ovulation. In the rabbit ovary, LOX activity increases after hCG-induced
ovulation and an increase in LOX mRNA occurs after progestin-induced ovulation in the
perch (Himeno 1986; Langenau et al. 1999).
In preantral/early antral follicles the LOX gene is negatively regulated by FSH in a dose-
dependent manner, as is connective tissue growth factor (CTGF) (Harlow et al 2002;
Harlow et al. 2003). The down-regulation of LOX by FSH is mediated through the
elevation of cAMP which co-ordinates signals that up-regulate steriodogenic enzymes
and LH receptors (Harlow et al. 2003). cAMP also suppresses basal and TGF-(3-induced
collagen and LOX mRNA levels in human lung fibroblasts (Choung et al. 1998) but has
the opposite effect on LOX in vascular smooth muscle cells, suggesting a tissue specific
response (Ravid et al. 1999).
The expression of CTGF mRNA is up-regulated at the early stages of antral follicle
development at the same point that LOX gene expression increases (Harlow & Hillier
2002). This is also when intense connective tissue biosynthesis occurs and ECM is laid
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down (Harlow & Hillier 2002), implying that the regulation of CTGF and LOX may be
linked.
Interactions between androgens and FSH enhance differentiation processes such as sex
steroid synthesis, induction of LH receptors and carbohydrate metabolism (Harlow et al.
2003). Androgens intensify the action of cAMP, and when FSH and the androgen
dihydrotestosterone (DHT) were cultured with rat granulosa cells an enhanced down-
regulation of both LOX mRNA and activity was seen (Harlow et al. 2003; Hillier & de
Zwart 1982). DHT alone caused an increase in LOX expression (Harlow et al. 2003;
Slee et al. 2001) showing that FSH strongly influences the timing and extent of LOX
expression.
LOX has also been investigated in polycystic ovarian syndrome (PCOS) where ovaries
have a thickened fibrotic tunica alguginea as well as cystic follicles. When PCOS was
induced in a rat model using dehydroepiandrosterone (DHEA) an increase in LOX
expression was observed whilst there was a reduction in MMP-2 expression. This was
opposite to what was observed in normally cyclic controls (Henmi et al. 2001). These
findings could help to explain the cystic, thickened ovarian phenotype of PCOS and also
suggests how important LOX is to normal ovarian function.
LOX (as well as BMP-1 and PCPE) in follicular development remains poorly
understood.
Therefore the overall scope and purpose of this thesis is to determine how collagen
pathway biology alters in the developing ovarian follicle, asking specifically how LOX,
BMP-1 and PCPE are involved; if these genes and their resultant proteins are
developmentally and hormonally regulated; and whether they are subject to pro- and/or
anti-inflammatory modulation.
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1.4. Hypothesis
l. I propose the collagen pathway genes are localised in different ovarian
compartments and function via paracrine signalling to create functional ECM
remodelling during follicular development. I hypothesise that BMP-l and PCPE
will be localised to the theca cell compartment to regulate collagen processing in the
stroma. BMP-l will also act on pro-LOX to create active enzyme. LOX is known to
be expressed by the granulosa cells implying that BMP-l will cross the basement
membrane to cleave pro-LOX. LOX would then move to collagenous areas of the












Figure 1.16. The proposed two-cell model for collagen pathway
genes.
Therefore if the candidate collagen pathway genes are present in different
compartments their expression and activation is most probably regulated by the
gonadotrophins that regulate the development of ovarian follicles. Other influences
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could be ovarian steroids, growth factors and cytokines. Ovarian steroids include
glucocorticoids, the accumulation of which is regulated by the expression of
11(3HSD isoforms. Glucocorticoids as anti-inflammatories, would be expected to
have strong influences on collagen pathway genes.
2. As glucocorticoids are likely to be key post-ovulatory anti-inflammatories this raises
the question what might occur if their formation was dysregulated? If
glucocorticoids were not present in the biological system, or if glucocorticoids could
not be activated normally at ovulation, ovulation-associated inflammation might not
be adequately resolved. This would be predicted to involve measurable alteration in
collagen pathway biology.
3. Collagen IV is possibly the most important collagen in the ovary as it is part of the
basement membrane. Therefore if collagen IV is partially disrupted it is predicted
that the basement membrane would not form normally. This could lead to abnormal
communication between granulosa and theca cells, perhaps resulting in impaired
localisation of collagen pathway biology and reduced fertility.
Thus, the principal aims of this thesis were to establish if:
1. Collagen pathway genes (PCPE, BMP-1 and LOX) are present in ovary.
2. Compartmentalisation of gene expression and translated proteins for collagen
pathway genes and glucocorticoid signal regulators occurs in ovary.
3. Collagen pathway genes are regulated by gonadotrophins, growth factor,
cytokine and steroids during follicular development.
4. Disruptions in the glucocorticoids regulatory mechanism affect ovarian
function and collagen pathway biology.
5. Disruptions in collagen IV of the ovarian basement membrane affect ovarian
function.
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2. Materials and Methods
The commercial sources of all reagents/chemicals/plastics/antibodies used in these
investigations are shown in Appendix 1.
2.1 Animals
2.1.1 Wistar rat model for follicular maturation
Immature 21-day old female Wistar rats were housed on a 12h light: 12h dark lighting
regime in a temperature-controlled environment. Rats were fed rat chow ad libitum and
water was freely available. Rats were allocated to one of three experimental groups to
simulate different stages of the oestrous cycle by giving hormone treatments in vivo. All
hormones were made up in filtered Dulbecco's phosphate buffered saline (DPBS)
supplemented with 1% bovine serum albumin (BSA).
• Group 1 received no in vivo hormone injections. The ovaries of these animals
consisted of preantral and early antral follicles.
• Group 2 received lOIU/rat pregnant mare serum gonadotrophin (PMSG) 48
hours before sacrifice. The ovaries of these animals produced large numbers of
preovulatory follicles.
• Group 3 received lOIU/rat PMSG 60h before sacrifice and lOIU/rat human
chorionic gonadotrophin (hCG) 48h after the PMSG injection and 12h before
sacrifice. These ovaries provided a population of largely periovulatory follicles.
All injections were given inter-peritoneally in accordance with Home Office regulations.
Animals were killed by CO2 asphyxiation followed by cervical dislocation. Ovaries
were immediately resected and immersed in culture medium or placed in fixative.
2.1.2. 11f3HSD1-null mice
11(3HSD1 was mutated in the mouse genome using targeted gene disruption
(Kotelevtsev et al. 1997). 11 [SHSDl-null mice were housed under a 12 hour light: 12
hour dark regime with free access to food and water. Female 1 ipHSDl-null mice aged
3 months and 12 months were allocated to one of three groups and received the same
hormone treatments as the Wistar rat model (Section 2.1.1), to generate untreated
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ovaries, PMSG-treated ovaries and PMSG/hCG treated ovaries. Mice were sacrificed
and tissues collected as stated above (Section 2.1.1).
2.1.3. COL4a1-mutant mice
Missense mutations of the COL4al gene were generated as part of an N-ethyl-N-
nitrosourea (ENU) mutagenesis project to generate mice with a dominant mutant eye
phenotype (Thaung el al. 2002). Of the many phenotypes generated, three were
accessible for these investigations through collaboration with Dr Tom Van Agtmael
(The University of Edinburgh). The three groups ofmutant mice were:
1. retinal arteriolar wiring (Raw)
2. small with vacuolar cataracts (Svc)
3. Bruised (Bru)
The reported phenotypes of these three mutants are shown in Table 2.1. Raw and Svc
were created using a BALB/c mouse strain and Bru originated from a C3H/101 strain
(Van Agtmael et al. 2005). Wild-type littermates were used as controls.
Table 2.1. Reported phenotypes of Raw, Svc and Bru mutant mice (Van Agtmael et al 2005;
Thaung etal 2002).
Mutant Phenotype
Raw Retinal arterioles have a silvery appearance.
Svc Silvering of the arteriolar, vacuolar cataracts, body size is small and
pups are bruised at birth.
Bru Eye defects (including opaque cornea, iris and corneal adhesions),
bruising at birth, peripheral kidney glomerulopathy and small body size.
Mutant and wild-type mice were housed under a 12h light: 12h dark lighting regime in a
temperature-controlled environment. Mouse chow and water were available ad libitum.
Female mice were culled by C02 asphyxiation at three months, six months and nine
months and ovaries were resected and fixed. Post-fixation, excess tissue and fat were
removed from the ovaries using forceps. The ovaries were weighed post-fixation.
A cohort of Raw and WT 21-day old female mice received 10IU PMSG/mouse 60h
before sacrifice and 10IU hCG/mouse 48h after PMSG injection and 12h before
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sacrifice. After sacrifice, the mice were individually weighed then ovaries were resected
and weighed separately before being fixed.
2.1.4 CYP11B1 null mice
CYP11B1 was mutated in the mouse genome using targeted gene disruption.
CYP1 IB1-deficient mice were accessible for these investigations through collaborations
with Dr Linda Mullins, Dr Chris Kenyon and Dr Judy McNeilly (The University of
Edinburgh). Animals were housed under a 12 hour light: 12 hour dark regime with free
access to food and water. Females were sacrificed by C02 asphyxiation aged 3 months,
when ovaries were removed and fixed as stated in Section 2.1.1.
2.2. Granulosa cell culture
2.2.1. Granulosa cell collection and preparation for cell culture
Granulosa cells were collected from the ovaries of female 21-day old Wistar rats that
had received the hormone treatments previously described (Section 2.1.1.). Ovaries
were resected and visualised under a dissecting microscope to enable the removal of
extraneous tissue and fat. The ovaries were punctured using a 27 gauge needle and
granulosa cells were expelled into culture medium (Medium 199 supplemented with
2mM L-glutamine, penicillin 50IU/ml, streptomycin 50gg/ml, 0.1% (w/v) BSA).
Unless stated otherwise this supplemented medium is referred to as Medium 199
throughout the remainder of this text. Cells were gently pipetted through a 10ml pipette
to break up cell clumps. The cell suspension was centrifuged at 120xg for 5min to form
a pellet of cells, which was resuspended in a known volume of Medium 199. A 20pl
volume of cell suspension was mixed with an equal volume of trypan blue to assess cell
number and viability using a haemocytometer.
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2.2.2. Granulosa cell culture
Cells were plated into 24-well tissue culture plates that had been pre-coated overnight
with donor calf serum to provide a thin layer of ECM-related substances that encourage
the cells to adhere to the plastic. Plates were washed twice with phosphate-buffered
saline (PBS) before cells were plated out at 50,000 cells per well and cultured overnight
in 500pi Medium 199 to allow cell attachment to the culture dishes. Cells then received
different treatments (Table 2.2) and were incubated for 48 hours at 37°C in an
atmosphere of 20% (v/v) 02 and 5% (v/v) C02.
Table 2.2. Culture treatments given to granulosa cells and number of experimental repeats.
Corticosterone (CORT), follicle-stimulating hormone (FSH), transforming growth factor-3 (TGF),
luteinising hormone (LH), interleukin-1 (IL-1), progesterone (PROG).
Untreated rat granulosa cells




CORT dose response (0/0.01/0.1/1 pM) 3
PMSG-treated rat granulosa cells





CORT dose response (0/0.01/0.1/1 pM) 3
Control/PROG/LH/PROG+LH 3
Control/PROG/IL-1/PROG+IL-1 3
PMSG/hCG-treated rat granulosa cells





CORT dose response (0/0.01/0.1/1 pM) 3
Control/PROG/LH/PROG+LH 4
Control/PROG/IL-1/CORT+IL-1 4
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2.2.4. Termination of culture
Spent medium was collected and stored at -20°C. Cells were removed for later RNA
extraction by incubation with trypsin until they detached from the plastic surface. The
resulting suspension was centrifuged at 300xg for 5min and the pellet was washed in
lml DPBS. This suspension was centrifuged at 600xg for 3min before being
resuspended in 350pl Qiagen lysis buffer containing 10p,l/ml (3-mercaptoethanol. Cells
were homogenised by passing them through a fine-gauge needle several times.
Alternatively cells were removed from culture by placing 350pl Qiagen lysis buffer
containing lOpl/ml p-mercaptoethanol onto cells after medium had been removed,
followed by a brief vortex. The cell homogenates were stored at -70°C. Both methods
were in accordance with the Qiagen RNasy kit protocol used to extract RNA. No
differences were observed between the two methods when granulosa cell RNA quality
and quantity were compared.
2.3. Theca cell culture
2.3.1. Theca cell extraction
Theca cells were extracted from residual ovary tissue using a protocol adapted from
Magoffin & Erickson (1982) and Smyth et al (1993). Once granulosa cells had been
removed, the remains of the ovaries were rinsed in Medium 199, then incubated in 2ml
digestion medium (0.1% collagenase, 0.01% DNase, Medium 199) for 30min with
agitation. The suspension was dispersed to achieve a single-cell suspension by gentle
pipetting every 15min. Cells were centrifuged at 800xg for 5min, followed by
resuspension in 2ml Medium 199 containing 5% (v/v) donor calf serum. Cell number
and viability were assessed with a haemocytometer.
2.3.2. Theca cell separation
Following the digestion step the theca cell suspension was enriched using discontinuous
gradient centrifugation. This was achieved by creating two layers of Percoll® in a Rohen
tube. 2ml of Percoll® solution adjusted to a specific gravity of 1.055 was placed into the
tube. The specific gravity was calculated using the following formula:
Chapter 2 Materials and Methods 56
V0 = V d-0.1 dy-0.9
d0 - 1
V0 = volume of Percoll® (ml)
d0 = density ofPercoll® (1.130g/ml)
dx = density of Medium 199 (1,058g/ml)
V = volume required for final working solution (ml)
d = density required for final working solution (g/ml)
lml of 44% Percoll® was placed beneath the 1.055 specific-gravity layer using a glass
pipette. The dispersed ovarian cells were layered over the Percoll® layers and the tube
centrifuged at 400xg for 20 min. Theca cells were aspirated from between the two
layers of Percoll®. Cells were washed in Medium 199, collected by centrifugation and
resuspended in Medium 199 with 5% donor calf serum. Density and viability were
checked with a haemocytometer, then cells were plated at 50, 000 per well in 24-well
culture dishes in 500pl Medium 199 with 5% donor calf serum. After 12h the medium
was changed to Medium 199 and cells were treated with specific treatments (Table 2.3).
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Table 2.3 Culture treatments given to theca cells and number of experimental repeats.
Corticosterone (CORT), follicle-stimulating hormone (FSH), transforming growth factor-P (TGF),
luteinising hormone (LH), interleukin-1 (IL-1), progesterone (PROG).
Untreated rat theca cells




CORT dose response (0/0.01/0.1/1 pM) 3
PMSG-treated rat theca cells





CORT dose response (0/0.01/0.1/1 pM) 5
Control/PROG/LH/PROG+LH 4
Control/PROG/IL-1/PROG+IL-1 4
PMSG/hCG-treated rat theca cells




Control/CORT/I L-1 /CORT+1L-1 3
CORT dose response (0/0.01/0.1/1 pM) 3
Control/PROG/LH/PROG+LH 3
Control/PROG/IL-1 /CORT+1L-1 3
2.3.3. Termination of culture
Theca cells were removed from culture as described in Section 2.2.4 for granulosa cells.
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2.4. Radioimmunoassays
2.4.1. Androstenedione
Coat-a-count® direct androstenedione kits were used to measure androstenedione
quantity in cell culture medium from theca cells. Briefly, the coat-a-count® kit supplies
polypropylene tubes coated with polyclonal androstenedione antibody, direct
androstenedione calibrators and 125I-androstenedione. Total counts and non-specific
binding were measured for each assay. Calibration solutions of known androstenedione
concentrations were used to create a standard curve. Culture cell medium was added to
coated tubes in duplicate at lOOpl/tube. Tubes were incubated at room temperature for
2h, then decanted and counted on a gamma counter (1261 Multigamma, LK3 Wallac)
for 1 min. Androstenedione values were read from the standard curve using MultiCal
analysis software (Wallac).
2.5. Extraction of RNA from cells
2.5.1. RNA Extraction
RNA was extracted from freshly isolated and cultured granulosa and theca cells, using
Qiagen RNasy kits with a centrifugation protocol. All centrifugation steps were carried
out at 900xg in a mini-centrifuge. Cell suspensions stored in lysis buffer supplemented
with 1 Opl/ml (3-mercaptoethanol were defrosted, diluted with an equal volume of 70%
(v/v) EtOH and applied to the mini columns supplied with the kit. The columns were
washed with the supplied wash buffer, and then treated with DNase for 15min, to
remove any contaminating genomic DNA. DNase was inactivated and removed by
washing with wash buffer. Columns were then washed twice with supplied elution
buffer and RNA was eluted into 30pl RNase-free water.
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2.6. RT-PCR
2.6.1. cDNA for PCR
Extracted RNA was quantified using the Agilent 2100 Bioanalyser in conjunction with a
RNA6000 nano chip. RNA was used to synthesise cDNA for use in standard RT-PCR.
First a Superscript III first strand was synthesised. For each different RNA sample a
mix of the reagents shown in Table 2.4. was prepared in 0.2ml Eppendorfs tubes.




10mM dNTP mix 1|J|
2pg total RNA Xpl
Nuclease free H20 to a total of 13pl
Eppendorf tubes were heated to 65°C for 5min, then placed on ice for 1 min and briefly
centrifuged. The next step produces cDNA from the first strand synthesis. The reagents
shown in Table 2.5. were added to each tube depending on whether cDNA synthesis was
required (positive) or not (negative control).
Table 2.5. Reagents added to each first-strand reaction for cDNA synthesis.
Reagent +ve -ve
5x 1st strand buffer 4pl 4pl
0.1 M DTT 1pl 1 Ml
RNase OUT 1pl 1 [Jl
Superscript III 1pl
Nuclease free H20 1 |JI
Reagents were mixed and heated to 50°C for 50min (transcription), followed by 70°C for
15min (final extension step). The resultant cDNA was stored at -20°C.
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2.6.2. Reverse Transcriptase (RT)-PCR
cDNA was used for PCR, using primers generated specifically for this project or primers
that had been constructed previously in the laboratory. Mastermix solutions shown in
Table 2.6. were made fresh for each reaction from a double-strength Promega PCR
stock.
Table 2.6. Mastermix for a 1 x reaction for RT-PCR.
Reagent Volume
Promega mastermix 25pl
DNase/RNase free H20 19pl
5' primer (50pmol) 2(J|
3' primer (50pmol) 2pl
The mastermix was vortexed and aliquotted into 0.2ml Eppendorf tubes. 2pl cDNA was
added to each reaction, mixed by pipetting and then on a heat cycled TECHNE TC-312
PCR machine with the following PCR programme.
> Step 1 93°C 3min 1 cycle initialisation
denaturing> Step 2 93°C 30 sec




> Step 3 72°C 5 min 1 cycle final extension
Hold at 4°C
The variable temperature (U) was calculated for each set of primers using the following
formula:
[2 x (A + T) + 4 x (C + G)] - 5 = U°C
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2.6.3. Gel electrophoresis
PCR products were size-fractionated by electrophoresis in the presence of ethidium
bromide for visualisation under UV light. PCR products were mixed with 5x loading
dye in a 1:5 ratio and loaded onto a 1.5% (w/v) agarose gel (1.8g agarose, 120ml lxTAE
buffer, 2pl ethidium bromide) in lxTAE buffer. A 100-base pair ladder was used as a
reference size marker. Electrophoresis was done at 100 volts until the PCR products had
run three-quarters the length of the gel. Bands were observed and photographed under
UV light (254nm).
2.7. Quantitative real-time PCR
2.7.1. cDNA synthesis for quantitative real-time PCR
RNA extracted from ovarian cells was quantified and its quality assessed using an
Agilent 2100 Bioanalyser in conjunction with a RNA60oo nano chip. RNA that
displayed intact 18S and 28S peaks was reverse transcribed using the Applied
Biosystems Taqman™ reverse transcriptase reagents kit. A mastermix of the reagents
was prepared for the desired number of reactions as shown in Table 2.7.
Table 2.7. Reverse transcription regents required for a 1 x reaction mastermix.
Reagent x 1 reaction
Nuclease-free water 1.85pl





7.75|il of the mastermix was removed to be used as an RT-negative control. Multiscribe
Reverse Transcriptase was added to the remaining mastermix using the calculation 0.25
x number of reactions required - 0.25. The mastermix was vortexed, and portions (8pi
for a single volume reaction or 16pl for a double volume reaction), were transferred into
0.2ml Eppendorf tubes. 2pl (single volume) or 4pl (double volume) sample RNA was
Chapter 2 Materials and Methods 62
added to each reaction tube (including the RT-negative reaction) and 2pl/4pl of
nuclease-free water was added to a separate tube as an RT-H20 control. All reaction
tubes were subjected to the following temperature cycle: 25°C for lh (incubation step),
48°C for 45min (reverse transcription step), 95°C for 15min (denaturing step).
2.7.2. qRT-PCR
Quantitative real-time RT-PCR was used to measure gene expression in freshly isolated
and cultured ovarian cells. Quantitative real-time RT-PCR can be performed using
fluorescence-labelled custom-made primer and probe sets (previously validated) or using
Assay-On-Demand assays. Both were used in this project. An endogenous control of
18S was used in all quantitative real-time RT-PCR assays. Table 2.8. shows the
custom-made primer/probe sets and Assay-On-Demand assays used in this project.
Table 2.8. Primer/probe sequences for the genes of interest used in this project

































Assay-On-Demand assays - sequences are not published
Working reagent solutions were prepared for either custom-made primer/probe sets or
for Assay-On-Demand assays. Typical mastermix components for a 1 x reaction for
primer/probe sets and Assay-On-Demand assays are shown in Table 2.9.
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12.5pl Taqman mastermix 12.5p,l
Nuclease-free water 8.525ql Nuclease-free water 8.875(1,1
18s primer/probe 0.375pl 18s primer/probe 0.375pJ





The reagent mix was vortexed and aliquotted into 0.2ml Eppendorf tubes at a volume of
23pl/tube. Custom-made primer/probe sets were run in triplicate and Assay-On-
Demand assays in duplicate. cDNA was added to the mastermix aliquots at a volume of
2pl/tube. A PCR water-control was set up by adding nuclease-free water in place of
cDNA. After vortexing the Eppendorf tubes, 23pi portions of their contents were
transferred to the chambers of 96-well optical reaction plates. The plates were sealed
with optical caps or film and then processed on the ABI PRISM® 7900 heat-cycler
system. The PCR cycle was: stage 1, 50°C for 2min; stage 2, 95°C for lOmin; stage 3,
95°C for 15sec; and stage 4, 59°C for lmin; stage 3 was repeated for 40 cycles.
2.7.3. Data analysis
Data were analysed using ABI 7900 software. Three important parameters were
considered when analysing such data. These were the 'baseline', 'threshold' and
'threshold cycle' (CT) values. The baseline value refers to baseline fluorescence in the
reaction plate. The threshold is the numerical value reflecting the point above the
calculated baseline that represents statistical significance. The threshold was set in the
exponential region of the amplification plot (i.e. not in the plateau phase or baseline
region). Ct reflects the cycle number taken for the fluorescence generated in a reaction
to cross the threshold. Therefore, the CT value for each sample indicates when
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amplification has significantly exceeded the baseline value. Data was exported to a
Microsoft Excel spreadsheet for further analysis.
The 'comparative Cj method' was used to further analyse raw data. The comparative CT
method uses arithmetic formulae to calculate relative quantitation. This is summarised
below:
Step 1: calculate ACTfor each well in the optical plate
ACt =Ct target gene " CT reference gene
Step 2: calculate the average of duplicates/triplicates
Step 3: calculate AACT
AACt = ACt target gene " AC/p reference gene
Step 4: calculate the arithmetic formula
2-aact
Values were expressed as fold-difference relative to the untreated controls. Repeated
measures ANOVA with the Tukey post-hoc test were used to assess differences between
gene expression levels, with significance set at P<0.05.
2.8. Lysyl oxidase enzyme assay
LOX oxidatively deaminates peptidyl lysine to peptidyl a-aminoadipic-6-semialdehyde
to cause collagen and elastin cross-linking. Tropoelastin can be used as a substrate to
measure LOX activity as the rate of peptidyl lysine oxidation. Two principal assay
methods have been described for measuring LOX activity. Both were used here:
1. Tritium vacuum distillation (Bedell-Hogan el al. 1993). This method uses
tritium-labelled tropoelastin as substrate and measures the amount of tritiated
water formed when samples are incubated with the tracer (as LOX activity is a
direct measurement of released tritium).
2. Fluorometric LOX activity assay (Palamakumbura & Trackman 2002). This
assay utilises 1, 5-diaminopentane as a substrate. The reaction releases hydrogen
peroxide, which is detected by N-acetyl-3,7-dihydroxyphenoxazine (Arnplex
Red) in horseradish peroxidase-coupled reactions. Unfortunately, this method
proved too insensitive for the present purpose, so all measurements of LOX
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activity described in this thesis were carried out by the tritium vacuum
distillation method as described in Section 2.8.1.
2.8.1. Lysyl oxidase tritium distillation enzyme assay
2.8.1.1. Tropoelastin biosynthesis
The procedure was adapted from Bedell-Hogan et al (1993). An E.coli clone for
recombinant tropoelastin (pAS-tElastin) was obtained from Dr Joel Rosenbloom
(University of Philadelphia, School of Dental Medicine, Philadelphia, PA.). Clones were
grown overnight at 37°C on Luria-Bertani (LB) plates supplemented with 50pl/ml
ampicillin. A single colony was picked and grown overnight in 100ml LB broth
supplemented with 50pl of lOOmg/ml ampicillin. 25ml culture was transferred into two
11 Erlenmeyer flasks containing 500ml of fresh LB media supplemented immediately
before use with ampicillin. The culture was immediately agitated at 37°C until the
OD620nm of the suspension reached 0.3-0.4. This was then centrifuged at 4000xg for
lOmin at 4°C. Cell pellets were washed three times in lysine-free medium and
transferred into a sterile 11 Erlenmeyer flask. 500ml of lysine-free medium was added
and the culture was agitated for lOmin at 37°C to reach an OD^onm of 0.6. To induce
protein expression, 2.0ml fresh nalidixic acid (dissolved in 0.1N NaOH) was added to
the culture, and agitated for a further 2h at 37°C. 2 mCi [3H]-(4,5)-lysine was added to
the culture and incubated for 3h at 37°C with shaking. Cells were centrifuged at 4000xg
and washed twice with PBS. The cell pellet was resuspended in 20ml cold buffer A
(50mM Tris pH 8.0, 2mM EDTA, ImM dithiothreitol containing 15% (v/v) glycerol)
and stored overnight at -80°C.
After defrosting the cells on ice, 1/100 volume of fresh phenylmethylsulphonyl fluoride
(PMSF) was added to inhibit proteases. The cells were then centrifuged at 4000xg for
lOmin and resuspended in cold buffer A containing 5% (v/v) glycerol. To break down
the polysaccharide cell wall of the bacteria, 200pl of lysozyme was added and incubated
on ice for 30min. Cells were centrifuged at 15000xg for 20min and resuspended in 10ml
of cold buffer A containing 5% glycerol. 1/100 volume PMSF and sodium deoxycholate
(0.05% w/v) were added to further break down cell membranes and cells were
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homogenised. The resultant suspension was centrifuged at 15000xg for 30min and
resuspended in 6.3ml of 70% (v/v) formic acid, lg cyanogen bromide (CNBr) was added
and stirred overnight under nitrogen at room temperature in a fume hood. CNBr cleaves
all peptide bonds at methionine residues. Tropoelastin is one of the few proteins that
does not possess this bond and is therefore not cleaved.
To neutralise CNBr, 2ml water was added to the solution. After 4-5h, the homogenate
was centrifuged at 15000xg for 15min. Radioactivity of a 10pl sample was measured by
(3-scintillation counting and the supernatant was dialysed against 41 0.1% (v/v) acetic
acid to remove unwanted solutes. Dialysis solution was replaced every 12h. The
dialysed solution was centrifuged and its radioactivity content measured. Finally, the
solution was distributed into microfuge tubes (1 x 106 cpm/tube), freeze-dried and stored
at -80°C.
2.8.1.2. Sample incubation
Culture media were assayed for LOX enzyme activity using the vacuum distillation
assay. For each sample, two positive and one negative assay tubes were set up. The
positive assay tubes contained 750pl test sample, 650pl borate buffer (0.1M sodium
borate, 0.15M NaCl, pH 8.0) and 100,000cpm of [3H]-tropoelastin tracer. The negative
control tubes contained 750pl test sample, 45Opil borate buffer, 100,000cpm [3H]
tropoelastin tracer and 50pM fl-aminopropionitrile (BAPN), an irreversible inhibitor of
LOX activity. All assay tubes were incubated at 55°C for 4h, and then frozen at -20°C in
preparation for distillation.
2.8.1.3. Vacuum distillation
The reaction product, tritiated water, was collected by vacuum distillation in a fume
cupboard. A rolled up sheet of Kleenex tissue was inserted into the top of each assay
tube (Fig. 2.1 insert) to prevent excessive rapid evaporation. The assay tubes were
placed in a heated (70°C) water bath and collection tubes were placed in a cooled (-
70°C) dry ice/industrial methylated spirit bath (Fig. 2.1). The two tubes were connected
by a glass swan-neck and were connected to a vacuum pump by tubing and valve taps.
The distillation apparatus contained a bleed-valve to control the distillation rate.






Figure 2.1. Vacuum distillation equipment used for measurement of LOX enzyme activity.
When the vacuum pump is switched on samples in the 70°C water bath boil under vacuum
and pass along the swan-neck tubes to condense in the ice bath. Insert shows assay tube
with assay medium below a Kleenex tissue inserted to prevent rapid evaporation.
When the system was ready for use the vacuum pump was turned on and the bleed-valve
shut. This caused the assay samples in the 70°C water bath to boil (the water vapour
then transfers along the swan necks and condenses in the tubes immersed in the ice
bath). The procedure was run for lOmin, whereupon the vacuum pump was switched off
and the bleed-valve opened to release the vacuum. The collection tubes were
disconnected and 1ml distillate was mixed with scintillation fluid and counted on a Tri-
Carb 2100R P-scinti 1 lation counter (Packard).
2.9. Histological staining
2.9.1. Tissue processing
Animal tissue from hormone-treated Wistar rats, raw COL4al-mutant mice, CYPl lBE"
mice and l l(3HSDr/_ mice that had been fixed in Bouin's for 6h were submerged in
70% EtOH and processed through a series of EtOH washes before being embedded in
paraffin wax blocks. Tissue blocks were sectioned (5pm) using a Microm microtome,
and sections floated onto water (50°C) and placed on Superfrost slides. Tissue was heat-
fixed to slides overnight at 40°C.
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2.9.2. Haematoxylin and Eosin staining
Slides were placed in xylene (2x5min) to remove paraffin wax and then re-hydrated
through successive EtOH solutions [100%, 95% (v/v), 70% (v/v), 50% (v/v)]. The
nuclei of the cells in the fixed tissue were stained with haematoxylin, and sections were
washed in running tap water. The intensity of staining was checked microscopically and
if satisfactory was "blued up" in Scott's tap water, followed by a further wash in tap
water. The slides were then placed in eosin for 20-30sec to stain cytoplasm and washed
in tap water. When the required staining had been achieved, slides were dehydrated
quickly through increasing solutions of EtOH concentrations [50%(v/v), 70% (v/v), 95%
(v/v), 100%, 100%] followed by xylene (2x5min). Coverslips were mounted using DPX
mounting medium and left to dry before being examined and photographed under
brightfield microscopy (Provis AX70, Olympus Corp. London, UK, fitted with a Canon
DS6031 camera).
2.9.3. Picro-sirius red staining
The Picro-sirius red staining protocol stains collagens. Slides were dewaxed in xylene
(2x5min) and rehydrated through decreasing EtOH concentrations [100%, 100%, 95%
(v/v), 85%(v/v), 70% (v/v)]. Following a 30min wash in tap water, tissue sections were
stained with Picro-sirius red stain (sirius red 0.5g; aqueous picric acid 500ml) for 60min.
Two changes of acidified water (5ml glacial acetic acid in 11 water) then followed.
Excess water was shaken from the slides and they were dehydrated in 100% EtOH,
cleared in xylene and mounted with DPX mounting medium. When viewed under
polarised light, stained collagens appeared as bright areas against the dark non-
collagenous areas, due to the birefringence of the collagen fibrils (Junqueira et al. 1981).
The birefringent properties of collagens are due to the parallel orientation of fibrils
(Montes 1996). Photographs were taken under brightfield and polarising microscopy
(Leitz DMRB, Leica, Milton Keynes, UK, connected to a JVC KY-F55B camera).
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2.9.4. Jones methenamine silver staining
The Jones methenamine silver staining protocol stains basement membranes. Following
dewaxing in xylene (2x5 min) and rehydration through decreasing EtOH solutions
[100%, 100%, 95% (v/v), 85% (v/v), 70% (v/v)], slides were placed in distilled water.
The sections were oxidized with 1% periodic acid for 15min, then washed in distilled
water. Slides were immersed in methenamine silver working solution (1.25ml 5% silver
nitrate; 25ml 3% methenamine; 10ml 5% borax; 2ml distilled H2O) and heated to 58°C
for 30-60min until basement membranes started to turn black. After washing in distilled
water, 0.2% gold chloride was used to emphasise intensity of staining (lmin). Excess
gold chloride was removed by washing in distilled water, followed by fixation for 2min
in 3% sodium thiosulphate and further washing with distilled water. A light
haematoxylin nuclear counterstain was used before slides were dehydrated through a
series of ethanol concentrations [50% (v/v), 70% (v/v), 95% (v/v), 100%, 100%] and
mounted with DPX mounting medium. Basement membranes were stained black.
Photographs were taken through a brightfield microscope as stated in Section 2.9.2.
2.9.5. Immunohistochemistry
2.9.5.1. Dewaxing and rehydration
Slides were dewaxed in xylene (2x5 min) and rehydrated through decreasing alcohol
concentrations [100%, 100%, 95% (v/v), 85% (v/v), 70% (v/v)] followed by a wash in
deionised water for 5min. Three washes in 0.01M PBS buffer with agitation for 3min
followed.
2.9.5.2 Antigen retrieval
Antigen retrieval allows the exposure of epitopes to allow antibodies to bind, whilst
preserving the morphology of the tissue. This was performed by pressure cooking
sections in 0.01M Na citrate (pH 6.0) buffer for 5min and leaving the slides to rest for a
further 20min. The slides were washed (3x3min) in 0.01M PBS buffer with agitation.
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2.9.5.3. Blocking
Endogenous peroxidase blocking prevents unrelated peroxidases from being visualised.
An endogenous peroxidase block (3% H2O2 in MeOH) was performed for lOmin at room
temperature. Sections were washed in 0.01M PBS buffer (3x3min) with agitation. An
avidin/biotin block was used to prevent non-specific binding. This consisted of
incubations with both blocking agents for 15min, each separated by a 2min wash with
0.01M PBS. Serum blocking with non-immunised animal serum prevents binding of
unrelated antibody, helping to reduce background staining. A non-immunised block was
carried out using a 1 in 5 dilution of goat serum (rabbit serum for the 11 [3HSD2 antibody)
in 0.01M PBS plus 5% BSA (this is referred to as goat serum in the following text) for
60min.
2.9.5.4. Primary antibodies
Primary antibodies diluted in goat serum were added (50pl per slide), covered with
parafilm and incubated at 4°C overnight. Table 2.10. shows the primary antibodies and
dilutions used. Negative controls were performed with each immunohistochemistry
performed; these controls were correctly matched IgG antibodies. Fig. 2.2 shows an
example of two negative control slides, all negative controls were negative for staining
but not all are shown in the following experimental chapters.
-v, -j -*
/ - ■ * A
Figure 2.2. Examples of negative
controls for DAB (A) and fluorescence
(B) immunohistochemistry.
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Table 2.10. Primary antibodies used on tissue.
Primary antibody Dilution Host species Secondary antibody Source
11PHSD1 1 100 Rabbit Goat anti-rabbit Cayman
11 (3HSD2 1 600 Sheep Rabbit anti-sheep Gift1
BMP-1 1 100 Rabbit Goat anti-rabbit Sigma
GR 1 1000 Rabbit Goat anti-rabbit ABR
Laminin 1 100 Rabbit Goat anti-rabbit Abeam
LOX 1 100 Rabbit Goat anti-rabbit Gift2
MMP-2 1 200 Rabbit Goat anti-rabbit Nova Castra
Mouse COL4a1 1 100 Rat Rat anti-mouse Gift3
Mouse COL4a2 1 100 Rat Rat anti-mouse Gift3
Mouse COL4a3 1 100 Rat Rat anti-mouse Gift3
Mouse COL4a4 1 100 Rat Rat anti-mouse Gift3
Mouse COL4a5 1 100 Rat Rat anti-mouse Gift3
Mouse COL4a6 1 100 Rat Rat anti-mouse Gift3
Nidogen 1 1 500 Rabbit Goat anti-rabbit Gift4
Nidogen 2 1 500 Rabbit Goat anti-rabbit Gift4
Perlcan 1 500 Rabbit Goat anti-rabbit Gift4
Gift a kind gift from Prof. Ian Mason, The University of Edinburgh.
Gift2 a kind gift from Dr Dawn Kirschmann, University of Iowa
Gift3 a kind gift from Dr Tom Van Agtmael, The University of Edinburgh (originally sourced from
Dr Yoshikazu Sado, Shigei Medical Research Institute, Japan).
Gift4 a kind gift from Dr Tom Van Agtmael, The University of Edinburgh (originally sourced from
Prof. Rupert Timpl, The Max Planck Institute of Biochemistry, Germany).
2.9.5.5. Secondary antibodies
Positive and negative slides were kept separate through all the wash stages. All washes
on the second day were performed in PBST (8g NaCl, 100pi Tween-20/litre 0.01M
PBS). Tween-20 is a detergent and helps to remove non-specifically bound antibody.
Overnight parafilm covers were removed and slides were washed (3x3min).
Biotinylated secondary antibodies were diluted 1:500 using goat serum and incubated on
slides at room temperature for 60min. The slides were washed (3x3min). The ABC
method was used to facilitate visualisation of primary-antibody staining by using the
affinity of avidin for biotin attached to the secondary antibody. ABC Elite was prepared
by adding 2 drops of solution A and 2 drops of solution B to 5ml 0.01M PBS buffer.
ABC Elite was prepared 30min prior to use to allow cross links to form between the two
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solutions. ABC Elite was then added to each slide. Tissue sections were covered and
incubated at room temperature for 60min. This was followed by 3x3min washes.
2.9.5.6. Antigen detection
Localisation of bound antibodies was determined using 3,3'-Diaminobenzidine
tetrahydrochloride (DAB) to visualise biotin peroxidase attached to the primary antibody
(ABC complex). One drop of DAB solution was mixed with 2ml of DAB buffer. The
bound antibody complex was visualised following 30sec incubation with DAB, and the
reaction was stopped by washing with distilled water. Slides were counterstained in
haematoxylin and dehydrated through increasing alcohol concentrations [70% (v/v),
85% (v/v), 95% (v/v), 100%, 100%] followed by xylene (2x5min) and mounted with
DPX mounting medium. Photographs were taken using brightfield microscopy as stated
in Section 2.9.2.
2.9.5.7. Fluorescence visualisation
Preparation for fluorescent visualisation is as detailed above up to the addition of the
primary antibody. After these steps positive and negative slides were kept separate
through all the wash stages. All washes were performed in PBST for 5min followed by
0.01M PBS for 5min.
Slides were washed and the secondary antibody was diluted (1:200 in goat serum) and
incubated at room temperature for 30min. Streptavidin 463 (red) or streptavidin 488
(green), which bind to the antibody complex and fluoresce, was diluted 1:200 in 0.01M
PBS and incubated on tissue sections for lh. Visualisation of the 11|3HSD1 antibody
was enhanced using a tyramide visualisation system (TSA™-Plus Tiramide Cy3nine 3
system). This kit is used in the place of streptavidin and involves a lOmin incubation of
tyramide diluted 1:50 in the kit diluent. The slides were then washed and counterstained
with TOPRO for 3min or Sytox green for 5min, to visualise cell nuclei. Slides were
washed with 0.01M PBS alone and mounted with Permafluor. Slides were stored at 4°C
in dark conditions. Staining was visualised using confocal microscopy (Zeiss LSM 510
Meta Axiovert 100M confocal microscope; Carl Zeiss Ltd., Welwyn Garden City, UK).
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2.10. Western Blotting
2.10.1. Sample preparation and electrophoresis
Animal tissues were homogenised in a protein lysis buffer supplemented with a protease
cocktail, using a Qiagen TissueLyser. Homogenised tissues were mixed with 4pl of 5 x
protein loading buffer (50mM Tris-HCl, 2% SDS, 0.1% Bromophenol Blue, 10%
Glycerol, lOOmM fi-mecaptoethanol), denatured by heating to 100°C for 5min, briefly
centrifuged and then loaded on to a polyacrylamide gel in a tank containing 1 x running
buffer (25mM Tris-base, 250mM Glycine (pH 8.3), 0.1% SDS). A voltage of 100 volts
was applied to the gel until the samples had run three-quarters of the way down the gel.
2.10.2. Blotting
The gel was then removed and placed into transfer buffer (192mM glycine, 25mM Tris,
20% MeOH). A transfer cassette was prepared consisting of: a fibre pad soaked in
transfer buffer placed against the black side of the cassette, and overlaid with a sheet of
filter paper. The gel was then placed onto the filter paper surface. A sheet of
Immobilon-P transfer membrane was placed in 100% MeOH for lmin, rinsed in water
then in transfer buffer, and then placed over the gel. A second sheet of filter paper and a
fibre pad were placed on top of the membrane. The cassette was closed and placed in
the transfer gel tank with an ice-cooling unit. Transfer buffer was added to the gel tank
and 100 volts were applied for one hour. The membrane was then removed and washed
in lxTBST (lOxTBST - 0.5M Tris, 9% NaCl, 0.5% Tween 20, pH 7.4, diluted 1:10 for
working concentration).
2.10.3. Blocking and primary antibody incubation
The membrane was placed into a blocking solution (5% milk in lxTBST) for one hour.
The primary antibody was diluted 1:1000 in blocking solution and the membrane was
placed in this solution overnight at 4°C.
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2.10.4. Secondary antibody incubation
The membrane was washed in lxTBST (3x5min) at room temperature. The secondary
antibody was added to the membrane at a dilution of 1:5000 in lxTBST and incubated at
room temperature for one hour, followed by further washes in lxTBST (3x5min).
2.10.5. Detection
Chemiluminescence was used to detect antibody binding using ECL Plus™ Western
Blotting Detection Reagents. ECL Plus™ was brought to room temperature according
to the protocol. Solutions A and B were mixed in a 1:40 ratio and applied to the
membrane for lmin. Excess ECL Plus was drained from the membrane which was then
wrapped in Saran Wrap™ and exposed to Kodak BioMax XAR film in the darkroom for
different exposure times and developed using a Compact x4 automatic developer
(Xograph, Imaging System Ltd).
2.11. in situ hybridisation
2.11.1. In situ probe preparation
All probes were designed previously and inserted into plasmid vectors. Plasmids were
amplified using RT-PCR with primers to T3 (AATTAACCCTCACTAAAGGG), T7
(GTAATACGACTCACTATA) or SP6 (AGCTATTTAGGTGACACTATAGA). Table
2.11. shows the plasmids, the inserted sequences and the primers used to amplify these
sequences.
Table 2.11. Plasmids into which probe sequences were inserted and primers used to amplify
these sequences.
Probe sequence Plasmid Primers
LOX pBluescript SK T7 (antisense), T3 (sense)
BMP-1 pGEM T easy T7 (antisense), SP6 (sense)
PCPE pGEM T easy T7 (antisense), SP6 (sense)
11pHSD1 pBluescript KS T3 (antisense), T7 (sense)
11PHSD2 pGEMT T7 (antisense), SP6 (sense)
11(BHSD1 and 11PHSD2 were kind gifts from the Endocrinology Unit, The University of
Edinburgh.
Chapter 2 Materials and Methods 75
Amplification creates a cDNA template for generating the in situ labelled probe. cDNA
templates were run on low melting-point agarose electrophoresis gels and visualised
under UV light. Bands of the correct size were excised with a clean scalpel blade, then
purified using a QIAquick gel extraction kit. An aliquot of the extracted DNA bands
was run on an agarose electrophoresis gel to confirm recovery.
2.11.2. Radiolabelling of RNA
cDNA template at a concentration of 0.5-1 pg/pi was radiolabelled using a transcription
reaction containing ImM ATP, CTP and GPT, 4pl 35S-UTP (1.48 MBq/pl), lOmM
dithiothreitol (DTT), 0.4pl RNase inhibitor and lpl of the appropriate RNA polymerase
(T3, T7 or SP6) to a total volume of lOpl in 1 x transcription buffer. After incubation at
either 37°C (T3 and T7) or 40°C (SP6) for 90min, lpl of RNase-free DNase was added
and incubated for a further 15min to degrade the template. Probes were then incubated
on ice for 5min before purification using NICK columns. Columns were washed with
3ml TE buffer (lOmM Tris HC1, ImM EDTA, pH 8.0) before application of the probe.
The column was washed with 400pl TE buffer then the probe was eluted in 400pl TE
buffer. Total activity of each probe was determined by scintillation counting using a [3-
counter. Probes were frozen at -20°C and used within 4 weeks.
2.11.3. Tissue sectioning
Paraffin embedded tissues were cut under RNase-free conditions using a Microm
microtome cleaned with RNAzap. Sections were floated on DEPC-H20 at 50°C, and
placed onto RNase-free polysine-coated slides. Slides were placed in baked slide racks
and tissue was heat-fixed overnight at 40°C.
2.11.4. De-waxing and fixation
All glassware was baked to remove RNases and DEPC-H20 was used to make up
solutions. Slides were dewaxed (2xl0min) in xylene then rehydrated through decreasing
EtOH solutions each for 2min (3x100% EtOH, 95% EtOH, 85% EtOH, 70% EtOH, 50%
EtOH and 30% EtOH). EtOH was removed by washing in 0.9% NaCl for 5min. Tissue
sections were then permeabilised in 0.3% Triton X-100 in lxPBS for 15min, followed
by 2x5min washes in lxPBS. Proteinase K digestion was performed on paraffin-
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embedded tissue to facilitate penetration of the probe. Proteinase K (lpg/ml in lOOmM
Tris-HCl, pH 8.0; 50mM EDTA) was incubated for 30 min at 37°C. Slides were washed
in 0.2% glycine to stop the proteinase K digestion.
Sections were immersed in cold 4% (w/v) paraformaldehyde in 0.1M phosphate buffer
(20mM NaH2P04, 80mM NaHP04) for lOmin to fix tissue, then washed (2x5min) in
lxPBS (137mM NaCl, 2.7mM KC1, lOmM Na2HP04, 2mM KH2P02). Tissue sections
were acetylated with 0.25% (v/v) acetic anhydride in 0.1M triethanolamine to reduce
non-specific binding of the probe to positively-charged amino groups in the tissue.
Slides were washed in lxPBS for 5 min then dehydrated through increasing EtOH each
for 2min (70% EtOH, 80% EtOH and 95% EtOH). Slides were left to dry, then either
pre-hybridised or stored at -20°C for 1-2 days (if stored slides need to be brought to
room temperature before prehybridisation).
2.11.5. Pre-hybridisation
Double strength pre-hybridisation buffer was prepared as follows; DEPC-H20 (5.88ml),
5M NaCl (2.4ml), 1M Tris, pH 7.5 (200pl), 50 X Denhardt's (400pl), 250mM EDTA,
pH 8.0 (80pl), lOmg/ml Salmon Sperm DNA (1ml), 50mg/ml Yeast tRNA (40pl). The
buffer was mixed well, aliquotted into RNase-free Eppendorf tubes and stored at -20°C.
'Box' buffer was prepared by mixing solutions in the following ratio (v/v): 20% 20 X
SSC (3M NaCl, 0.3M trisodium citrate in distilled-H20, pH 7.0 and autoclaved), 30%
DEPC-H20, 50% deionised formamide (150ml formamide mixed with 15g mixed bed
for lh at RT, then filtered twice and stored in a light-proof bottle). Whatman 3MM
chromatography paper was cut to fit hybridisation boxes. Two pieces of paper were
placed in each box and 20ml 'box' buffer was added to create a humid atmosphere.
A pre-hybridisation mix was prepared by diluting 2 x pre-hybridisation buffer 1:1 in
molecular-grade deionised formamide. Each slide required even dispersion of 200gl of
pre-hybridisation mix and was then placed in the hybridisation box. Slides were
incubated at 50°C for 2-3h.
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2.11.6. Hybridisation
Double strength hybridisation buffer was prepared as follows; DEPC-H20 (6.68ml), 5M
NaCl (2.4ml), 1M Tris, pH 7.5 (200pl), 50 X Denhardt's (400pl), 250mM EDTA, pH
8.0 (80pl), lOmg/ml Salmon Sperm DNA (200pl), Dextran sulphate (2.0g), 50mg/ml
Yeast tRNA (40pl). The buffer was mixed well, aliquoted into RNase-free Eppendorf
tubes and stored at -20°C.
The hybridisation step was carried out in a dedicated radioactive area. Probes were
removed from the -20°C freezer and allowed to thaw behind a Perspex screen. A
hybridisation mix was prepared by first calculating the required volume of mix. Each
slide required 200pl of hybridisation mix and an antisense and a sense mix was prepared
for each probe. For each hybridisation mix, 10 million counts were required per ml.
This was calculated from the cpm measured when the probes were generated. For each
ml of hybridisation mix, 500pl molecular grade deionised formamide was added, plus
the calculated amount of probe. The remaining volume was made up with 2 x
hybridisation buffer. The hybridisation mix was vortexed and incubated at 75°C for
lOmin to denature the probe. The hybridisation mix was cooled on ice, then lOpl/ml 1M
dithiothreitol (DTT) was added to reduce cross-linking of sulphur residues.
The prehybridisation mix was drained off the slides and excess solution was carefully
wiped off with a lens tissue. The hybridisation mix was then added to the slides, before
being returned to the hybridisation box and incubated at 50°C for 16h.
2.11.7. RNase treatments and washes
At this stage equipment no longer needs to be RNase-free, and distilled-H20 can be used.
Hybridisation mix was drained from the slides before placing the slides into racks.
Slides were washed (3x5min) in 2xSSC, and then treated with RNase to remove any
probe that had not hybridised. RNase 'box' buffer was prepared as follows for each
box: 5M NaCl (1ml), 1M Tris (lOOpl), 250mM EDTA (40pl) made up to 10ml with
distilled-H20. The 'box' buffer was added to Whatman 3MM chromatography paper cut
to fit the RNase boxes. 200pl of the same buffer was added to each slide, then RNase
(30pg/ml) was added (at 3pl/ml) to the RNase buffer. 2xSSC was drained from the
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slides and dried using lens tissue. Finally, the RNase mix was added and slides were
incubated at 37°C for lh.
Slides were then subjected to three stringent washes (2xSSC at room temperature for lh,
O.lxSSC at 60°C for lh followed by O.lxSSC at 60°C). The latter solution was removed
from the heat source when slides were placed into it allowing the temperature to fall for
lh. Slides were then dehydrated through 50% (v/v) EtOH, 70% (v/v) EtOH and 90%
(v/v) EtOEl (all containing 0.3M ammonium acetate), and allowed to dry overnight in a
fumehood.
2.11.8. Autoradiography
After the slides had dried the signal was visualised by exposure to Kodak BioMax MR
film for 1-7 days. Slides were placed into an autoradiography cassette in darkroom
conditions. Kodak BioMax MR film was positioned (matt side towards the slides) and
the cassette was closed. Films were developed using a Compact x4 automatic developer
(Xograph, Imaging System Ltd).
2.11.9. Nuclear emulsion
Nuclear emulsion was used to visualise radioactive grains where the target mRNA had
bound. Ilford G.5 emulsion was diluted 1:1 with distilled water and heated to 42°C.
Slides were dipped into the emulsion, and then left to dry overnight. Dry slides were
stored in light-proof boxes at 4°C for varying lengths of time (1-7 weeks) before being
developed.
2.11.10. Developing
All solutions were cooled on ice to 15°C and the developing protocol was conducted in
darkroom conditions. Slides were taken through the following solutions: Kodak D-19
developer (diluted 1:2 with tap water) for 4min, tap water (lOsec), Kodak GBH fixer
(diluted 1:5 with tap water) for lOmin, followed by a final 5min wash in tap water.
Slides were allowed to air dry for l-2h.
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2.11.11. Staining and mounting
Slides were counterstained with haematoxylin (lOsec), washed in tap water, and
followed by 20sec in Scott's tap water to "blue up" the haematoxylin stain. After a
further wash in tap water, slides were dehydrated through a series of alcohols, and
placed in Xylene (2x5min). Coverslips were mounted with DPX mounting medium.
Photographs were taken under darkfield microscopy (Provis AX70; Olympus Corp.
London, UK, fitted with a Canon DS6031 camera).
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3. Spatiotemporal expression of collagen pathway
biology genes and glucocorticoid signalling
components in the rat ovary: isolated cell studies.
3.1. Introduction
The ovarian ECM is subject to remodelling and injury during each oestrous cycle as
follicles grow and approach ovulation. The inflammatory mechanisms underpinning
tissue degradation leading to ovulation are well characterised and known to involve
proteases such as MMPs and their inhibitors (TTMPs) (Curry & Osteen 2003; Ny et al.
2002). However, the mechanisms involved in ECM reorganisation/remodelling during
follicular development have not been extensively investigated. One such mechanism is
likely to involve processing and cross-linking of collagen. Important collagen biology
pathway genes are BMP-1, LOX and PCPE. BMP-1 cleaves the C-terminal of
procollagen to create active collagen; a prerequisite for collagen incorporation into the
ECM. BMP-1 also cleaves pro-LOX to form active LOX and it is this latter enzyme that
leads to the covalent cross-linking of collagen that gives it its tensile strength
(Panchenko et al. 1996; Smith-Mungo & Kagan 1998). PCPE is important for the action
of BMP-1 on procollagen as it enhances the cleavage of the collagen precursor (Hulmes
et al. 1997). LOX has previously been shown to be present in the ovary of the mouse
(Hayashi et al. 2004), rat (Slee et al. 2001), rabbit (Himeno 1986), perch (Langenau et
al. 1999) and human (Yong et al. 2002). Slee et al (2001) have shown that LOX
expression dramatically decreases in rat granulosa cells as the ovarian follicle matures.
Within the ovary LOX has only been studied in granulosa cells and OSE. It is not yet
known whether this gene is expressed in theca cells. BMP-1 and PCPE have not been
studied to date in the ovary. However, their presence would be predicted as collagen
processing occurs in this tissue. Also since LOX, is known to be active in the ovary
(Harlow et al. 2003) BMP-1 is an obvious candidate for causing this activation.
Glucocorticoids are potential regulators of collagen pathway biology components in the
ovary because of their involvement in anti-inflammatory signalling. The ovary does not
actively synthesise glucocorticoids de novo, due to absent or immeasurably low levels of
Chapter 3 Isolated Cell Studies 81
CYP21 and CYP11B1 expression (Omura & Morohashi 1995). However, pre-receptor
regulation of glucocorticoid action presumably occurs due to differential expression of
lipHSD isoforms that interconvert active and inactive circulating adrenal
glucocorticoids (Mercer & Krozowski 1992). llpHSDl, the enzyme that activates
glucocorticoids (Section 1.2.1.2) increases as the follicle matures being most strongly
expressed at ovulation where it is proposed to be instrumental in the local regulation of
corticosterone that contributes to resolution of ovulation-associated inflammation
(Tetsuka et al. 1999a; Tetsuka et al. 1999b). Conversely, 11 [3HSD2 is responsible for
inactivating glucocorticoids and decreases with follicle maturation (Tetsuka et al.
1999b). Since ovarian GR seems to be expressed constitutively throughout follicular
maturation (Tetsuka et al 1999b), the differential expression of 11(3HSD1 and
11(3HSD2 is likely to be the major determinant of glucocorticoid signalling.
Evidence for the importance of glucocorticoid signalling in ovarian tissue remodelling
includes that the MMP and urokinase PA degradation pathways in granulosa cells are
suppressed by the synthetic glucocorticoid dexamethasone (Canipari et al. 1987; Harlow
et al. 1987; Pross et al. 2002). Additionally, dexamethasone has been shown to enhance
LOX expression in fetal lung cell cultures (Chinoy et al. 2000). Taken together this
evidence suggests that different aspects of tissue remodelling can be negatively
regulated by glucocorticoids. Therefore if both collagen pathway genes and
glucocorticoid regulatory genes are expressed in the ovary it is possible that
glucocorticoid signalling during follicular development could influence collagen
pathway genes.
This chapter aims to determine whether individual collagen pathway components are
expressed in particular ovarian cell types and whether their pattern of expression
changes as follicles mature. It also aims to confirm the presence of integral modulators
of the glucocorticoid signal.
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3.2. Materials and methods
3.2.1. Animals
Female rats treated with hormones to stimulate different stages of follicle development
as described in Section 2.1.1.
3.2.2. Cell isolation
Granulosa and theca cells were freshly isolated from rat ovaries as described in Sections
2.2.1 and 2.3.1.
3.2.3. RT-PCR
Qualitative RT-PCR was performed as described in Section 2.6, using the primers
shown in Table 3.1. that were designed specifically for rat tissue.
Table 3.1. Primer sequence and annealing temperature used for RT-PCR
Gene Forward primer sequence Reverse primer sequence Annealing
temperature
LOX CACTGGCAGTCTATGTCTGC TACTTCCAGTACGGTCTCC 55°C
BMP-1 AGAGGTAGATGAGTGTTCAAGG GTCAGACTTGAACTCCACACGC 61 °C
PCPE GCATCTGGACAATAACGGTGCC CAGTATGTGTCAGGCTCC 55°C
GR CTCTGCCTGGTGTGCTCCGATGAA CCTTAGGAACTGAGGAGAGAAGCA 65°C
11PHSD1 GTCCTGGTGCTCTGCCTGGGT ATGAAGCCGAGGACACAGAGA 65°C
113HSD2 GATGGACCTGACCAAGCCAGAGGATA CACATTAGTTCACTGCCTCTGTCTT 65°C
Actin CATTGAACACGGCATTGTCACC GGATGCCACAGGATTCCATACC 62°C
3.2.4. qRT-PCR
qRT-PCR was performed as described in Section 2.7 using custom designed
primer/probes for LOX, BMP-1 and PCPE rat mRNAs. Custom made primer/probe sets
for 11 (3HSD1 and 11 (3HSD2 rat mRNAs were also tested but proved ineffective. Rat
MMP-2 mRNA was quantified using an Assay-On-Demand™ assay (#Rn01538172_gl,
Applied Biosystems). Quantification of rat MMP-9 using the corresponding Assay-On-
Demand™ (#Rn00675894_gl, Applied Biosystems) was also attempted but failed due
to technical problems.
3.2.5. Statistical Analysis
Statistical analysis was performed on qRT-PCR data using ANOVA with Tukey post-
hoc testing or Student's paired t-test, depending on number of treatments. Statistical
difference was assigned at P<0.05. For each experimental set of data treatment groups
Chapter 3 Isolated Cell Studies 83
are compared to the untreated control group which was defined as a value of 1 and
therefore is shown graphically without variation about the mean. However statistical
analysis was performed on raw data (CT values) and this does account for variation
around the mean.
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3.3. Results
3.3.1. Expression of collagen pathway genes in relation to follicular
maturation.
Qualitative RT-PCR revealed that mRNA encoding the collagen pathway genes LOX,
BMP-l and PCPE were all expressed in granulosa and theca cells irrespective of stage of
follicular maturation (Fig. 3.1).
Figure 3.1. Expression of collagen pathway genes during follicular maturation. RT-PCR was
performed as described in Section 2.6 on freshly isolated granulosa and theca cells, from
21-day old female rats treated in vivo with or without gonadotrophins. Electrophoresis was
used to separate and visualise PCR products to show qualitative gene expression of the
collagen pathway genes: A, LOX; B, BMP-1; C, PCPE; D, p-Actin control. Loading for each
gel is as follows: lane 1, untreated granulosa cells; lane 2, untreated theca cells; lane 3,
PMSG granulosa cells; lane 4, PMSG theca cells; lane 5, PMSG/hCG granulosa cells; lane
6, PMSG/hCG theca cells.
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3.3.2. Expression of glucocorticoid signalling genes in relation to
follicular maturation.
Qualitative RT-PCR showed the presence of mRNAs encoding gene products necessary
for the production and activation of glucocorticoid metabolism and action throughout
follicular development (Fig. 3.2) i.e. both isoforms of 11 (3HSD and GR.
Figure 3.2. Expression of glucocorticoid signalling genes during follicular maturation. RT-PCR
was performed as described in Section 2.6 on freshly isolated granulosa and theca cells, from
21-day old female rats treated in vivo with or without gonadotrophins. Electrophoresis was used
to separate and visualise PCR products to show qualitative gene expression PCR gels showing
qualitative gene expression of the mechanisms that regulate the anti-inflammatory
glucocorticoids: A, 11 (3HSD1; B, 11 (3HSD2; C, GR; D, p-Actin control. Loading for each gel is as
follows: lane 1, untreated granulosa cells; lane 2, PMSG granulosa cells; lane 3, PMSG/hCG
granulosa cells; lane 4, untreated theca cells; lane 5, PMSG theca cells; lane 6, PMSG/hCG
theca cells.
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3.3.3. Quantitative assessment of collagen pathway genes in freshly
isolated rat granulosa cells in relation to follicle development.
Freshly isolated granulosa cells from follicles at various stages of development were
used for quantitative assessment of target inRNAs for LOX, BMP-1, PCPE and MMP-2.
The mRNA expression of these genes is shown in Figure 3.3. LOX mRNA
progressively declined with increasing follicular maturity. Conversely, MMP-2 mRNA
significantly increased during follicle maturation. BMP-1 and PCPE mRNAs did not















Figure 3.3. Quantitative measurement of collagen pathway gene expression in freshly isolated
granulosa cells from 21-day old female rats treated in vivo with and without gonadotrophins. qRT-
PCR, as described in Section 2.7, was used to measure mRNA expression of LOX (A), BMP-1 (B),
PCPE (C) and MMP-2 (D). * = P<0.05, ** = P<0.01 (compared to untreated).
Chapter 3 Isolated Cell Studies 87
3.3.4. Quantitative expression of collagen pathway genes in freshly
isolated rattheca cells in relation to follicle development.
The levels of LOX, BMP-1, PCPE and MMP-2 mRNAs in freshly isolated rat theca cells
were determined by qRT-PCR (Fig. 3.4). No significant effects of gonadotrophin
treatment were observed for BMP-1 or PCPE expression, although trends similar to those
observed for granulosa cells were detected. LOX mRNA decreased and MMP-2






























Figure 3.4. Quantitative measurement of collagen pathway gene expression in freshly isolated
theca cells from 21-day old female rats treated in vivo with or without gonadotrophins. qRT-PCR,
as described in Section 2.7, was used to measure mRNA expression of LOX (A), BMP-1 (B),
PCPE (C) and MMP-2 (D). * = P<0.05, ** = P<0.01.
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3.3.5. Granulosa versus theca expression of collagen pathway
genes.
Total mRNA from freshly isolated granulosa and theca cells was compared with respect
to quantitative gene expression of LOX, BMP-1, PCPE and MMP-2 (Fig. 3.5). There
was a significant difference between the expression of LOX mRNA in these two cell
types, with the greater expression in granulosa cells. No significant differences were
observed between the two cell types for BMP-1 or PCPE mRNAs. MMP-2 mRNA was





























Treatment and cell type Treatment and cell type
MMP-2
Figure 3.5. Comparison of collagen pathway mRNA from granulosa and theca cells freshly
isolated from gonadotrophin treated or untreated 21-day old female rats. LOX, BMP-1, PCPE
and MMP-2 mRNA levels were compared using qRT-PCR as described in Section 2.7.
Granulosa cells (GC), theca cells (TC). * = P<0.05, ** = P<0.01.
Chapter 3 Isolated Cell Studies 89
3.4. Discussion
These data show that genes involved in collagen deposition and remodelling are present
in the rat ovary, along with those genes required for glucocorticoid action and pre-
receptor glucocorticoid metabolism. Furthermore, these genes are regulated as follicles
mature and are expressed at different levels in granulosa and theca cells.
Most notably, LOX expression decreased as the follicle matured. The granulosa cell
located LOX decrease has previously been shown (Slee et al. 2001) but the LOX data
for theca cells are novel. Moreover, the results show that the LOX mRNA content of
theca cells is significantly lower than that of granulosa cells. This suggests that the main
follicular site of LOX mRNA expression is granulosa cells. LOX expression in theca
cell preparations could be due to granulosa cell contamination as the cell population
studied was essentially an enriched thecal cell population unavoidably contaminated
with granulosa cells.
Since the granulosa cell layer does not contain collagen the question arises as to why
LOX is expressed there. Presumably LOX that is involved in collagen cross-linking
may move to the basement membrane separating the granulosa and theca cells where it
could be instrumental in cross-linking collagen IV. However, it should be noted that it
has not been conclusively demonstrated that LOX causes cross-linking in the collagen
IV network, as discussed in Section 1.3.3.1.2.2. Interestingly, ,OSE cells also synthesise
and secrete large amounts of LOX (Rae et al 2007 in preparation). OSE cells also sit on
a basement membrane, further suggesting that LOX may have a role in cross-linking of
collagen IV. Collagens I and III are present in the stromal matrix (Palotie et al. 1984),
and LOX may cross the basement membrane to cross-link these collagens too.
Increased MMP-2, which is known to hydrolyse collagen substrate and basement
membrane components (Johnson et al. 1998), was observed in granulosa cells as
follicles matured. Thus the pattern of MMP-2 expression was inverse to that of LOX.
This might be expected given the opposing functions of these two remodelling enzymes.
Overall the data suggest that LOX is likely to be instrumental in matrix remodelling as
follicles mature. Thus as follicles grow, LOX action could allow for the expansion and
remodelling of the basement membrane and stromal collagens. As ovulation
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approaches, the follicle ceases to grow and the surrounding tissues must be broken down
to allow ovulation to occur. Hence the expression of MMPs such as MMP-1, -2, -9 and
-13 (Curry & Osteen 2003) increases, leading to degradation of the follicle wall to allow
oocyte release. The expression of these genes must therefore be tightly regulated to
sustain an environment conducive to development of the oocyte (within the growing
follicle) and its release at the appropriate time (ovulation). In vivo gonadotrophin
treatment in rats has shown that MMP-2 mRNA and activity were up-regulated as
ovulation approached (Curry et al. 2001). Therefore, there could be a direct influence of
gonadotrophins on MMP-2 expression and/or an indirect (autocrine or paracrine) effect
following cell stimulation by gonadotrophin. It is possible that the positive regulator of
MMP-2 may have an opposing effect on LOX. These questions are yet to be answered.
The data shown here confirm the prediction that BMP-1 and PCPE are present in both
granulosa and theca cells. Unlike LOX there is no significant regulation of these two
genes as follicles mature, suggesting that gonadotrophins may not regulate BMP-1 and
PCPE with increasing maturation. However, there was an increasing trend in the
expression of BMP-1 and PCPE. This could result in the synthesis of collagen necessary
for cross-linkage after ovulation, a time when LOX is up-regulated as shown in rabbit
and perch ovaries (Himeno 1986; Langenau et al. 1999). Fibrillar collagens are mainly
seen in corpus luteum (Luck & Zhao 1993). Thus collagen types I and III are both
increased in luteinised granulosa cells and are expressed in the early corpus luteum of
the cow and mouse (Oksjoki et al. 1999; Zhao & Luck 1995; Zhao & Luck 1996). This
would create a depot of substrate for LOX to cross-link during the development of the
corpus luteum, and during its subsequent remodelling throughout gestation if pregnancy
occurs.
When BMP-1 and PCPE expression were compared in granulosa and theca cells, no
differences were observed in relation to follicular maturation. This could be due to
cross-contamination of the cell populations by each other. More likely, these genes are
expressed in both cell types. As the thecal cells appear to express both BMP-1 and
PCPE, this would suggest that the area in which they are found outside the basement
membrane is rich in collagen. Their expression by granulosa cells may help boost that
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of the theca cells to cope with the high demand needed at times of intense tissue
reorganisation. This implies that, similar to LOX, both BMP-1 and PCPE have to cross
the basement membrane from the granulosa cell compartment to process procollagen.
This is plausible, as the molecular weight cut-off for the basement membrane is
estimated to be 100-850 kDa (Andersen et al. 1976) and the largest of these proteins is
BMP-1 which has an Mr of 70 kDa. Collagen I is expressed in the theca layer of the
follicle, but some collagen III is produced in the granulosa cell layer (Zhao & Luck
1995) suggesting that some procollagen processing may occur in the granulosa cell
compartment. Mature collagen could then pass across the basement membrane where it
could be incorporated into stromal ECM.
MMP-2 is a gelatinase that breaks down collagen. This enzyme has been reported
previously to be primarily expressed in theca/interstitial cells. The results of the
comparison of mRNA expression in this investigation confirm that there is a higher level
of expression in the theca cell population. This implies that MMP-2 may have an
important role in the degradation of collagens surrounding the follicle, especially at
ovulation when it was significantly up-regulated. Interestingly, compartmentalisation of
MMP-2 and LOX mRNA places them either side of the follicular basement membrane
where they exist in a distinctly inverse relationship. Perhaps paracrine interactions
between granulosa and theca cells control the expression of these genes, or possibly
unknown regulators of these genes act on both cell types. As yet, these questions cannot
be answered.
Proteolytic elements of tissue remodelling have been shown to be regulated by
glucocorticoids. In the ovary, it has been shown that the urokinase-PA system, (which
converts plasminogen to plasmin triggering a proteolytic cascade), is suppressed by
glucocorticoids (Canipari et al. 1987; Harlow et al. 1987; Ny et al. 2002). Potential
regulation of ovarian collagen pathway genes is via the (in)activation of glucocorticoids
by 11(3HSD enzymes, the presence of which, along with GR, were confirmed here at the
mRNA level. Although technical problems prevented quantitation of lipHSD mRNA
levels during this work, reference data published elsewhere are informative (Tetsuka et
al. 1999a; Tetsuka et al. 1999b; Tetsuka et al. 1997). Thus the preovulatory rise in
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llfiHSDl and corresponding fall in 11[SHSD2 activities cause a net increase in the intra-
follicular availability of active glucocorticoid (Harlow et al. 1997; Tetsuka et al. 1997).
At the same time LOX gene expression is depressed. So the potentially increased
availability of active glucocorticoid could suppress collagen remodelling. However,
whether the increase in llflHSDl (i.e. increased glucocorticoid availability) and
decrease in LOX are causally related remains to be determined.
In summary, collagen pathway genes and glucocorticoid regulatory genes are expressed
and regulated as the rat ovarian follicle matures. Therefore, there is potential for
glucocorticoid regulation of these collagen pathway genes. Whether and how such
regulation might occur is further explored in the following chapters.
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4. Spatiotemporal expression of collagen pathway
genes and glucocorticoid signalling components in the
rat ovary: histological studies.
4.1. Introduction
In the previous chapter the expression of collagen pathway genes and glucocorticoid
signalling regulators in freshly isolated rat ovarian cell types were explored and it was
concluded that expression changed during follicular development. Once expressed,
genes are then translated into protein, which then communicates, via signalling, to alter
the function of target cells. Therefore, it is important to assess the localisation of these
proteins as well as gene expression within these tissue compartments. This will give
valuable information on the sites of protein action and can shed light on relationships
between sites of synthesis and action in the different cellular compartments. The classic
ovarian example of this is the two-cell, two-gonadotrophin model of oestrogen synthesis
described in Section 1.1.1.2.
As discussed in Sections 1.1 and 1.3.3, granulosa and theca cells are separated by a
basement membrane. This basement membrane has been shown to contain collagen IV,
laminin, nidogen and perlecan proteins (McArthur et al. 2000; Rodgers et al. 1998; van
Wezel et al. 1998). Focimatrix, a novel ECM, is located between granulosa cells of
antral follicles (Irving Rodgers et al. 2004). Much of the work on the follicular
basement membrane has been conducted on bovine tissue. Therefore in some instances,
cross-species conclusions as to the nature of the basement membranes have been drawn.
Collagen pathway biology is important in the follicle, as LOX cross-links collagen and
BMP-1 processes the ECM components probiglycan, the y2 and a3 laminin chains and
chordin, as well as pro-lysyl oxidase. Outside the follicle, BMP-1 is essential in
processing fibril procollagen, a process enhanced by PCPE, and the resultant collagen
fibrils are stabilised by LOX.
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Protein localisation studies for BMP-1 and PCPE expression have not been conducted in
ovarian tissue. Investigations in rat bone types have revealed that BMP-1 protein is
present in the chondrocytes of growth plates as well as in osteoblasts and their
progenitor fibroblasts of the metaphyseal, metaphysic and epiphysis regions (Anderson
et al. 2000). These are areas of intense ECM remodelling during development, where
BMP-1 would be needed to cleave procollagens and pro-LOX, suggesting that BMP-1 is
required in areas of concentrated remodelling. BMP-1 and PCPE mRNA have been
localised in identical areas of mouse embryos using in situ hybridisation (Scott et al.
1999). This would be expected, as PCPE augments BMP-1 action on procollagens.
Therefore, given that growth of ovarian follicles is a period of intense remodelling, it is
likely that BMP-1 and PCPE proteins will be co-localised in follicles.
Studies of LOX protein expression in different mouse tissues show this protein is found
in most, if not all, regions of the body (Hayashi et al. 2004), as would be predicted,
given the role of LOX. LOX and LOXL proteins have been localised to the granulosa
cells of primary follicles of the mouse ovary (Hayashi et al. 2004). However, detailed
studies of LOX protein distribution have not been conducted during follicle growth. In
situ hybridisation showed LOX was confined to the granulosa cell layer of follicles of
the rat ovary, suggesting that LOX processing of the ECM stems from this cell layer
(Slee et al. 2001).
If collagen pathway components are regulated by glucocorticoids, the location of the
glucocorticoid signal regulators in the ovary will determine whether glucocorticoids
could affect expression of these genes. As the ovary does not produce glucocorticoids
de novo it is important to look at glucocorticoid signal regulators (1 IflHSD l, 11(3HSD2
and GR). Studies of localisation of these regulators in the ovary are limited. Ricketts et
al (1997) showed that lipHSDl protein was present in human liver, adrenal, ovary,
decidua and adipose tissue. 1 lpHSDl protein was observed in the oocyte and luteinised
granulosa cells of the corpus luteum of human ovarian tissue (Ricketts et al. 1997),
reflecting the expression of lipHSDl following ovulation (Tetsuka et al. 1997).
11PHSD2 protein localisation in the ovary has not been studied, but as gene expression
of this protein decreases as follicles mature it may be predicted that the protein will
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mirror this pattern (Tetsuka et al. 1997). Previous in situ hybridisation analysis of rat
ovaries has shown 11PHSD2 to be expressed in late luteal stages, indicating that this
tissue autoregulates glucocorticoid availability (Roland & Funder 1996). 11[1HSD
isoforms regulate the availability of active glucocorticoid, which then signals via GR.
GR protein has not been localised in the ovary. Immunolocalisation of GR protein
expression in human utems is unchanged across the menstrual cycle, in line with mRNA
expression in this tissue (McDonald et al. 2006). Hence it would be predicted that GR
protein will be present throughout follicle development in the rat ovary, mirroring the
expression pattern of GR mRNA (Tetsuka et al. 1999b).
This chapter aims to establish the spatiotemporal pattern of collagen pathway and
glucocorticoid signalling genes at mRNA and protein levels during rat follicular
development as the basis for mechanistic studies that will be described in Chapter 5.
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4.2 Materials and methods
4.2.1 Animals
Immature female rats were given in vivo hormone treatments to stimulate different
stages of follicular development as described in Section 2.1.1.
4.2.2 Tissue
Whole ovaries were fixed as described in Section 2.9.1.
4.2.3 Histological staining
The following histological stains were performed on the tissue: haematoxylin and eosin
as described in Section 2.9.2, Jones' methenamine silver basement membrane stain as
described in Section 2.9.4, and the picro-sirius red collagen stain as described in Section
2.9.3.
4.2.4 Western blotting
Ovarian homogenates were blotted for LOX and BMP-1 as described in Section 2.10, to
verify that these antibodies identified proteins of the correct size. PCPE was not studied,
as an antibody for this protein was not available. Other antibodies were verified
previously, either by other workers in the laboratory or by original sources.
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4.2.5 Immunohistochemistry
Immunohistochemistry was performed on tissue sections as described in Section 2.9.5.
Table 4.1. shows the antibodies used, the type of detection method and the
concentrations at which they were applied to the tissue sections.
Table 4.1. Antibodies used, their dilutions and method of detection used for visualisation.
Antibody Dilutions Detection method
BMP-1 1 100 Fluorescence
Collagen type IV 1 25 DAB and fluorescence
Laminin 1 100 DAB
LOX 1 100 Fluorescence
MMP-2 1 400 DAB
11PHSD1 1 100 Fluorescence
11pHSD2 1 600 Fluorescence
4.2.6 In situ hybridisation
In situ hybridisation was performed for BMP-1, LOX, PCPE, 11|3HSD1 and 11(3HSD2
as described in Section 2.11. In situ hybridisation for lipHSDl was unsuccessful.
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4.3 Results
4.3.1. Morphology of rat ovary following gonadotrophin treatment in
vivo.
The oestrous cycle is associated with follicular maturation and is driven by
gonadotropins. Figure 4.1 shows the morphology of ovaries from pre-pubertal rats that
have not been exposed to exogenous gonadotrophins. Follicles are situated within the
cortical interstitial tissue (Fig. 4.1A). Such follicles are recruited from primordial
cohorts, members of which have a single layer of flattened granulosa cells and no
distinguishable theca cell layer (Fig. 4.IB insert): through primary preantral follicles
(Fig. 4. IB) with one layer of granulosa cells, to secondary preantral follicles (Fig. 4. IB)
with multiple granulosa cell layers. In preantral follicles, the oocyte is in close contact
with the granulosa cells, allowing easy signalling between these cells (Fig. 4.1C). As
follicle growth progresses a cavity known as the antrum forms and the oocyte is
surrounded by cumulus cells to form the cumulus oocyte complex (Fig. 4.ID). Within
the cohort of follicles, which will be at different stages of development, larger follicles
begin to emerge (Fig. 4.IE). These are preovulatory follicles, which have multiple
layers of granulosa cells and are surrounded by several layers of theca cells (Fig. 4.IE).
The increase in follicle size is due to increased FSH stimulation, which was simulated by
giving PMSG in vivo. The final stage of follicle development is caused by a surge of
LH (mimicked by administration of hCG in vivo) to produce follicles on the verge of
ovulation (Fig. 4.1G/H).































Figure 4.1. Ovarian morphology of in vivo gonadotrophin-treated rat ovaries. Fixed
ovaries were stained with haematoxylin and eosin as described in Section 2.9. Immature
ovaries (A-D), pre-ovulatory ovaries (E-F), peri-ovulatory ovaries (G-H). A, immature rat
ovary, scale bar 100pm; B, preantral follicles, scale bar 50pm, black arrow, primary
follicle, green arrow, secondary follicle, the insert shows a primordial follicle, scale bar
20pm; C, preantral follicles, scale bar 20pm; D, antral follicle, scale bar 50pm; E, pre¬
ovulatory ovary, scale bar 100pm; F, preovulatory follicle, scale bar 100pm; G, peri-
ovulatory ovary, scale bar 100pm; H, peri-ovulatory follicle, scale bar 100pm. Primordial
follicle (Pr), ovarian surface epithelium (OSE), preantral follicle (PA), early antral follicle
(EA), primary follicle (PF), secondary follicle (SF), antral cavity (A), granulosa cells (GC),
theca cells/interstitial tissue (TC/IN), oocyte (O), stroma (S).







Figure 4.2. Histological localisation of basement membranes in the rat ovary.
Fixed rat ovaries were sectioned and stained for basement membrane using Jones'
methenamine silver basement membrane stain, as described in Section 2.9.4. A,
preantral and antral follicles in untreated rat ovary, scale bar 100pm, black arrow
shows basement membrane between granulosa and theca cells, purple arrow
shows basement membrane enclosing thecal layer; B, preovulatory follicle in
PMSG-treated ovary, scale bar 50pm. Black arrow shows basement membrane
between granulosa and theca cells; red arrow shows the basement membrane on
which the OSE are situated. Granulosa cells (GC), theca cells (TC).
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Figure 4.3. Histological localisation of ovarian basement membranes during rat follicular
development. Ovaries from gonadotrophin treated rats were stained with picro-siruis red as
described in Section 2.9.3. A, picro sirius red staining in the rat ovary viewed under light
microscopy, scale bar 100pm; B, ovarian stroma viewed under polarising light microscopy, scale
bar 50pm; C, untreated rat ovary viewed under light microscopy, scale bar 50pm; D, untreated rat
ovary (seen in C) viewed under polarising light microscopy, scale bar 50pm; E, preovulatory
follicle wall viewed under light microscopy, scale bar 50pm; F, follicle wall (from E) viewed under
polarising light microscopy, scale bar 50pm; G, periovulatory follicle wall viewed under light
microscopy, scale bar 50pm; H, follicle wall from G viewed under polarising light, scale bar 50pm.
Granulosa cells (GC), theca cells/interstitial tissue (TC/IN), basement membrane (BM).


























Figure 4.4. Localisation of laminin protein during follicular development.
Ovaries from gonadotrophin-treated 21-day old rats were fixed and stained with
laminin antibody as described in Section 2.9.5. A, immature ovary, insert shows
negative control, scale bar 100pm; B, preantral follicle, scale bar 20pm; C, early
antral follicle, scale bar 50pm; D, pre-ovulatory ovary, insert negative control,
scale bar 100pm; E, preovulatory follicle, scale bar 50pm; F, peri-ovulatory rat
ovary, insert negative control, scale bar 100pm; G, follicle wall of periovulatory
follicle, scale bar 50pm. Basement membrane (BM), - preovulatory follicle (PO),
periovulatory follicle (Peri), antral cavity (A), granulosa cells (GC), theca
cells/interstitial tissue (TC/IN), oocyte (O).
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4.3.3. Visualisation of collagen pathway gene and protein expression
in the ovary
In situ visualisation of the location of mRNA expression was performed using radio-
labelled probes for candidate collagen pathway genes (BMP-1, LOX and PCPE).
Protein localisation was performed for BMP-1, LOX and MMP-2. Western blotting
confirmed that the antibodies for BMP-1 and LOX detected proteins of the required size
(Fig. 4.5).
PCPE mRNA in rat ovarian tissue (Fig. 4.6) showed mRNA present around follicles,
with more intense hybridisation in the thecal region of the immature ovary. Expression
declined as follicle maturation progressed, with PCPE being faint or absent in pre¬
ovulatory and peri-ovulatory follicles.
BMP-1 mRNA labelling in the maturing rat ovary was most intense in the immature
ovary, and mainly localised to the stromal/theca area around follicles (Fig. 4.7).
Follicular maturation was associated with a decrease in BMP-1 mRNA, although
periovulatory follicles had some thecal/stromal hybridisation, with discrete patches
being observed in the granulosa cells (Fig. 4.7). BMP-1 protein was not observed
around primordial follicles nor at the outer surface of the immature ovary (Fig. 4.8A).
However, protein staining was strong in the granulosa cells of preantral and early antral
follicles (Fig. 4.8B/C). In these follicles there was some nuclear staining of the
granulosa cells. As follicles matured, BMP-1 was also detected in the theca layers (Fig.
4.8D/E/F). BMP-1 protein was localised in oocytes (Fig. 4.8A/C), oocytes are
recognised as a sticky tissue therefore caution should be used when drawing conclusions
as to the specificity of the location of protein in this tissue.
Preantral and early antral follicles of untreated rat ovaries had the highest expression of
LOX mRNA, and expression appeared to decline as follicles matured (Fig. 4.9). LOX
mRNA in these follicles was confined to the granulosa layer. There was some LOX
expression in pre-ovulatory ovaries, at the periphery of the pre-ovulatory follicles.
Lower levels of LOX were present in peri-ovulatory ovaries. In the immature ovary,
LOX protein was not associated with primordial follicles (Fig. 4.10A) but was seen in
the granulosa cell layer and thecal region of preantral and early antral follicles (Fig.
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4.10B/C). Small amounts of LOX protein were seen in the OSE basement membrane
(Fig. 4.1 OA). LOX protein continued to be associated with granulosa and theca cells as
follicles matured (Fig. 4.10D/E/F).
Expression patterns for the collagen pathway genes are compared in Figure 4.12.
In situ hybridisation was not attempted for MMP-2 but protein was localised to the
interstitial tissue of the immature ovary (Fig. 4.11A/B). However, as ovulation
approached some MMP-2 protein was observed in the granulosa cell compartment,
although the majority was outside this layer (Fig. 4.11C/D). This trend continued up to
ovulation (Fig. 4.11E/F).
Figure 4.5. Western blotting for BMP-1 and LOX in rat
ovarian tissue. Antibodies for BMP-1 and LOX were used
to detect protein in rat ovary culture medium or tissue
homogenate as described in Section 2.10. Samples were
run against a commercial size marker. A, BMP-1 in
granulosa cell culture medium; B, LOX in ovary
homogenates.
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Figure 4.6. PCPE mRNA localisation during follicular development. In situ hybridisation as
described in Section 2 11 was performed on fixed ovarian tissue from untreated or
gonadotrophin-treated 21-day old female rats. Anti-sense positively hybridised tissue is
shown on the left and sense controls on the right for each of the three rat treatment groups.
Granulosa colls (GC), theca layers/interstitial tissue (TC/IN). Scale bars untreated
antisense 50 pm, all other scale bars 100pm.
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Senss conlrol
Figure 4.7. BMP-1 mRNA localisation during follicular development. In situ hybridisation as
described in Section 2.11. was performed on fixed ovarian tissue from untreated or
gonadotrophin-treated 21-day old female rats. Anti-sense positively hybridised tissue is
shown on the left and sense controls ori the right for each of the three rat treatment groups.
Granulosa cells (GC), theca layers/interstitial tissue (TC/IN). Scale bars untreated
antisense 50 pm, all other scale bars 100pm.
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Figure 4.8. Localisation of BMP-1 protein during follicular development. Ovaries from
untreated or gonadotrophin-treated 21-day old female rats were fixed and stained with
BMP-1 antibody as described in Section 2.2.9.5. Red = BMP-1, Green = nuclear
counter stain. A, Immature ovary with primordial follicles and OSE; B, immature ovary
with preantral follicles; C, antral follicle from immature ovary; D, follicle wall of a
preovulatory follicle (PMSG treated); E, follicle wall of a periovulatory follicle (inner
section); F, follicle wall of a periovulatory follicle (outer section) with OSE edge.
Primordial follicle (Pr), ovarian surface epithelium (OSE), preantral follicle (PA), antral
cavity (A), granulosa cells (GC), theca cells/interstitial tissue (TC/IN), oocyte (O). Scale
bars 20pm.
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Figure 4.9. LOX mRNA localisation during follicular development. In situ hybridisation
as described in Section 2.11. was performed on fixed ovarian tissue from untreated or
gonadotrophin-treated 21-day old female rats. Anti-sense positively hybridised tissue is
shown on the left and sense controls on the right for each of the three rat treatment
groups. Granulosa cells (GC), tneca layers/interstitial tissue (TC/IN). Scale bars 100pm.
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Figure 4.10. Localisation of LOX protein during follicular development. Ovaries
from untreated or gonadotrophin-treated 21-day old female rats were fixed and
stained with LOX antibody as described in Section 2.2.9.5. Red = LOX, green =
nuclear counterstain. A, immature ovary showing OSE and primordial follicles;
B, preantral follicle from immature ovary; C, early antral follicle from immature
ovary; D, preovulatory follicle; E, inner wall of periovulatory follicle; F, external
wall of periovulatory follicle. Antral cavity (A), granulosa cells (GC), theca
cells/interstitial tissue (TO/IN), ovarian surface epithelium (OSE), primordial
follicle (Pr), preantral follicle (PA). Scale bars 20pm.
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Figure 4.11. Localisation of MMP-2 protein during follicular development. Ovaries
from untreated or gonadotrophin-treated 21-day old female rats were fixed and
stained with MMP-2 antibody as described in Section 2.2.9.5. Rat ovaries stained
with MMP-2 antibody. A, immature ovary, scale bar 100pm, insert negative control;
B, interstitial area between immature follicles, scale bar 20pm; C, preovulatory rat
ovary, scale bar 100pm, insert negative control; D, preovulatory follicle, scale bar
100pm. E, periovulatory ovary, scale bar 100pm, insert negative control; F,
periovulatory follicle, scale bar 20pm. Preantral follicle (PA), early antral (EA), antral
cavity (A), granulosa cells (GC), theca cells/interstitial tissue (TC/IN), preovulatory
follicle (PO), periovulatory follicle (Peri).
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Figure 4.12. The spatiotemporal expression patterns of the collagen pathway genes during
follicular development. Here comparisons between the expression patterns of PCPE, BMP-
11 and LOX can be made at the different simulated stages of follicular maturation shown in
the figures above using in situ hybridisation as described in Section 2.11. on fixed ovarian
tissue from untreated or gonadotrophin-treated 21 day old female rats.
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4.3.4. Localisation of glucocorticoid regulation mechanisms during
follicular maturation.
Glucocorticoid signalling components were localised by in situ hybridisation and/or
immunohistochemistry.
The in situ hybridisation analysis of 1 lpHSDl (Fig. 4.13) generally showed a very low
level of specific hybridisation signal with a possible increase in peri-ovulatory ovaries.
The overall impression of the 11 [1HSD1 expression by in situ hybridisations would
suggest that the analysis failed for unknown technical reasons. l lfiHSDl protein was,
however, clearly located around granulosa and theca cells of preantral and antral
follicles from immature ovaries (Fig. 4.14A/B). As follicles matured lipHSDl protein
was mostly associated with granulosa cells (Fig. 4.14C/D).
The 11PHSD2 in situ hybridisation analysis was successful and showed 11PHSD2
mRNA expression in rat ovaries (Figure 4.15). The expression of this gene was greatest
in the granulosa region of follicles from immature rat ovaries and decreased as follicles
grew. This was reflected in the protein localisation, where llpHSD2 was strongly
associated with preantral and early antral granulosa cells and decreased as follicles
matured (Fig. 4.16).
GR in situ hybridisation was not attempted. GR protein was mainly localised to follicles
at all stages of development and was present in both the granulosa and theca layers (Fig.
4.17). Stromal tissue did not contain much GR.






















Figure 4.13. 11PHSD1 mRNA localisation during follicular development. In situ
hybridisation as described in Section 2.11. was performed on fixed ovarian tissue
from untreated or gonadotrophin-treated 21-day old female rats. Anti-sense
positively hybridised tissue is shown on the left and sense controls on the right for
each of the three rat treatment groups. Granulosa cells (GC), theca layers/interstitial
tissue (TC/IN). Scale bars 100pm.
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Figure 4.14. Localisation of 11pHSD1 protein during follicular development.
Ovaries from untreated or gonadotrophin-treated 21-day old rats were fixed and
stained with 11[3HSD1 antibody as described in Section 2.2.9.5. Red = 11(BHSD1,
green = nuclear counter stain. A, preantral follicles from immature ovaries; B, early
antral follicle from immature ovary; C, wall of preovulatory follicle; D, wall of a
periovulatory follicle. PA, preantral follicle. Antral cavity (A), granulosa cells (GC),
theca cells/interstitial tissue (TC/IN), oocyte (O). Scale bars 20pm.
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Figure 4.15. 11(3HSD2 mRNA localisation during follicular development. In situ
hybridisation as described in Section 2.11. was performed on fixed ovarian tissue
from untreated or gonaaotrophin-treated 21-day old rats. Anti-sense positively
hybridised tissue is shown on the left and sense controls on the right for each of
the three rat treatment groups. Granulosa cells (GC), theca layers/interstitial
tissue (TC/IN). Scale bars 100pm.
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Figure 4.16. Localisation of 11PHSD2 protein during follicular development.
Ovaries from untreated or gonadotrophin-treated 21-day old rats were fixed and
stained with 11PHSD2 antibody as described in Section 2.2.9.5. Red = 11PHSD2,
green = nuclear counter stain. A, preantral follicles from immature ovaries; B, early
antral follicle from immature ovary; C, follicle wall of preovulatory follicles from PMSG
treated rats; D, periovulatory follicle wall. Preantral follicle (PA), antral cavity (A),
granulosa cells (GC), theca cells/interstitial tissue (TC/IN), oocyte (O). Scale bars
20pm.
Chapter 4 Histological Studies 118














Figure 4.17. Localisation of GR protein during follicular development. Ovaries
from untreated or gonadotrophin-treated 21-day old rats were fixed and stained
with GR antibody as described in Section 2.2.9.5. A, immature ovary, scale bar
100pm; B, preantral and antral follicles, 50pm; C, pre-ovulatory ovary, scale bar
100pm, D, pre-ovulatory follicle wall, scale bar 20pm; E, periovulatory ovary,
scale bar 100pm; F, wall of a periovulatory follicle, scale bar 50pm. Preantral
follicle (PA), early antral (EA), Antral cavity (A), granulosa cells (GC), theca
cells/interstitial tissue (TC/IN), oocyte (O), periovulatory follicle (Peri).
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4.4 Discussion
As seen in the previous chapter, mRNA levels for collagen synthesis and degradation
genes change in response to in vivo gonadotrophin treatment of immature female rats.
By further using gonadotrophin-treated rats, ovaries were obtained at staged points
during follicular development (Fig. 4.1). These developmentally staged ovaries were
used to establish spatiotemporal distribution of genes and their transcribed proteins from
the collagen pathway (BMP-1, LOX, PCPE and MMP-2) and from glucocorticoid
signalling (llpHSDl, llpHSD2 and GR).
The major findings from these investigations were that LOX mRNA was prominently
localised to the granulosa cells of immature follicles, whereas the translated protein was
observed in all ovarian compartments. BMP-1 mRNA was mostly located in the theca
and interstitial regions with protein mainly detected in the granulosa layers. The two
11PHSD isoforms were seen to have an inverse relationship; with 11PHSD2 being
predominant in early follicle development and lipHSDl prevails as follicles matured.
The rat ovary is compartmentalised by the basement membrane between granulosa and
theca cells, as well as basement membranes that enclose the thecal layer, and the
external circumference of the ovary on which the OSE reside (Fig 4.2). Rat ovaries
showed fibrillar-collagens I and III in the stroma, and collagen IV in the basement
membrane of the follicles (Fig. 4.3). Although faint it could be seen that this basement
membrane appeared to lose its integrity as follicles approached ovulation.
Fragmentation of the basement membrane has been reported previously in luteinising
and atretic rat follicles (Bagavandoss et al. 1983; Palotie et al. 1984). This is a
consequence of the actions of degrading proteases which have been shown to destroy the
follicular basement membrane and which are up-regulated approaching ovulation (Espey
1994; Ohnishi et al. 2005).
To confirm the position of basement membranes in the rat ovary, laminin was used as a
marker as this protein is one of the major components, forming a network that interacts
with the collagen IV network (Sasaki et al. 2004). Immunohistochemical localisation
showed that laminin protein in maturing ovaries was localised to the basement
membrane, as previously shown by Leardkamolkarn & Abrahamson (1992). As follicles
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matured, laminin staining became less discrete at the basement membrane, further
highlighting the effects of degradation initiated by the LH surge that breaks down this
structure in preparation for ovulation (Espey 1994; Ohnishi et al. 2005).
Laminin protein detected within the granulosa cell layer of antral follicles could mark
what has been termed the 'focimatrix', a novel matrix between granulosa cells of antral
bovine follicles that is believed to effect cell polarity (Rodgers et al. 2004). ECM
components, in particular laminin, appear to promote cell survival and proliferation of
granulosa cells (Le Bellego et al. 2002; Taipale & Keski-Oja 1997). Given that laminin
was more abundant in growing follicles compared to follicles on the verge of ovulation,
its distribution mirrors that of cell proliferation that occurs through development.
The previous chapter showed that collagen pathway components were present in the rat
ovary. Here these elements were visualised within this tissue. In situ hybridisation for
PCPE and BMP-1 showed similar patterns of expression (Fig. 4.12). These two genes
have been shown to be similarly distributed in other tissues (Scott et al. 1999). PCPE
and BMP-1 were both expressed in preantral/early antral follicles, with expression being
most intense in the theca layer. However, there was also some expression observed
within the granulosa cell layer. Presence of PCPE mRNA in the immature follicles
implies that the translated protein would serve to enhance the actions of BMP-1 in
cleaving procollagen to produce the substrate for LOX to form mature collagen in the
stroma. Collagen I and III have been observed in the connective tissue of the theca layer
during follicle maturation (Palotie et al. 1984). As follicles developed, expression of
PCPE and BMP-1 declined. This would result in a decrease in the cleavage of
procollagen, reflecting a decline in the need for mature collagen. Prior to ovulation,
PCPE and BMP-1 mRNA were expressed in the theca layer and in discrete regions of
the granulosa layer of the periovulatory follicle, indicating a resumption of collagen
processing. After ovulation, early luteal tissue contains collagen fibrils (Luck & Zhao
1993). Perhaps the expression of BMP-1 and PCPE in follicles on the verge of
ovulation produces collagen substrate for the remodelling necessary to form the corpus
luteum. Given the speed at which this structure forms, a pre-synthesised source of
collagen may aid this remodelling event.
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The presence of PCPE and BMP-1 denotes the production of mature collagen fibrils,
therefore the localisation of LOX will give information as to where these collagen fibrils
are stabilised into rigid structures by cross-linking in the ovary. The localisation of LOX
gene expression using in situ hybridisation showed that the main site and stage of LOX
mRNA expression was in preantral/early antral granulosa cells. This discrete mRNA
expression pattern of LOX could create a tight window of expression in preantral/early
antral follicles that might produce enough pro-LOX to be used during follicular
remodelling. This could in turn be regulated by BMP-1 in areas where remodelling
needs to occur. Evidence for this comes from studies in skin wounding, that show that
there can be an extensive period of time between mRNA expression and activation of
LOX protein (Fushida-Takemura etal. 1996; Siegel 1979).
LOX protein was observed at all stages of follicular growth, apart from primordial
follicles (which are quiescent) and protein was localised to both granulosa and theca cell
compartments in growing follicles. Other possible sources of LOX are ovarian
fibroblasts though they may not have been visualised on the in situ hybridisation.
Myofibroblasts cells surrounding human breast tumours and fibroblasts associated with
the skin have been shown to produce LOX (Chanoki et al. 1995; Peyrol et al. 1997). In
the ovary, fibroblasts are thought to reside found in the stroma and thecal regions,
potentially providing a source of LOX. As these cells were not observed by in situ
hybridisation, it may be assumed that their contribution would be small.
In the previous chapter, it was shown that the theca cell population expressed
significantly less LOX mRNA than the granulosa cell population. These mRNA levels
were measured by quantitative real-time PCR, which is a more sensitive technique than
in situ hybridisation, suggesting that the theca population may in part contribute to
ovarian LOX. Another ovarian source of LOX are the OSE cells (Rae et al. 2004a; Rae
et al 2007 in preparation). As LOX gene expression was predominantly localised to the
granulosa cell layer of preantral/early antral follicles, and protein was seen throughout
the ovary, it is possible that the protein moves from its site of origin. This would
involve traversing the basement membrane, a region where LOX may act to stabilise
collagen IV by cross-linking.
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Interestingly, not every preantral follicle expressed LOX mRNA. Is the lack of
expression a factor determining the fate of a follicle, or a consequence of its fate? TGF-
(3 is low or undetectable in atretic follicles (Chegini & Flanders 1992) and TGF-J3
stimulates LOX expression and activation (Harlow et al. 2003; Hong et al. 1999;
Shanley et al. 1997). This suggests that in follicles that do not express TGF-P, LOX will
not be stimulated and therefore LOX will not be present to stabilise collagen
remodelling around the follicle leading to atresia.
The antibody used in these investigations was shown to detect pro-forms of LOX (Fig.
4.5) as well as the active form. Hence, LOX staining may not necessarily parallel
biochemical enzyme activity. It is not known how much of the protein that was
visualised was active. Even if not all the protein is active, this staining represents a
potential pool from which active protein can be formed. This phenomenon is seen in
wounding studies, where mRNA levels peak at 3 days post-wounding but activity is
measured only 8-10 days after injury (Fushida-Takemura et al. 1996; Siegel 1979).
The focus of these studies was the function of LOX in ECM remodelling and LOX
protein was either localised to the cytoplasm of cells or was extracellular; it was not
localised to the nuclei of cells. However, this enzyme has also been shown to have
intracellular functions and other systems see LOX associated with the nuclei, at nuclear
pores and in association with condensed chromatin in the nucleus, indicating
involvement in the cell cycle (Kagan & Li 2003; Molnar et al. 2005). Work by
Palamakumbura et al (2004) has shown that the cleaved pro-peptide region of LOX will
associate with the nucleus of cells. This region has been shown to have tumour-
suppressor properties by stopping over-proliferation via the ras pathway (Contente et al.
1990; Palamakumbura et al. 2004). The probable intracellular targets are histones,
which can be oxidised by LOX and subsequently influence gene transcription
(Giampuzzi et al. 2003). LOX (and LOXL) have been localised in proliferating cells
such as spermatocytes, chondocytes, cornea epithelia as well as granulosa cells (Hayashi
et al. 2004). The significance of this localisation to proliferating cells has not been
determined but may relate to the nuclear functions of LOX. The antibody used here
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does not detect this 18kDa pro-region. Hence LOX could have nuclear actions on the
cell cycle of granulosa cells.
The distribution of BMP-1 may provide clues as to where LOX is active in the ovary, as
BMP-1 must cleave pro-LOX to form the active protein (Pappano et al. 2003; Uzel et al.
2001). Hence, areas that contain both BMP-1 and LOX protein are most likely to be
areas where LOX is active. BMP-1 protein was localised in the granulosa cells of
preantral follicles, which are sites of intense LOX mRNA expression. As follicles
matured, BMP-1 was observed more extensively throughout the ovary in areas where
LOX protein was also observed. This implies that LOX has the potential to be activated
in these areas during development where it is likely to function locally in remodelling.
By in situ hybridisation, BMP-1 gene expression was predominantly thecal. Therefore
the BMP-1 protein presumably passes across the basement membrane to the granulosa
cells of immature follicles in order to activate LOX. This can be likened to thecal
androgen passing to granulosa cells to provide substrate for aromatisation (Ryan & Short
1965), reinforcing the concept that cell-to-cell communication is integral to follicular
maturation. BMP-1 also cleaves probiglycan, the y2 and a3 laminin chains and chordin.
There are no specific reports of these ECM components in the rat follicle. However, in
situ hybridisation in embryonic mouse tissue showed that BMP-1 and chordin were
expressed in similar patterns in the hindlimb (Scott et al. 1999). Therefore, BMP-1 may
transverse the basement membrane to cleave other proteins besides pro-LOX. The
presence of BMP-1 would permit the activation of several ECM elements, highlighting
again the importance of protein components moving across the basement membrane of
the follicle to act in different cellular compartments.
Gene expression of MMP-2 was shown in Chapter 3 to have an inverse relationship with
that of LOX during follicle maturation, and was strongly expressed in theca cells. Here
MMP-2 protein was mainly localised to the thecal/interstitial area of all stages of
follicular development in the rat (Fig. 4. 11). MMP-2 is a gelatinase that breaks down
collagen, and as ovulation approaches this protein and other proteases start to degrade
the follicle wall of preovulatory follicles (Ny et al. 2002). Consequently, MMP-2
protein is seen in granulosa cells as well as theca cells. MMP-2 mRNA has previously
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been localised to the thecal/interstitial area of the ovary by in situ hybridisation during
follicular development (Curry et al. 2001; Liu et al. 1998). Thus initially, both MMP-2
mRNA and protein are confined to the theca/interstitial area but as the LH surge initiates
the process of ovulation, proteases are activated and MMP-2 protein can move to the
granulosa cell layer as the basement membranes degraded. In chapter 3 the levels of
MMP-2 mRNA were seen to increase as ovulation approached, yet the
immunohistochemistry does not appear to show an increase in protein levels. This could
be due to qRT-PCR being a more sensitive technique than immunohistochemistry and
therefore able to detect discreet changes in expression, changes in mRNA may not be
reflected in protein translation or may be seen after a timelag and immunohistochemistry
relies on the sensitivity of the antibody used.
Previous investigations have studied the mRNA levels of the signal regulators of
glucocorticoids in cells isolated from the rat ovary but there are only limited reports
about their localisation within this tissue.
The ovary does not produce glucocorticoid de novo but does contain the enzymatic
machinery to regulate the availability of active glucocorticoid (Tetsuka et al. 1997).
This regulation occurs through the expression of lipHSD isoforms (Lakshmi & Monder
1988; Mercer & Krozowski 1992). The expression profile of 11PHSD2, as shown by in
situ hybridisation, was greatest in the granulosa cells of immature follicles, but absent in
more mature follicles, confirming previous reports by Tetsuka et al (1999b). 11(3HSD2
protein was localised to the same areas as the mRNA.
Gene localisation studies for llfSHSDl gave inconclusive results in this study.
Therefore published data alluding to llfSHSDl mRNA localisation in the granulosa cells
has to be relied upon (Tetsuka et al. 1999b). When the protein localisation of 11|3HSD1
was examined, this enzyme appeared to be most strongly expressed in more mature
follicles, where the protein was present in both granulosa and theca cells. In the present
work, staining of 1 lflHSDl was not as intense as expected. This may be explained by
the time-lag of only 12h between the in vivo treatment of hCG and the time of animal
sacrifice. This time-delay is accounted for by the need for llpHSDl mRNA translation
to protein as well as subsequent glucocorticoid conversion. At the stage at which the
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ovaries in the present investigation were removed, mRNA would have been increasing
but protein levels may have only just have started increase, accounting for the low
intensity of the staining observed.
The data for the 11 (3HSD isoforms shows their inverse relationship in the ovary,
allowing for tightly-controlled regulation of glucocorticoid action in this tissue. Another
possible level of control is GR, as receptor availability ultimately determines whether
cells can receive the available signal. GR mRNA is expressed continually throughout
the rat oestrous cycle (Tetsuka et al. 1999b), and here GR protein was observed in both
the granulosa and theca layers of the follicle at all stages studied. Therefore,
glucocorticoid signalling during follicle development is not limited by receptor
availability as GR is readily available throughout follicle development. This highlights
the likely importance of the inverse expression pattern of lipHSD isoforms in
regulating glucocorticoid activity.
In summary, these investigations into mRNA and protein localisation have shown that
cellular sites of collagen pathway gene expression are reasonably compartmentalised
and change during follicular growth, whereas translated proteins are not so discretely
confined and are observed in most areas of the ovary during follicular development. The
genes encoding 11 pHSD isoforms involved in glucocorticoid pre-receptor regulation are
differentially expressed and developmentally regulated during follicular development.
Therefore, spatiotemporal expression of llflHSD genes has the potential to influence
collagen pathway biology within the ovary. The implications of this are examined in the
next chapter by using in vitro cultures of rat granulosa and theca cells to investigate the
actions not only of glucocorticoids but also of other known effectors of follicular
maturation on collagen pathway biology.
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5. Spatiotemporal expression of collagen pathway
genes in the rat ovary: in vitro studies.
5.1. Introduction
As seen in the previous chapters, collagen pathway genes and proteins are regulated during the
process of follicle development in the female rat. The factors responsible for these changes can
be scrutinised by removing granulosa and theca cells from the rat model and studying cause-
effect relationships.
As LOX seems to be active in many different situations, its expression is presumably
regulated by specific factors such as cytokines and growth factors (Smith-Mungo &
Kagan 1998). Some of these factors have been described, with TGF-(3 being the most
widely studied. TGF-(3 has been shown to increase LOX mRNA and activity time- and
dose-dependently, as well as up-regulating the LOX substrate, collagen type I (Feres-
Filho et al. 1995). In neonatal rat aorta smooth muscle cells, TGF-P increased LOX
mRNA expression but decreased cell proliferation (Gacheru et al. 1997). It is thought
that the increase in LOX by TGF-P is due to stabilisation of LOX mRNA (Gacheru et al.
1997).
LOX is activated by BMP-1, therefore regulators of this protein will also influence the
availability of LOX. BMP-1 was first isolated in a complex with two other proteins
from human bone (Wozney et al. 1988). The two other proteins were BMP-2 and -3,
which are part of the TGF-P superfamily, and suggested that BMP-1 may be involved in
activation of TGF-P family members (Bond & Beynon 1995). TGF-P is initially
secreted in a latent form that can be processed by BMP-1 causing a positive feed¬
forward regulation of matrix deposition (Ge & Greenspan 2006; Lee et al. 1997).
BMP-1 is up-regulated by TGF-P in fibrogenic cells and keratinocytes (Lee et al. 1997).
This positive regulation may involve TGF-p up-regulation of furin, the protease that
activates BMP-1 by cleaving its pro-domain (Leighton & Kadler 2003). Procollagen N-
proteinase is also up-regulated by TGF-P in fibrogenic cells (Wang et al. 2003) and
demonstrates that collagen cleavage can be regulated by TGF-p. Evidence for BMP-
1/TGF-P interactions also comes from the Drosophila tolloid (tld) gene. This has 41%
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homology to human BMP-1 and displays interactions during embryogenesis with
decapentaplegic (dpp), the Drosophila form of BMP-2, a TGF-P superfamily member
(Shimell et al. 1991; Wozney et al. 1988). Null mutants for dpp and tld show similar
phenotypes indicating a possible link between these two genes (Finelli et al. 1994;
Shimell et al. 1991).
BMP-1 cleaves procollagen to active collagen, a process that is enhanced by PCPE.
Therefore PCPE regulation will influence the effect that BMP-1 has on procollagen
cleavage. Collagen production shows a similar pattern to PCPE expression in bovine
smooth muscle cells (SMC) with respect to the stage of cell proliferation (Kindy et al.
1988). Presumably PCPE expression is stimulated or inhibited by cytokines expressed
by proliferating cells. Possible candidates also include TGF-P, as it causes the
expression of PCPE in SMC (Kanaki et al. 2000) and the up-regulation of PCPE and
procollagen I in rat liver stellate cell lines (Ogata et al. 1997).
TGF-P is an important regulator of ECM accumulation (Feres-Filho et al. 1995; Lee et
al. 1997; Massague 1990). In the rat ovary all three members of the TGF superfamily,
TGFp-1, -2 and -3, are differentially expressed in developing oocytes, granulosa cells
and theca cells (Chegini & Flanders 1992; Schmidt et al. 1992; Teerds & Dorrington
1992). Most studies of TGF-P influencing collagen pathway biology use TGF-pi. This
member of the TGF family is first expressed in preantral oocytes and granulosa cells
then at the time of antrum development appears in theca cells (Teerds & Dorrington
1992). The expression of TGF-pi increases in both cell types with follicle maturation.
Receptors for TGF-P family proteins are present in oocytes and follicular cells, as are
signal pathway components, Smad-2 and -3 (Juengel & McNatty 2005). In rodents,
TGF-P causes granulosa cell proliferation (although in other systems TGF-Ps can be
inhibitory) (Dorrington et al. 1988). TGF-P enhances the production of FSH-stimulated
oestrogen production in granulosa cells (Adashi et al. 1989). However, in theca cells,
TGF-P has inhibitory effects on LH-stimulated androgen production, but promotes
differentiation (Magoffin et al. 1989).
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To date there are no investigations of the regulation of BMP-1 and PCPE in the ovary,
but it would be predicted that these genes would be influenced by regulators of follicle
development.
Thus the available data suggest that TGF-(3 and related growth and differentiation factors
are likely to be of importance in mediating developmental-related changes in collagen
pathway biology gene expression during follicular development. The likelihood that
these genes are also subject to anti-inflammatory (glucocorticoid) modulation effects of
corticosterone may also be important. Here I describe interactions between
gonadotrophins/TGF-p/corticosterone on collagen pathway genes in isolated follicular
cells from immature rat follicles. In more mature follicles, where LH is the major
gonadotrophin drive, ovulation-associated cytokines such as IL-1 are also likely to be
important. Therefore the effect of this pro-inflammatory cytokine was also examined on
cells from preovulatory follicles.
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5.2. Materials and methods
5.2.1. Animals
Female Wistar rats were given in vivo hormone injections as described in Section 2.1.
5.2.2. Cell culture
Granulosa and theca cells were isolated and cultured as described in Sections 2.2 and
2.3.
5.2.3. RIA
Androstenedione was measured in culture medium used for theca cell cultures, as
described in Section 2.4.
5.2.4. RT-PCR
Freshly isolated granulosa and theca cells were assessed for the presence or absence of
aromatase (CYP19) gene expression as described in Section 2.6. The primer sequences
are shown in Table 5.1.
Table 5.1. Primer sequence and annealing temperature used for RT-PCR
Gene Forward primer sequence Reverse primer sequence Annealing
temperature
Aromatase GTATGAGAGATCCGTCAAGGAC TTGATCATCACATGGCGATGTAC 60°C
5.2.5. Quantitative real-time PCR
The mRNA expression for LOX, BMP-1 and PCPE was measured using quantitative
real-time PCR as described in Section 2.7.
5.2.6. LOX activity assay
LOX activity was measured in culture samples using the vacuum distillation method
described in Section 2.8. Many problems were encountered using this method so
activity data is not complete for all culture experiments.
5.2.7 Statistical analysis
All data (average dCT valves for qRT-PCR) were statistically tested with either a paired
t-test or repeated measures ANOVA according to the number of treatment groups being
assessed. The lowest level of accepted significance was P<0.05. For each experimental
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set of data treatment groups are compared to the untreated control group which was
defined as a value of 1 and therefore is shown graphically without variation about the
mean. However statistical analysis was performed on raw data (CT values) and
therefore does account for variation around the mean.
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5.3. Results
5.3.1. Cell morphology
Granulosa cells cultured from rats that have received in vivo hormone treatments showed
phenotypic differences when cultured (Fig 5.1). Granulosa cells (highlighted with black
arrows) from untreated rats (Fig. 5.1A) and rats that received PMSG (Fig. 5.IB) are
relatively small in size, whereas luteinised cells from animals treated with PMSG and
hCG (Fig. 5.1C) are larger. Theca cell populations (shown by blue arrows) from the
three groups of female rats showed similar differences in morphology (Fig. 5.1).









Figure 5.1. Cultured ovarian cell morphology. Cells
were isolated as described in Sections 2.2 (granulosa
cells) and 2.3 (theca cells) and cultured for 48h. A,
untreated rat granulosa cells; B, PMSG treated rat
granulosa cells; C, PMSG- plus hCG-treated rat
granulosa cells; D, untreated rat theca cells; E, PMSG
treated rat theca cells; F, PMSG- plus hCG-treated rat
theca cells. Arrows highlight representative cells, black
- granulosa cells, blue - theca cells, white - stromal
fibroblasts.
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5.3.2. Assessment of ovarian cell purity
The purity of the theca cell population studied was assessed by measuring androgen
(androstenedione) production. As shown in Fig. 5.2., treatment with LH (0.01 IU/ml) for
48h significantly increased androstenedione production, confirming the presence of
functional thecal cells. Further evidence for the quality of the thecal cell preparations
came from comparisons of CYP19 (aromatase) levels in separated theca and granulosa
cells. As shown in Fig. 5.3., theca cells were devoid of aromatase mRNA, whereas it
was readily detectable in granulosa cells from the same ovaries. This latter result, with
evidence that aromatase mRNA expression by granulosa cells was enhanced by PMSG















Figure 5.2. Theca cell population responsiveness to LH stimulus
measured by production of androstenedione. Thecal cells were
cultured as described in Section 2.4. with and without LH [0.01 lU/ml],
androstenedione production was measured in spent culture medium as
described in Section 2.4. N=4. *** = P<0.001 (compared to
untreated).
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Figure 5.3. Qualitative gene expression of aromatase during follicular
development. Cultured granulosa and theca cells were used for RT-PCR
as described in Section 2.6. Loading for each gel is as follows: lane 1,
untreated granulosa cells; lane 2, PMSG granulosa cells; lane 3,
PMSG/hCG granulosa cells; lane 4, untreated theca cells; lane 5, PMSG
theca cells; lane 6, PMSG/hCG theca cells; lane 7, negative control.
/
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5.3.3. Immature ovarian cells
Immature ovarian cells respond to an array of different growth factors, until the antrum
starts to form and the follicle becomes gonadotrophin-dependent. It is at this time that
granulosa cells respond to the influences of FSH and theca cells respond to LH.
5.3.3.1. Granulosa cells
Collagen pathway gene expression was assessed in granulosa cells cultured for 48h with
TGF-p (lOng/ml) or FSH (O.OlIU/ml) alone and in combination with corticosterone
(CORT) (lpM). Cells were also cultured with increasing concentrations of CORT
(OpM, O.OlpM, 0.1 uM. lpM). Changes in mRNA levels for PCPE, BMP-1 and LOX
were assessed as well as LOX enzyme activity.
No significant differences were found in mRNA levels for BMP-1 with any of the
culture treatments. PCPE mRNA expression was significantly decreased in the presence
of CORT. This was not consistently observed in additional experiments, therefore may
not be a real effect (Fig. 5.4). CORT alone did not significantly change LOX gene
expression or enzyme activity (Fig. 5.4).
When granulosa cells were cultured in the presence of TGF-P, a known enhancer of
LOX, a significant increase in both mRNA and activity was observed (Fig. 5.5). CORT
did not alter the TGF-P stimulated increase in LOX mRNA but may have reduced
activity levels (Fig. 5.5).
Immature granulosa cells were also cultured with FSH, the gonadotrophin to which these
cells would respond in vivo. LOX mRNA was not affected by FSH alone, but was
significantly decreased when both CORT and FSH were present (Fig. 5.6). A significant
difference was observed between cells treated with CORT with and without FSH,
indicating that FSH depressed the expression of this gene. Interestingly, FSH
significantly increased LOX enzyme activity data, and this effect was significantly
suppressed by the addition of CORT (Fig. 5.6).
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Figure 5.4. PCPE (A), BMP-1 (B) and LOX (C) mRNA expression
levels in cultured granulosa cells from untreated immature female
rats. Granulosa cells were cultured with increasing concentrations
of CORT for 48h as described in Section 2.2. Resultant mRNA
was measured for collagen pathway mRNA levels using qRT-PCR
as described in Section 2.7. N=3, * = P<0.05.
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Figure 5.5 PCPE (A), BMP-1 (B), LOX (C) mRNA expression levels and LOX enzyme activity (D)
levels in cultured granulosa cells from untreated immature female rats. Granulosa cells were
cultured with CORT [1pM] and/or TGF-(B [10ng/ml] for 48h as described in Section 2.2. Resultant
mRNA was measured for LOX mRNA levels using qRT-PCR as described in Section 2.7. Culture
medium was assessed for LOX enzyme activity using the LOX tritium vacuum distillation enzyme
assay as described in Section 2.8.1. N=4, * = P<0.05, ** = P<0.01.
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Figure 5.6 PCPE (A), BMP-1 (B), LOX (C) mRNA expression levels and LOX enzyme activity (D)
levels in cultured granulosa cells from untreated immature female rats. Granulosa cells were
cultured with CORT [1pM] and/or FSH [0.011U/ml] for 48h as described in Section 2.2. Resultant
mRNA was measured for LOX mRNA levels using qRT-PCR as described in Section 2.7. Culture
medium was assessed for LOX enzyme activity using the LOX tritium vacuum distillation enzyme
assay as described in Section 2.8.1. N=4, * = P<0.05, ** = P<0.01.
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5.3.3.2. Theca cells
Results for theca cells from immature follicles cultured with increasing concentrations of
CORT (OpM, O.OlfiM, 0.1 pM, lpM) or LH (O.OlIU/ml) or TGF-|3 (lOng/ml) with and
without CORT (lpM) are shown in Figures 5.7-5.9. LOX enzyme activity was not
measured in these cells.
BMP-1 gene expression was not affected by any of the culture treatments. PCPE mRNA
was not significantly affected by CORT or TGF-J3, and LOX mRNA was not influenced
by LH. LOX mRNA was significantly increased by CORT alone at 0.1pM and lpM
(Fig. 5.7). TGF-(3 was stimulating and the effects of TGF-(3 and CORT were additive
(Fig.5.8). There was a significant difference between CORT with or without TGF-fl.
Theca cells express LH receptors and therefore respond to LH. This gonadotrophin
significantly increased PCPE mRNA levels but this was reduced when CORT was also
present (Fig. 5.9).
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Figure 5.7. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from untreated
immature female rats. Granulosa cells were cultured with
increasing concentrations of CORT for 48h as described in
Section 2.2. Resultant mRNA was measured for collagen
pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=4, * = P<0.05.
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Figure 5.8. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from untreated
immature female rats. Granulosa cells were cultured with
CORT [1pM] and/or TGF-(B [10ng/ml] for 48h as described in
Section 2.2. Resultant mRNA was measured for collagen
pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=3, * = P<0.05, ** = PO.01, *** = P<0.001.
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Figure 5.9. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from untreated
immature female rats. Granulosa cells were cultured with
CORT [1pM] and/or LH [0.011U/ml] for 48h as described in
Section 2.2. Resultant mRNA was measured for collagen
pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=4. *** = P<0.001.
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5.3.4. PMSG-treated ovarian cells
In vivo treatment of PMSG in immature female rats simulates cells receiving FSH. This
allows continued development of the antrum so the follicle reaches its preovulatory
stage. Prior to ovulation granulosa cells begin to express LHR as a consequence of
ovarian FSH (Bums et al. 2001). Therefore cells from these follicles respond to LH as
well as growth factors. At this stage of development theca cells are responsive to
progesterone as they have receptors for this steroid. Granulosa cells however do not
acquire receptors until after the LH surge (Drummond 2006).
5.3.4.2. Granulosa cells
Granulosa cells from immature rats that had received PMSG to stimulate preovulatory
follicular maturation were cultured with LH (O.OlIU/ml), TGF-fl (lOng/ml) or IL-1
(500pg/ml), with and without anti-inflammatory steroids: CORT or progesterone
(PROG) (lpM). Readouts assessed were PCPE, BMP-1 and LOX mRNA, as well as
LOX enzyme activity.
PCPE was not affected by CORT, BMP-1 (Fig. 5.10) was significantly decreased by
CORT, while LOX gene expression and activity were significantly increased by CORT
(lgM) (Fig. 5.10/11).
TGF-|3 did not alter BMP-1 and PCPE expression, but did significantly increased LOX
mRNA expression with and without the addition of CORT (Fig. 5.11). LOX enzyme
activity was increased by CORT plus TGF-[3 over the untreated control and over
corticosterone alone (Fig. 5.11).
BMP-1 and LOX mRNA as well as LOX enzyme activity were unaffected by either LH
or IL-1. However, LH given to granulosa cells with or without CORT significantly
decreased PCPE gene expression (Fig. 5.12). The cytokine IL-1, used to simulate the
inflammation of ovulation, significantly decreased PCPE mRNA expression (Fig. 5.13)
when given alone or with corticosterone.
No significant differences were observed for any of the genes when PROG was given to
cells (Fig. 5.14/15).

















Figure 5.10. PCPE (A), BMP-1 (B) and LOX (C) mRNA expression levels in cultured granulosa
cells from PMSG-treated immature female rats. Granulosa cells were cultured with increasing
concentrations of CORT [0, 0.01, 0.1, 1pM] for 48h as described in Section 2.2. Resultant
mRNA was measured for collagen pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=4. Insert for BMP-1 shows CORT [OpM] compared to CORT [1pM] for N = 11.
*
= P = P<0.05, ** = P<0.01, *** = P<0.001.
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Figure 5.11 PCPE (A), BMP-1 (B), LOX (C) mRNA expression levels and LOX enzyme activity (D)
levels in cultured granulosa cells from PMSG-treated immature female rats. Granulosa cells were
cultured with CORT [1pM] and/or TGF-P [10ng/ml] for 48h as described in Section 2.2. Resultant
mRNA was measured for LOX mRNA levels using qRT-PCR as described in Section 2.7. Culture
medium was assessed for LOX enzyme activity using the LOX tritium vacuum distillation enzyme
assay as described in Section 2.8.1. N=3, * = P<0.05, ** = P<0.01.
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Figure 5.12. PCPE (A), BMP-1 (B), LOX (C) mRNA expression levels and LOX enzyme activity
(D) levels in cultured granulosa cells from PMSG-treated immature female rats. Granulosa cells
were cultured with CORT [1pM] and/or LH [0.01 lU/ml] for 48h as described in Section 2.2.
Resultant mRNA was measured for LOX mRNA levels using qRT-PCR as described in Section
2.7. Culture medium was assessed for LOX enzyme activity using the LOX tritium vacuum
distillation enzyme assay as described in Section 2.8.1. N=6. ** = P<0.01, *** = P<0.01.
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Figure 5.13. PCPE (A), BMP-1 (B), LOX (C) mRNA expression levels and LOX enzyme activity
(D) levels in cultured granulosa cells from PMSG-treated immature female rats. Granulosa cells
were cultured with CORT [1pM] and/or IL-1 [500pg/ml] for 48h as described in Section 2.2.
Resultant mRNA was measured for LOX mRNA levels using qRT-PCR as described in Section
2.7. Culture medium was assessed for LOX enzyme activity using the LOX tritium vacuum
distillation enzyme assay as described in Section 2.8.1. N=6. ** = P<0.01, *** = P<0.01.
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Figure 5.14. PCPE (A), BMP-1 (B), LOX (C) mRNA expression levels and LOX enzyme activity
(D) levels in cultured granulosa cells from PMSG-treated immature female rats. Granulosa cells
were cultured with PROG [10pM] and/or LH [0.01IU/ml] for 48h as described in Section 2.2.
Resultant mRNA was measured for LOX mRNA levels using qRT-PCR as described in Section
2.7. Culture medium was assessed for LOX enzyme activity using the LOX tritium vacuum
distillation enzyme assay as described in Section 2.8.1. N=3.


























Figure 5.15. PCPE (A), BMP-1 (B), LOX (C) mRNA expression levels and LOX enzyme activity
(D) levels in cultured granulosa cells from PMSG-treated immature female rats. Granulosa cells
were cultured with PROG [10pM] and/or IL-1 [500pg/ml] for 48h as described in Section 2.2.
Resultant mRNA was measured for LOX mRNA levels using qRT-PCR as described in Section
2.7. Culture medium was assessed for LOX enzyme activity using the LOX tritium vacuum
distillation enzyme assay as described in Section 2.8.1. N=3. ** = P<0.01, *** = P<0.01.
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5.3.4.2. Theca cells
Theca cells from 21-day old female Wistar rats treated in vivo with PMSG were
quantitatively assessed for mRNA levels of the collagen pathway biology genes. Theca
cells were cultured with CORT (OpM, O.OlpM, O.lpM, lpM), TGF-P (lOng/ml), LH
(O.OlIU/ml), IL-1 (500pg/ml) or PROG (lOpM).
CORT significantly down-regulated BMP-1 and PCPE mRNA, whilst up-regulating
LOX mRNA (Fig. 5.16).
TGF-P did not alter the expression of BMP-1 or PCPE mRNAs. This growth factor did
significantly up-regulate LOX mRNA expression (Fig. 5.17) with or without the
addition of CORT. A significant difference was also observed between CORT and
CORT plus TGF-P, and there was an additive effect of these two treatments.
LH did not affect BMP-1, but caused a suppression of PCPE mRNA expression (Fig.
5.18). Whilst LH alone did not influence LOX gene expression, the addition of CORT
significantly up-regulated LOX mRNA (Fig. 5.18).
The pro-inflammatory IL-1 did not affect LOX or PCPE mRNA levels, however it did
significantly down-regulate BMP-1 mRNA (Fig. 5.19).
PROG did induce a significant down-regulation of BMP-1 and PCPE (Fig. 5.20).
PROG alone had no effect on LOX, but when cultured with a combination of PROG and
IL-1, LOX expression was significantly increased over the expression with either
treatment alone (Fig. 5.21).
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Figure 5.16. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG-treated
immature female rats. Theca cells were cultured with
increasing concentrations of CORT [0, 0.01, 0.1, 1pM] for 48h
as described in Section 2.2. Resultant mRNA was measured
for collagen pathway mRNA levels using qRT-PCR as
described in Section 2.7. N=5. Inserts for all genes show
CORT [OpM] compared to CORT [1pM] for N = 9. * = P<0.05,
** = P<0.01, *** = P<0.001.
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Figure 5.17. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG-treated
immature female rats. Theca cells were cultured with CORT
[1pM] and/or TGF-p [1 Ong/ml] for 48h as described in Section
2.2. Resultant mRNA was measured for collagen pathway
mRNA levels using qRT-PCR as described in Section 2.7.
N=3, * = P<0.05, ** = P<0.01, *** = P<0.001.































Figure 5.18. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG-treated
immature female rats. Theca cells were cultured with CORT
[1pM] and/or LH [0.01 lU/ml] for 48h as described in Section 2.2.
Resultant mRNA was measured for collagen pathway mRNA
levels using qRT-PCR as described in Section 2.7. N=3.
Insert for PCPE (A) shows untreated compared to LH [0.01 lU/ml]
alone for N = 4. * = P<0.05, ** = P<0.01, *** = P<0.001.




























Figure 5.19. PCPE (A), BMP-1 (B) and LOX (C) mRNA expression levels in
cultured theca cells from PMSG-treated immature female rats. Theca cells were
cultured with CORT [1pM] and/or IL-1 [500pg/ml] for48h as described in Section
2.2. Resultant mRNA was measured for collagen pathway mRNA levels using
qRT-PCR as described in Section 2.7. N=4. * = P<0.05, ** = P<0.01.
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Figure 5.20. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG-treated
immature female rats. Theca cells were cultured with PROG
[10pM] and/or LH [0.01 lU/ml] for 48h as described in Section
2.2. Resultant mRNA was measured for collagen pathway
mRNA levels using qRT-PCR as described in Section 2.7.
N=4. Insert for PCPE (A) shows untreated compared to LH
[0.01 lU/ml] for N = 4. *= P<0.05, **= P<0.01.











































Figure 5.21. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured granulosa cells from PMSG-
treated immature female rats. Granulosa cells were cultured
with PROG [1 OpM] and/or IL-1 [500pg/ml] for 48h as
described in Section 2.2. Resultant mRNA was measured
for collagen pathway mRNA levels using qRT-PCR as
described in Section 2.7. N=4. ** = P<0.01.
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5.3.5. Results for ovarian cells from rats treated with PMSG + hCG
PMSG replicates the actions of FSH, by also giving an in vivo treatment of hCG the
action of the LH surge is simulated, producing a population of periovulatory follicles.
The cells of these follicles have begun the process of luteinisation which commences
with the LH surge. Thus expression of the LH receptor is being down-regulated so cells
are less responsive to LH (Towns et al. 1999). Granulosa cells now respond to
progesterone as the LH surge causes the expression of progesterone receptors
(Drummond 2006).
5.3.5.1. Granulosa cells
Granulosa cells from 21-day old rats that had received PMSG and hCG were cultured
with CORT (0, 0.01, 0.1, luM), TGF-p (lOng/ml), LH (O.OlIU/ml), IL-1 (500pg/ml)
and/or PROG (lOpM), and gene expression levels measured for collagen pathway genes
using real-time PCR. Measurements for LOX enzyme activity were unobtainable due to
problems with the distillation assay.
PCPE gene expression was unchanged by any of the culture treatments. However, LOX
mRNA expression was significantly increased in the presence of CORT (lpM) (Fig.
5.22). LOX mRNA in granulosa cells was significantly up-regulated by TGF-(3, with or
without CORT (Fig. 5.23). LH alone suppressed BMP-1 and LOX (Fig. 5.24), whilst
LOX expression was also suppressed by IL-1 (Fig. 5.25). PROG alone caused a
significant increase in LOX gene expression (Fig. 5.26). No combined effects were
observed for the addition of progesterone with either LH or IL-1 (Fig. 5.26/27).
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Figure 5.22. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured granulosa cells from PMSG-
plus hCG-treated immature female rats. Granulosa cells
were cultured with increasing concentrations of CORT [0,
0.01, 0.1, 1 pM] for 48h as described in Section 2.2.
Resultant mRNA was measured for collagen pathway
mRNA levels using qRT-PCR as described in Section 2.7.
N=3. Insert for LOX (C) shows CORT [OpM] compared to
CORT [1pM] for N = 6. ***=P<0.001.

















































Figure 5.23. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured granulosa cells from PMSG- plus
hCG-treated immature female rats. Granulosa cells were
cultured with CORT [1pM] and/or TGF-(3 [1 Ong/ml] for 48h as
described in Section 2.2. Resultant mRNA was measured for
collagen pathway mRNA levels using qRT-PCR as described
in Section 2.7. N=3. * = P<0.05, ** = P<0.01, *** = P<0.001.









































Figure 5.24. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured granulosa cells from PMSG- plus
hCG-treated immature female rats. Granulosa cells were
cultured with CORT [1pM] and/or IL-1 [500pg/ml] for 48h as
described in Section 2.2. Resultant mRNA was measured for
collagen pathway mRNA levels using qRT-PCR as described
in Section 2.7. N=3. Inserts BMP-1 (B) and LOX (C) show
untreated compared to LH [0.011U/ml] for N = 5. ** = P<0.01.
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Figure 5.25. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured granulosa cells from PMSG- plus
hCG-treated immature female rats. Granulosa cells were
cultured with CORT [1pM] and/or IL-1 [500pg/ml] for 48h as
described in Section 2.2. Resultant mRNA was measured for
collagen pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=3. Insert BMP-1 (B) shows untreated
compared to IL-1 [500pg/ml] for N = 7. * = P<0.05.
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Figure 5.26. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured granulosa cells from PMSG- plus
hCG-treated immature female rats. Granulosa cells were
cultured with PROG [10pM] and/or LH [0.011U/ml] for 48h as
described in Section 2.2. Resultant mRNA was measured for
collagen pathway mRNA levels using qRT-PCR as described
in Section 2.7. N=4. Insert LOX (C) shows Untreated
compared to PROG [10pM] for N=7. * = P<0.05.



























Figure 5.27. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG- plus
hCG-treated immature female rats. Granulosa cells were
cultured with PROG [10pM] for 48h as described in Section
2.2. Resultant mRNA was measured for collagen pathway
mRNA levels using qRT-PCR as described in Section 2.7.
N=4. * = P<0.05, ** = POD.01, *** = P<0.001.
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5.3.5.2. Theca cells
The expression of mRNA for LOX, BMP-1 and PCPE was measured in cultured theca
cells from female rats that had been treated in vivo with PMSG followed by hCG. Cells
were cultured with CORT (lpM), TGF-p (lOng/ml), LH (O.OlIU/ml), IL-1 (500pg/ml)
or PROG (lOpM).
BMP-1 and PCPE were unaffected by CORT. LOX was significantly up-regulated by
CORT (Fig. 5.28).
When theca cells were cultured with TGF-[], LOX expression was significantly
increased with or without CORT (Fig. 5.29), but expression of both BMP-1 and PCPE
was unaffected.
The presence of LH in culture had no effect on LOX gene expression but the addition of
corticosterone significantly increased LOX expression over LH-treated cells (Fig. 5.30).
LH caused an up-regulation of PCPE and a down-regulation of BMP-1 (Fig. 5.30).
The significant up-regulation of LOX by CORT was suppressed by the addition of IL-1
(Fig. 5.31), whilst not altering the expression of BMP-1 or PCPE.
PROG caused an up-regulation of LOX mRNA which just failed to reach significance
(Fig. 5.32). PROG was also combined in culture treatments with LH and IL-1, but no
differences were observed (Fig. 5.32/33).
Table 5.2. shows a summary of all the in vitro culture experiments described in this
results section.
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Figure 5.28. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG- plus
hCG-treated immature female rats. Theca cells were cultured
with increasing concentrations of CORT [0, 0.01, 0.1, 1pM] for
48h as described in Section 2.2. Resultant mRNA was
measured for collagen pathway mRNA levels using qRT-PCR
as described in Section 2.7. N=3. Insert LOX (C) shows
CORT [OpM] compared to CORT [1pM] for N = 13. * =
P<0.001.


















































Figure 5.29. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG- plus
hCG-treated immature female rats. Theca cells were
cultured with CORT [1pM] and/or TGF-(3 [1 On/ml] for 48h as
described in Section 2.2. Resultant mRNA was measured for
collagen pathway mRNA levels using qRT-PCR as described
in Section 2.7. N=3. *=P<0.05.


































Figure 5.30. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG- plus
hCG-treated immature female rats. Theca cells were cultured
with CORT [1pM] and/or LH [0.011U/ml] for 48h as described
in Section 2.2. Resultant mRNA was measured for collagen
pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=3. Inserts PCPE (A) and BMP-1 (B) show
untreated compared to LH [0.01 lU/ml] for N = 6. * = P<0.05,
** = P<0.01, ***=P<0.01.
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Figure 5.31. PCPE (A). BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG- plus
hCG-treated immature female rats. Theca cells were cultured
with CORT [1 pM] and/or IL-1 [500pg/ml] for 48h as described
in Section 2.2. Resultant mRNA was measured for collagen
pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=3. *=P<0.05































Figure 5.32. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG- plus
hCG-treated immature female rats. Theca cells were cultured
with PROG [10pM] and/or LH [0.01 lU/ml] for 48h as
described in Section 2.2. Resultant mRNA was measured for
collagen pathway mRNA levels using qRT-PCR as described
in Section 2.7. N=3.
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Figure 5.33. PCPE (A), BMP-1 (B) and LOX (C) mRNA
expression levels in cultured theca cells from PMSG- plus
hCG-treated immature female rats. Theca cells were cultured
with increasing concentrations of CORT for 48h as described
in Section 2.2. Resultant mRNA was measured for collagen
pathway mRNA levels using qRT-PCR as described in
Section 2.7. N=3.
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Table 5.2. Results summary for the gene expression changes described above for the rat
granulosa and theca cell culture experiments from animals that had either received no in vivo
treatment or that had received in vivo treatment with gonadotrophins.




Theca 1 1 1
Periovulatory Granulosa
Theca t







LOX FSH LH TGF-p CORT PROG JL-1
Immature Granulosa t
Theca t t t
Preovulatory Granulosa t t
Theca t t
Periovulatory Granulosa 1 t t t 1
Theca t t
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5.4. Discussion
The previous chapter identified the localities of genes and their translated proteins from
collagen pathway biology and glucocorticoid signalling regulator mechanisms, showing
that gonadotrophins and potentially glucocorticoids can influence collagen pathway
mRNA and protein levels in the rat ovary. To further analyse these interactions
granulosa and theca cells from gonadotrophin-treated 21-day old female rats were
cultured with specific hormones, growth factors, cytokines and steroids that would
influence normal follicle development.
Major findings were that components of ECM remodelling were regulated by the
changing profile of ovarian regulators. In the immature follicle, FSH in the granulosa
cells, LH in the theca cells and TGF-P in both cell types causes an overall increase in up-
regulation of collagen pathway biology to allow for follicle growth. Towards ovulation,
LH, progesterone, IL-1 and a proposed lack of TGF-P (Derman et al. 1999; Ingman et al.
2006; Juneja et al. 1996) caused a cessation of active remodelling. Post-ovulation,
remodelling was again active due to the positive influences by TGF-P and corticosterone.
Ovaries from immature rats have not undergone puberty. Therefore, the follicles have
not developed past the early antral stage of maturation as gonadotrophins are required to
sustain follicular development. These ovaries provided a population of immature
follicles to assess regulation of collagen pathway genes by substances known to
influence follicles at this stage of development, such as growth factors. As the antrum
begins to form, growth factors alone cannot maintain development and FSH causes the
continued proliferation of granulosa cells and growth of follicles (Matzuk 2000), as well
as inducing the expression of aromatase necessary for the production of oestrogen
(discussed in section 1.1.1.2.). Receptors for FSH are present only on granulosa cells,
hence only these cells can respond to this gonadotrophin (Simoni et al. 1997). The
addition of FSH to granulosa cells only affected LOX mRNA expression by reducing its
expression. Intriguingly, there was a significant increase in LOX enzyme activity
contradictory to LOX gene expression. This indicates that there is a residual pool of
LOX that is activated directly or indirectly by FSH. As FSH did not affect BMP-1
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mRNA, LOX may be either activated by an unidentified factor, or latent BMP-1 is
present and activated via the actions of FSH. Results for LOX activity are contrary to
results obtained previously by Harlow et al (2003) using immature rat granulosa cells.
This could be because this investigation used cells from untreated immature rats,
whereas Harlow and workers treated their rats with diethylstilboestrol (DES) to increase
the number of follicles present in the ovaries. DES is a synthetic oestrogen and may
have effects on the expression of LOX in these cells. Harlow et al (2003) also used a
higher dose of FSH (lOng/ml) compared to the dose used in this study (O.OlIU/ml =
3.2ng/ml). This suggests that FSH at initially low levels could stimulate LOX activity
when first acting on granulosa cells, but this effect becomes inhibitory at higher
concentrations. These effects could be direct or indirect due to FSH induction of
oestrogen production, suggesting that perhaps oestrogen has inhibitory effects on LOX
expression.
Theca cells do not respond to FSH, but as the antrum begins to develop these cells begin
to acquire the mechanisms required to produce androstenedione, which includes LHR.
Consequently, theca cells respond to LH, and this gonadotrophin increased, PCPE
mRNA levels 2-fold. PCPE increases BMP-1 action on procollagen 20-fold (Ricard-
Blum et al. 2002), so small changes in PCPE would greatly enhance the cleavage of
procollagen by BMP-1 even though BMP-1 expression itself was unchanged by LH.
The limiting aspect of this cleavage would be the amount of BMP-1 present in the
system, as PCPE works in a 1:1 ratio with BMP-1 (Ricard-Blum et al. 2002). Other
possible roles indicated for PCPE are its TIMP-like activities (Mott et al. 2000).
Therefore this increase in PCPE could be reducing ECM degradation of the ovarian
ECM.
As discussed in Section 5.1, TGF-(3 has been shown to enhance the synthesis of ECM,
including up-regulating the expression of LOX, BMP-1 and PCPE in different cell types
whilst inhibiting the production of proteolytic enzymes (Border & Ruoslahti 1992;
Centrella et al. 1992; Davidson et al. 1993; Massague et al. 1994; Okuda 1992;
Verrecchia & Mauviel 2002). Hence it was unsurprising to find that TGF-P significantly
increased LOX mRNA and activity in granulosa cells and LOX mRNA expression in
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theca cells. Interestingly, BMP-1 and PCPE mRNA were not affected by TGF-P in
these cells. Changes in granulosa cell expression in vivo could be regulated in a
paracrine fashion, as TGF-P is produced in theca cells at this stage of development
(Skinner et al. 1987). TFG-P also exists in a latent form which is bound to ECM, and
which can be activated by BMP-1 combined with the action of MMPs (D'Angelo et al.
2001; Ge & Greenspan 2006; Yu & Stamenkovic 2000).
The rat glucocorticoid, corticosterone, at the high dose (lpM) did not affect BMP-1 or
PCPE mRNA in granulosa and theca cells, but did significantly increase LOX mRNA in
theca cells but not granulosa cells (mRNA and enzyme activity). Corticosterone would
be present in preantral and early antral follicles at basal levels, with most glucocorticoid
present being inactivated by the greater ratio of 11PHSD2 to 1 lpHSDl (Tetsuka et al.
1997). As the granulosa cells show no response to corticosterone, perhaps it is these
cells that contain the lippfSD isoforms that regulate the availability of corticosterone as
hypothesised by Tetsuka et al (1999b). Therefore, corticosterone added to granulosa
cells would be inactivated, whereas corticosterone given to theca cells would remain
active.
Corticosterone was given to ovarian cells in combination with TGF-P, FSH (granulosa
cells) or LH (theca cells) to establish whether additive effects of ovarian regulators
occurred, as in vivo follicles would receive a multitude of different cellular signals. No
additive effects were observed in theca cells when corticosterone and LH were added.
In theca, but not granulosa cells, the up-regulation of LOX expression by TGF-P was
further increased by the addition of corticosterone showing a positive additive effect.
Granulosa cells treated with corticosterone and FSH showed a decrease in LOX enzyme
activity. Similar depressions in LOX activity, and mRNA expression have been
observed when FSH was combined with DHT, TGF-P, GDF-9 or activin (Harlow et al.
2003).
The up-regulation of LOX in immature follicles, along with the unchanging expression
pattern of BMP-1, suggests that a pool of pro-LOX may accumulate for use throughout
follicle development and is activated as required. Delays in activation of pro-LOX have
been shown in the bone cell line, MC3T3-E1. When these cells were given TGF-P, an
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increase in LOX mRNA was observed, but activity only increased after 6h (Feres-Filho
et al. 1995). Studies in vivo have also shown that pro-LOX can accumulate prior to
collagen substrate production (Fushida-Takemura et al. 1996). This was most notable in
studies of dermal wounding, where LOX was initially produced in the first few days but
full activation was not reached until 8-10 days later (Fushida-Takemura et al. 1996;
Siegel 1979). This indicates that post-translational processing of LOX is quite slow and
could be a rate-limiting factor.
Overall, the developmental influences assessed here in immature follicles initiates active
remodelling, allowing ovarian ECM to accommodate the increasing size of the follicle,
processes regulated by the same mechanisms (gonadotrophins and growth factors).
In vivo treatment of immature female rats with PMSG simulates FSH stimulation, and
progresses follicle development allowing continued development of the antrum, and
progression of the follicle to the preovulatory stage. The preovulatory follicle is not yet
ready to undergo ovulation, as a surge of LH is required for the final development and
initiation of the ovulatory process. Ovarian cells taken from 21-day old female rats
treated with PMSG were cultured with hormones, steroids and cytokines that mimic the
changes that occur in vivo.
Prior to ovulation, granulosa cells begin to express LHR as a consequence of FSH
stimulation (Bums et al. 2001). Therefore cells from these follicles respond to LH as
well as growth factors. LH down-regulated PCPE mRNA in both granulosa and theca
cells. The decrease in PCPE expression would limit the amount of procollagen cleavage
by BMP-1, which would in turn reduce the substrate for LOX to cross-link, resulting in a
net decrease in ECM accumulation. As follicles approach ovulation there would be a
reduction in accumulation of ECM, and a shift towards ECM remodelling and
degradation in preparation for oocyte release.
At this stage of development theca cells are responsive to progesterone as they express
receptors for this steroid (Gava et al. 2004). Theca cells cultured with progesterone
showed lower expression of BMP-1 and PCPE mRNA. Similar to the effects of LH, this
would result in a decrease in ECM accretion. If granulosa cells from PMSG-treated rats
(which now express LHR) experience an LH surge progesterone receptor expression will
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be induced (Drummond 2006). Granulosa cells given LH and progesterone show no
effects on gene expression.
Interleukins (IL-1) are pro-inflammatory cytokines that induce cells to act as though
they are in an inflammatory environment. In the ovary, IL-ls are one cytokine family of
many (Gerard et al. 2004). IL-1 is principally involved in the ovulatory process, and is
greatly up-regulated at this time (Simon et al. 1994). The only effect of IL-1 observed in
cultured granulosa cells was a decrease in PCPE expression, and IL-1 decreased BMP-1
mRNA expression in theca cells. LOX expression was unchanged by IL-1, though it has
been shown to be decreased by other pro-inflammatory cytokines, such as TNFa in
osteoblasts (Pischon et al. 2004). As ovulation is an inflammation-associated process,
the inhibition of genes involved in ECM build-up by pro-inflammatory mechanisms is
important in suppressing production of the ECM.
Ovarian cells treated with PMSG are approaching ovulation, the follicle will still be
increasing in size and remodelling of the ECM is actively continuing, though there is a
fine balance between proteolysis and ECM accumulation. Addition of TGF-(3 to
granulosa cells caused an up-regulation in LOX mRNA and enzyme activity and mRNA
in theca cells. Therefore, TGF-P could be involved in regulating ECM remodelling as
ovulation approaches. TGF-P has been shown to increase LOX mRNA and activity
time- and dose-dependently as well as up-regulating collagen type I (Feres-Filho et al.
1995). Therefore the amount of TGF-P available should influence the expression of
LOX and the amount of available substrate. A reduction in TGF-P at ovulation would
decrease active ECM remodelling. There is no direct evidence indicating the
involvement of TGF-P in ovulation, rather evidence suggesting that the presence of
TGF-P is inhibitory to ovulation, but it may be involved in triggering the processes that
lead to a successful ovulation (Derman et al. 1999; Ingman et al. 2006; Juneja et al.
1996). Even though the precise mechanism of TGF-P down-regulation in ovulation has
not been reported, the evidence that this growth factor can up-regulate LOX would
suggest that TGF-P effects would be suppressed at this stage of the follicular cycle.
As ovulation approaches, llpHSDl mRNA increases (Tetsuka et al. 1997), and
corticosterone is made available, which could have important effects on these follicles.
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Corticosterone increased LOX mRNA, but not its activity, when increasing doses were
given to granulosa cells. BMP-1 mRNA in both granulosa and theca cells, was down-
regulated by corticosterone and PCPE expression was down-regulated in theca cells.
Therefore, corticosterone could induce an accumulation of pro-LOX due to decreased
BMP-1 levels, so slowing the activation of LOX. Furthermore, decreasing PCPE (and
BMP-1) would also limit the accumulation of LOX substrate (collagen). Hence a pool
of pro-LOX may be created ready for activation post-ovulation, when repair of the
injury of ovulation is required, as seen in dermal wounding repair (Fushida-Takemura et
al. 1996; Siegel 1979).
When corticosterone in combination with TGF-f! was given to granulosa and theca cells,
LOX mRNA and activity were further up-regulated. However, when corticosterone was
combined with LH, only PCPE expression was decreased in granulosa cells, whereas
LOX was up-regulated in theca cells. The change in granulosa cell PCPE mRNA
appeared to be due to the effects of LH, whereas in the theca cells, corticosterone was
acting on the cells. The combination of corticosterone and IL-1 reflected the decrease in
PCPE mRNA achieved with IL-1 alone in granulosa cells and for BMP-1 in theca cells.
In conclusion, several mechanisms in follicles approaching ovulation lead to a reduction
in ECM accumulation. This is vital for ovulation to occur.
PMSG replicates the actions of FSH and by combining PMSG treatment with a bolus of
hCG in vivo, the action of the LH surge is simulated, producing a cohort of periovulatory
follicles on the verge of ovulation. The cells of these periovulatory follicles luteinise
commencing with the LH surge. The main steroid secreted in the luteal phase is
progesterone produced by luteinised granulosa and theca cells. These cells also possess
progesterone receptors, and can respond to this steroid (Nelson et al. 1992). Once
ovulation has occurred these cells form the corpus luteum. This is a period of intense
ovarian remodelling as the injury of ovulation is repaired and the corpus luteum created.
Progesterone increased LOX mRNA expression in luteinised granulosa cells, but had no
effect on the BMP-1 and PCPE expression and did not alter expression of these genes in
theca cells.
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Both luteinised rat granulosa and theca cells express LHR and respond to LH by
producing steroids (Nelson et al. 1992). Pulsatile bursts of LH maintain progesterone
secretion (Filicori et al. 1984; Wuttke et al. 1998). In granulosa cells, LH down-
regulated LOX and BMP-1 mRNA, but did not affect PCPE, whereas in theca cells, LH
down-regulated BMP-1 but up-regulated PCPE and did not alter LOX expression.
Although complex, these expression patterns would result in decreased ECM
accumulation.
Components of the IL-1 system are present in luteinised follicle cells and have been
shown to affect the function of these cells (Gerard et al. 2004), but the addition of IL-1
to cell cultures did not affect collagen pathway genes, and would therefore not affect
ECM remodelling.
TGF-P is expressed by rodent luteal cells (Ghiglieri et al. 1995; Matsuyama &
Takahashi 1995). Therefore, if collagen pathway genes are influencing remodelling in
luteal tissue, this known regulator of ECM deposition may be involved. TGF-(3
increased the expression of LOX in both cell types. TGF-P present in luteal cells peaks
at the mid-luteal phase and decreases in the late luteal phase (Chegini & Flanders 1992).
Hence TGF-P would be available to regulate collagen pathway genes in these cells, and
could therefore regulate ECM remodelling in the luteal phase.
Corticosterone is the dominant glucocorticoid in the ovary immediately after ovulation,
where it is involved in resolving the inflammation of ovulation (Hillier & Tetsuka 1998).
GR is present in the rat corpus luteum (Towns et al. 1999), allowing any corticosterone
present to act on these cells. Corticosterone had no effects on granulosa or theca cell
BMP-1 or PCPE, but did increase the expression of LOX. Corticosterone levels in early
luteal cells may reduce fairly rapidly and the aged corpus luteum of the rat has been
shown to have up-regulation of 1 ipHSD2 mRNA and activity but 1 lpHSDl mRNA was
undetectable (Hillier & Tetsuka 1998; Tetsuka et al. 2003; Waddell et al. 1996). This
results in a decrease in corticosterone as the luteal phase progresses. Therefore if
corticosterone does regulate collagen pathway genes it has more potential to act early in
the luteal phase: a time when tissue remodelling would be most active.
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Taken as a whole these results suggest that the collagen pathway is activated in these
luteinised ovarian cells to resolve the injury of ovulation and to remodel the follicle to
create the corpus luteum. A possible mechanism for post-ovulation remodelling, in
regard to the regulators assessed in these studies, would suggest an initial up-regulation
by corticosterone then, as this declines in the system, other regulators such as TGF-P
continue this process.
In summary, conclusions that can be drawn about collagen pathway biology across
follicle development in the rat from these investigations are that immature follicles show
changes in the expression pattern of collagen pathway genes and enzyme activities to
produce a net up-regulation of the factors that are actively involved in tissue
remodelling. As follicles develop and ovulation approaches, the remodelling priorities
of the follicle change as it prepares for release of the oocyte. Therefore a switch towards
ECM degradation emerges, and active ECM formation is suppressed. During ovulation,
follicle cells begin to luteinise. At this time, the injury of ovulation must be repaired.
Hence active remodelling of the follicle ECM is once again required. These conclusions
can be illustrated by proposing a model for the changes to collagen pathway biology
during follicular development in relation to the ovarian regulators studied (Fig. 5.34).






















Figure 5.34. Proposed model of collagen pathway biology in the developing ovarian follicle
based on current knowledge from these investigations. Red arrows indicate overall activation of
remodelling; blue arrows indicate overall non-activation of remodelling; green arrows indicate
accumulation of in-activated substrates of the collagen pathway. Boxes indicate changes
observed in the collagen pathway genes.
In summary, active ovarian remodelling is promoted in the immature follicle by the positive
influences of TGF-p and low granulosa levels of FSH as well as LFH acting on the thecal cells. In
the preovulatory follicle as ovulation approaches, active remodelling decreases due to negative
influences of progesterone, LFH and IL-1, although if TGF-p is present at this time it will drive
active remodelling. Post ovulation the collagen remodelling in the luteinised follicle is positively
driven by TGF-p and corticosterone.
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6. Collagen pathway biology and glucocorticoid
signalling in the ovary: transgenic models studies
6.1. Introduction
The previous chapters have shown that collagen pathway biology is an integral part of
ovarian development, affecting the stability of collagens present in the ovary. This
process is regulated during ovarian development by an array of endocrine and paracrine
factors. During this project the opportunity arose to study three different transgenic
mouse models, allowing insight into the regulation and function of the collagen pathway
genes in these altered environments. Animal models with novel genotypes allow
biological systems to be manipulated to scrutinise specific gene functions. Individual
genes can be manipulated in such mouse models allowing investigation of (abnormal)
function and phenotype of that biological system. This yields information about disease
states which can lead to an increased understanding and the development of treatments.
The three model systems available were the raw mouse (which has a mutation in its
collagen IV al chain), the CYP11B1_/" mouse (which does not produce adrenal
corticosterone), and the 11 [3HSDImouse (which does not enhance the activation of
deoxycorticosterone to corticosterone). Unfortunately the 11 |3HSD27" mice could not be
obtained.
Raw mice have a point mutation known as a missense mutation that renders the resulting
protein non-functional. This mutation was located in exon 34 of the COL4al gene and
has been shown to substitute a positively charged lysine residue at the Yaa position of
the Gly-Xaa-Yaa repeat with a negatively charged glutamic acid (Van Agtmael et al.
2005). Homozygous animals are dominant negative with adverse effects on normal
protein synthesis, secretion and function, whereas heterozygous animals show a semi-
dominant phenotype where adverse effects are not so severe (Van Agtmael et al. 2005).
This allows investigation of the effects of collagen substrate and enzyme movement
across the partially disrupted basement membrane. Raw mice were created from an
ENU mutagenesis project to generate phenotypes with eye defects (Thaung et al. 2002).
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Two other similar, but more severe phenotypes (Bruised and Small with vacuolar
cataracts) were also generated and available to study. However, due to severe reductions
in male and female fertility, it was not feasible to generate sufficient numbers of animals
to study. Homozygous raw mice are not viable, and do not develop past embryonic day
E9.5 (Van Agtmael et al. 2005). This is probably due to failure of basement membrane
integrity, as this is also seen in mutants that are null for the COL4al/a2 locus (Poschl et
al. 2004). The semi-dominant phenotype of the raw mouse shows that the basement
membrane of the eye was thinned, partially disintegrated, ruptured and detached from
the underlying cells, resulting in arteriolar silvering of the eye (Van Agtmael et al.
2005). To date, other basement-membrane related phenotypes have emerged in the
kidneys and aortas of these mice (personal communication, Dr Tom Van Agtmael).
Such mice are fertile but fertility levels and ovarian phenotype have not been
investigated. Collagen IV is an important component of the basement membrane of
ovarian follicles. Therefore, if basement membranes are disrupted, as observed in other
body systems, it would be predicted that follicle development might be affected.
Furthermore, as collagen pathway components appear to traverse the follicular basement
membrane, disruption may influence the movement of these proteins.
The literature has shown extensively that glucocorticoids are important in the resolution
of the inflammation-associated with ovulation (Section 1.2). CYP11B1 is the enzyme
required to convert deoxycorticosterone to the active glucocorticoid, corticosterone.
CYP11BT7" mice are viable even though they have lower circulating corticosterone
compared to wild-types (personal communication, Dr Chris Kenyon). The adrenals and
pituitaries of these mice are enlarged as they attempt to compensate for the lack of
corticosterone by trying to over-produce this steroid. The gonads of CYP1 lBT/_ male
mice are phenotypically normal and these animals are fertile, but females are infertile
(personal communication, Dr Chris Kenyon). This would be predicted to be due to an
impaired anti-inflammatory repair system due to a lack of corticosterone produced by
the adrenal gland.
The local activation of glucocorticoids is regulated by the two isoforms of lipHSD.
Tissue-specific regulation of the lipHSD isoforms determines whether or not active
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glucocorticoid is available in a specific tissue. The 11PHSD1mouse disrupts the
balance between these two isoforms. 11 (3HSD Y1" mice cannot enhance the conversion
of deoxycorticosterone to corticosterone and as a result there is a compensatory
hyperplasia in the adrenals as more corticosterone is being secreted in response to
ACTH (Kotelevtsev et al. 1997). Subsequently, these mice are not affected by
hyperglycemia caused by obesity or stress (Kotelevtsev et al. 1997). Moreover, the lack
of 11PHSD 1 in these knockout mice has shown to be important, for cognition with age,
improved glucose tolerance and a resistance to obesity (Morton et al. 2001; Morton et
al. 2004; Yau et al. 2001). It might be predicted that these mice (similar to the
CYP11B1 mouse) would be infertile due to a lack of resolution of inflammation-
associated with ovulation. However, 1 1PHSDI^ mice are fertile (Kotelevtsev et al.
1997).
Corticosterone was shown in Chapter 5 to affect collagen pathway biology in ovarian
cells, implying that disruption in glucocorticoid signalling in both the CYPllBl"'" and
the UPHSDI"7" mice might have ECM-related phenotypes. Therefore, as
glucocorticoids are believed to be important in the ovary, investigations of these two
mouse models may lead to a better understanding of the actions of these steroids and
their regulation in this tissue.
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6.2 Materials and methods
6.2.1 Animals
Transgenic animals were generated as described in Section 2.1. Female wild-type and
CYPl lBT " mice were culled at 3 months as described in Section 2.1.2. Female wild-
type and 1 lpHSDl"7" mice aged 3 months and 12 months were given hormone injections
in vivo and culled as described in Section 2.1.3. Raw mutant mice and wild-type litter
mates were culled at 3 months and 9 months old. Also a cohort of wild-type and raw
mice were injected with PMSG and hCG as described in Section 2.1.4.
6.2.2 Tissue
Whole ovaries were collected and fixed as described in Section 2.9.1.
6.2.3 Histological staining
Haematoxylin and eosin staining was performed on ovarian sections as described in
Section 2.9.2.
6.2.4 Immunohistochemistry
Immunohistochemistry was performed on tissue sections as described in Section 2.9.5.
Table 6.1 shows the antibodies used on these tissues.
Table 6.1 Antibodies, dilutions and methods of detection used in this study.
Antibody Dilution Detection method
11PHSD1 1 100 Fluorescence
11pHSD2 1 600 Fluorescence
BMP-1 1 100 Fluorescence
COL4a1 1 100 Fluorescence
COL4a2 1 100 Fluorescence
COL4c<3 1 100 Fluorescence
COL4a4 1 100 Fluorescence
COL4ct5 1 100 Fluorescence
COL4a6 1 100 Fluorescence
Laminin 1 100 DAB
LOX 1 100 Fluorescence
Nidogen 1 1 500 Fluorescence
Nidogen 2 1 500 Fluorescence
Perlecan 1 500 Fluorescence
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6.3 Results
6.3.1 Raw mice
No histological differences were observed between wild-types and raw mutants (Fig.
6.1) and there were no differences among age groups (data not shown). There was no
significant difference between ovary:body weight ratios between wild-type and raw
mice (Fig. 6.2). In vivo horomone treatments with PMSG and hCG showed no
differences between wild-type and Raw animals (data not shown).
Staining for collagen IV (COL4a-l, -2 and -5 chains) showed less continuous staining at
the follicular basement membranes in raw mice (Fig. 6.3). Collagen pathway proteins
LOX and BMP-1 showed no differences in immuno-localisation between wild-types and
mutants (Fig. 6.4).
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Wild-type Raw
Figure 6.1 Haematoxylin and eosin staining of ovaries from wild-type and raw mice aged 3
months and 9 months. Tissue was fixed and stained as described in Section 2.9. All scale
bars 100pm.
























Figure 6.2. Comparison of ovary:body weight ratio for wild-type and raw mice.
A cohort of wild-type and Raw mice were bred and given in vivo injections of
PMSG and hCG as described in Section 2.1.4. No significant difference in
ovarian weight was observed between the wild-type and Raw mice, which was
validated with the observation of no difference between body weight of the two
animal groups. Wild-type (N=7), Raw (N=6).
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Figure 6.3. Immunohistological localisation of collagen IV a-chain
proteins in wild-type and raw ovaries. Ovaries were fixed and stained
with antibodies raised against collagen IV a-1, -2 and -5 as described
in Section 2.9.5. Red, collagen a-chains; blue, nuclear stain.
Granulosa cells (GC), Theca cells/interstitial tissue (TC/IN). All scale
bars 20pm.






Figure 6.4. Immunohistological localisation of BMP-1 and LOX proteins in wild-type and
Raw ovaries. Ovaries were fixed and stained with antibodies raised against BMP-1 and
LOX as described in Section 2.9.5. Red, BMP-1 or LOX; green, nuclear stain. Granulosa
cells (GO), Theca cells/interstitial tissue (TO/IN). All scale bars 20pm.
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6.3.2 CYPHBI"7" mice
The ovaries from wild-type and CYP11B1" " mice showed phenotypic differences. Wild-
type ovaries showed normal follicular development, and contained follicles of increasing
size as well as corpora lutea that were discretely arranged within the stromal tissue (Fig.
6.5). The ovaries from CYP11B1 mice show antral follicle development (Fig. 6.5), but
entrapped oocytes have been observed (personal communication, Dr Judy McNeilly).
These ovaries also appear to contain luteinised granulosa cells similar to those normally
associated with corpora luteal structures. However, unlike wild-type ovaries, these cells
in the CYP11B1 ovaries (termed luteinised-like cells) were not located within obvious
corpora lutea. Instead they were present throughout the ovarian interstitum.
Laminin and collagen IVa2, the major components of the basement membrane which
are linked by perlecan, nidogen-1 and -2, were clearly detected in CYP11B1V" ovarian
follicles, similar to wild-types (Fig. 6.6/6.7). In the luteinised-like cells of the
CYPllBr " ovaries, these basement membrane proteins showed less intense staining
and were more disorganised than in wild-type ovaries (Fig. 6.6/6.7).
Collagen pathway proteins appeared less abundant in the CYPllBl^" ovaries and were
not associated with particular ovarian structures (Fig. 6.8).
The lipHSD isoforms were localised in follicles and corpora lutea of wild-type ovaries
(Fig. 6.9). Whereas, lipHSDl was hardly detected in the CYP11B17" ovary, 11PHSD2
was widespread and did not appear to be localised to any particular structure in
CYP1 IBl'1' ovaries (Fig. 6.9).
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Figure 6.5. Haematoxylin and eosin staining of wild-type and CYP11B1-/- ovaries. Ovaries from
wild-type and CYP11B1-/- mice were fixed and stained with haematoxylin and eosin as
described in Section 2.9.5. Follicles (F), corpus luteum (CL), luteinised-like tissue (LLT),
luteinised granulosa cells (LGC), luteinised-like cells (LLC). Upper panels scale bars 100pm;
lower panels scale bars 20pm.
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CYP11B1
Figure 6.6. Immunohistochemical localisation of laminin and collagen
IVa2 proteins in wild-type and CYP11 BT/_ ovaries. Ovaries were fixed
and stained with antibodies raised against laminin and collagen IVa2
as described in Section 2.9.5. Red, collagen IVa2; green, nuclear
staining. The nuclear staining of the CYP11B1"'" ovaries was not
optimal in the fluorescence photographs. No apparent reasons for
this could be determined as immunohistochemistry was performed on
wild-type and CYP11B1"'" tissue in parallel using the same reagents.
Time and tissue availability did not allow for further investigations. All
scale bars 200pm.
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Wild-type CYPllBl7"
Figure 6.7. Immunohistochemical localisation of nidogen-1, -2 and perlecan proteins in wild-type
and CYP11BTA ovaries. Ovaries were fixed and stained with antibodies raised against nidogen-
1, -2 and perlecan as described in Section 2.9.5. Red, nidogen-1,-2 or perlecan; green, nuclear
staining. The nuclear staining of the CYP11B1"'" ovaries was not optimal in the fluorescence
photographs. No apparent reasons for this could be determined as immunohistochemistry was
performed on wild-type and CYP11B1"'" tissue in parallel using the same reagents. Time and
tissue availability did not allow for further investigations. All scale bars 200pm.





Figure 6.8. Immunohistochemical localisation of BMP-1 and LOX proteins in wild-
type and CYP11B1"'" ovaries. Ovaries were fixed and stained with antibodies
raised against BMP-1 and LOX as described in Section 2.9.5. Red, BMP-1 or LOX;
green, nuclear staining. The nuclear staining of the CYP11B1 ' ovaries was not
optimal in the fluorescence photographs. No apparent reasons for this could be
determined as immunohistochemistry was performed on wild-type and CYP11BV'"
tissue in parallel using the same reagents. Time and tissue availability did not
allow for further investigations. All scale bars 200pm.
CYPl 1B1
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CYP11B1
Figure 6.9 Immunohistochemical localisation of 11pHSD1 and 11PHSD2
proteins in wild-type and CYP11B1"'" ovaries. Ovaries were fixed and
stained with antibodies raised against 11 (3HSD1 and 11(3HSD2 as
described in Section 2.9.5. Red, 11pHSD1 or 11PHSD2; green, nuclear
staining. The nuclear staining of the CYP11B1"' ovaries was not optimal
in the fluorescence photographs. No apparent reasons for this could be
determined as immunohistochemistry was performed on wild-type and
CYP11B1"'" tissue in parallel used the same reagents. Time and tissue
availability did not allow for further investigations. All scale bars 200pm.
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6.3.3 11pHSD1_/" mice
Haematoxylin and eosin staining of ovaries from mice aged 3 months and 12 months
that had received in vivo treatment to simulate gonadotrophin-driven follicle maturation
showed no differences between wild-type and 11 [iHSDr mice for any treatment groups
(Fig. 6.10/6.11).
Ovaries were immuno-stained for BMP-1 and LOX (Fig. 6.12/6.13). The only major
difference observed was an increased localisation of BMP-1 protein in untreated
lipHSDl7" compared to wild-type tissue. There were no major differences between
wild-type and 11 pHSDl~/~ mice with either antibody. Subtle differences observed were
an apparent lack of LOX staining in the granulosa cells of the PMSG-treated lipHSDl"7"
mice compared to wild-types, and preantral follicles of lipHSDF appeared to have
more BMP-1 localised to the granulosa layer.
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Figure 6.10. Haematoxylin and eosin staining of ovaries from wild-type and
11(3HSDT/_ mice aged 3 months. These mice had been treated in vivo with either
no treatment, PMSG or PMSG/hCG as described in Section 2.1. All scale bars
100pm.
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Figure 6.11. Haematoxylin and eosin staining of ovaries from wild-type and
11I3HSDT'" mice aged 12 months. These mice had been treated in vivo with either
no treatment, PMSG or PMSG/hCG as described in Section 2.1. All scale bars
100pm.





















Figure 6.12. Immunohistochemical localisation of BMP-1 protein in wild-type
and 11(3HSDT/_ ovaries. Mice had been treated in vivo with either no
treatment, PMSG or PMSG/hCG as described in Section 2.1. Ovaries were
fixed and stained with an antibody raised against BMP-1 as described in
Section 2.9.5. Red, BMP-1; green, nuclear stain. Granulosa cells (GC,
theca cells/interstitial tissue (TC/IN). All scale bars 20pm.
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Figure 6.13. Immunohistochemical localisation of LOX protein in wild-type and
11(3HSDT' ovaries. Mice had been treated in vivo with either no treatment, PMSG or
PMSG/hCG as described in Section 2.1. Ovaries were fixed and stained with an
antibody raised against LOX as described in Section 2.9.5. Red, LOX; green, nuclear
stain. Antrum (A), Granulosa cells (GO), theca cells/interstitial tissue (TO/IN). All scale
bars 20pm.
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6.4 Discussion
Previous chapters have explored the localisation and regulation of collagen pathway
genes and proteins in the rat ovary. Here these proteins were investigated in transgenic
mice that were deficient in either basement membrane components (raw mice that have
partially disrupted COL4A1) or glucocorticoid regulation (CYPllBT/_ mice and
llpHSDl " mice). Investigations using these model systems may expand understanding
of the role of collagen pathway biology in the ovary.
Raw mice were heterozygous for mutations in the collagen IV al-chain, and therefore
had partial disruption of their basement membranes. The follicular basement membrane
has been shown to contain collagen IV al throughout development (Rodgers et al.
1998). Hence, it was predicted that follicular development might have been disrupted in
some way in these animals. However, these mice were fertile, and although some
individual cases of infertility were observed and there was only a slight reduction in
average litter size (personal communication, Dr Tom Van Agtmael).
No obvious ovarian phenotype was observed at the level of gross morphology. The
distribution of collagen IV al and a2 appeared uneven in the ovaries from the raw
animals, but collagen IV a5 was unaffected. These disruptions did not appear to be
associated with abnormal ovarian function in the raw animals. Furthermore, no
differences were observed in the distribution of BMP-1 or LOX proteins either. These
data suggest that the function of the follicular basement membrane was unaltered in
these mice. However, basement membranes of other organs of these animals such as the
eye and kidney, showed prominent abnormal phenotypes that progressively worsened
with age (personal communication, Dr Tom Van Agtmael). Possible reasons for this are
that the basement membranes of the eye and the kidney are established structures that
function continuously throughout the life of the animal. Basement membranes are highly
stable and, once established, are not continually remodelled (Hudson et al. 1993).
Exceptions to this are developmental situations where structures are forming, and the
basement membrane of the ovarian follicle, which begins to develop as follicles are
recruited to grow throughout reproductive life (Rodgers et al. 2003). Once growth
commences the ovarian follicle in the mouse develops in only 4 days and then is
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destroyed at ovulation (Mandl 1951). Therefore, the period that the follicular basement
membrane is functional in the ovary is brief, when compared to other basement
membranes. The follicular basement membrane is also subjected to continuous
remodelling, and this may not allow time for gross abnormalities to develop. This is
supported by the report that raw mice show similar phenotypic alterations to the human
disease, Hereditary Angiopathy with Nephropathy, Aneurysm and Cramps (HANAC)
syndrome, an inherited disease that has no reported ovarian dysfunction (Plaisier et al
2007, in preparation).
The ovary does not produce glucocorticoids de novo. Therefore levels of circulating
corticosterone and local regulation by lipHSD isoforms determine the amount of
exposure of ovarian cells to this steroid. CYP11BTA mice do not produce circulating
corticosterone. The females are infertile, and the ovaries of these animals contain antral
follicles, but are devoid of structurally normal corpora lutea. The areas that are normally
stroma appeared to be full of weakly luteinised cells that were positive for 3PHSD (the
steroidogenic marker of luteinised ovarian tissue) (personal communication, Dr Judy
McNeilly). When observed under high power microscopy, these cells did not have the
appearance of healthy luteinised granulosa cells, but were negative for CYP17,
indicating that they were not thecal cells (personal communication, Dr Judy McNeilly).
This, together with the observation of entrapped oocytes, implies that that ovulation may
not occur normally, and that follicle cells do not luteinise to form a functional corpus
luteum. In the normal corpus luteum, basement membrane components surround the
luteinised cells. However, the corpus luteum-like cells of the CYPllBl"7" mouse had a
reduced amount of the major structural proteins (laminin and collagen IV) and basement
membrane cross-linkers (perlecan, nidogen-1 and -2).
The localisation of BMP-1 and LOX was irregular throughout the CYP11B17" ovary.
The basement membrane and collagen pathway protein localisations observed were
probably due to the abnormal morphology rather than a cause implying that functional
ovulation and steroidogenesis are needed for normal expression. Interestingly, the
developing follicles do not appear to bulge at the ovarian surface as seen in wild-type
ovaries, perhaps indicating an abnormality in follicle development or that a physical
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restriction is occurring that may account for the failure of ovulation. There were no
differences between CYP11BT" and wild-type in collagen IV localisation at the surface
of the ovary. Perhaps another collagen may be deposited in this area. The deficiency of
corticosterone in the CYP1 IB I7" mice appeared to dramatically reduce llpHSDl
protein in the ovary, but did not affect llflHSD2 expression. Cortisol has previously
been shown to enhance the expression of lipHSDl in human OSE cells (Rae et al.
2004b).
A problem that arose with the CYP11B1 ovaries was the poor quality of the
fluorescent nuclear stain. The staining was repeated at different times on different tissue
sections with the same results. Reasons for the staining may include the way the tissue
has been fixed, this was performed by a third party therefore fixation may not have been
optimal. If the fixation was performed correctly the difference seen in nuclear staining
between wild-type and CYP11B1-/- may reflect an effect caused by the genotype of
these mutant animals. This difference requires further investigation, which was beyond
the scope of this thesis.
The lipHSDl7" mouse, in which circulating deoxycorticosterone is not converted to
corticosterone in target tissues, showed no impairment in ovarian function. Ovaries
were phenotypically normal compared to wild-type controls. The only difference
observed in collagen pathway proteins in these ovaries was an increased localisation of
BMP-1 protein in the lipHSDl7" untreated ovaries. Reasons for this difference are
likely to be the lack of corticosterone enhancement in this tissue implying that
corticosterone maybe involved in regulating BMP-1. It was predicted that the ovaries of
the lipHSDl^" mice would be similar to the CYP11B17" mice as there should be a
deficiency in corticosterone exposure post-ovulation. However, any impairment of
ovarian repair caused by lipHSDl absence appeared to be rescued. These mice may
have an increased level of corticotrophic releasing hormone, which would lead to raised
ACTH levels and ultimately increased circulating corticosterone (Harris et al. 2001).
Presumably an elevation in circulating corticosterone could compensate for the lack of
lipHSDl and could be sufficient to resolve the inflammation of ovulation. However,
progesterone has also been shown to have anti-inflammatory effects on reproductive
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tissue (Kelly et al. 2001; Rae et al. 2004a), and progesterone is elevated in the corpus
luteum and suppresses the IL-1 stimulated inflammation response in OSE cells (Rae et
al. 2004a). Therefore, the actions of progesterone may be instrumental in resolving the
ovulation-associated inflammation in llpHSD"7" mice. To date, circulating progesterone
levels have not been measured in these mice. Even though a deficiency in lipHSDl did
not present an ovarian phenotype, there could be other effects on reproduction in these
mice, as they have been shown to have reduced litter sizes without a reduction in
ovulation rate (personal communication, Dr Chris Harlow), implying an impairment in
reproduction at some point after ovulation. 11 [3HSD1 has been shown to be present in
placenta, stromal decidua and endometrium, making these tissues targets for further
investigations (McDonald et al. 2006; Thompson et al. 2002).
These investigations have shed light on possible mechanisms involved in ovarian
function as well as collagen pathway biology. Further investigations will allow broader
conclusions to be drawn on all aspects identified in these initial observations.
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7. General Discussion
Early reports on the structure of the follicle during development indicated that the
basement membrane structure was sensitive to the effects of hormones (Baccarini 1971).
This has since been demonstrated in many species, suggesting that the mechanisms
involved in remodelling the basement membrane are influenced by ovarian hormones
(Palotie et al. 1984; Rodgers et al. 1999b). The follicular basement membrane is
degraded by proteases that are up-regulated by the LH surge, an effect that can be
inhibited in vivo by anti-sera to the protease, MMP-2 (Espey 1994; Gottsch et al. 2002).
Components of the basement membrane have also been shown to enhance the survival
and proliferation of granulosa cells during the period of follicle growth (Le Bellego et al.
2002). The destruction of the basement membrane ultimately allows for ovulation.
However, this degradation process may also remove growth factors such as TGF-(3 that
are required for proliferation, but are not necessary for ovulation. The collagen pathway
is one aspect of this remodelling process that had not been extensively investigated in the
rat ovary before the studies described here. Information gained in relation to this can be
combined with known concepts of MMP and PA regulation to expand our current
knowledge on the dynamics of tissue remodelling in the ovary.
Data showed that the collagen pathway genes, PCPE, BMP-1 and LOX, were all
expressed most intensely in the immature follicle and that as follicles matured expression
of these genes declined. Protein expression of BMP-1 and LOX was also seen in follicles
at all stages, implying that depots of inactive enzymes synthesised when follicle growth is
initiated are available for use throughout the period of follicle growth. Perhaps this could
provide a finite amount of collagen pathway enzymes for follicle remodelling, confined
to the preovulatory phase of the oestrous cycle, but that did not hinder ovulation.
Visualisation of the compartmentalisation of collagen pathway genes revealed that BMP-
1 mRNA was mostly thecal-derived, whereas LOX mRNA was located in the granulosa
cells. However, protein location was not confined to the sites of gene expression. This
implies that the encoded proteins must move across the basement membrane to other
target sites, and highlights the need for co-operation between the two principal somatic
ovarian cell types, a concept seen in the two-cell pathway of oestrogen production (Ryan
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& Short 1965). Figure 7.1 refines the model for interactions of the collagen pathway
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Figure 7.1. Model of proposed movements of collagen pathway
components in the ovary.
The pattern of expression of the collagen pathway components during the oestrous cycle
may be orchestrated by ovarian regulators such as glycoprotein hormones, growth factors
and steroids. Glucocorticoids are known anti-inflammatory agents that have been shown
to aid the resolution of ovulation-associated inflammation (Hillier & Tetsuka 1998; Rae
& Hillier 2005). Therefore it is predicted that they may influence collagen pathway
components involved in tissue remodelling post-ovulation. Localisation studies showed
that llpHSD2 was predominantly associated with immature follicles, indicating that
active glucocorticoid does not affect these follicles at a stage when the collagen pathway
components were most intensely expressed, and consequently implying that a lack of
glucocorticoid allows active remodelling. The initiation of the LH surge sees a change in
the expression of the lipHSD isoforms, resulting in the predominant expression of
11PHSD1, which makes more active glucocorticoid available in the ovary. When rat
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ovarian cells were cultured with corticosterone, LOX mRNA was increased but BMP-1
and PCPE mRNAs were decreased, resulting in pro-LOX accumulation without
activation and a lack of substrate formation. Similar to the inverse relationship of the
lipHSD isoforms, degrading proteases increase in expression as genes involved in
collagen synthesis decrease in the preparation for ovulation. The common feature in all
these changes in expression is the action of the gonadotrophic hormones. As these are
the co-ordinating factors in functional follicle development, it is the direct or indirect
affects of these hormones that drive the changes in expression patterns. Although this
does not rule out interactions between the different cells, it highlights the complexity
involved in the process of ovulation. This is summarised in Figure 7.2.
influences
Figure 7.2. Summary of changing profiles of remodelling pathways (collagen synthesis and
degrading proteases) and glucocorticoid activity in the ovary.
lUh-p up-regulates alt members ot the collagen pathway in many other body systems
(Gacheru et al. 1997; Kanaki et al. 2000; Lee et al. 1997). However, in the ovary, TGF-P
only appears to up-regulate LOX. In MG-63 human osteosarcoma cells TGF-P up-
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regulates BMP-1 at 12h and peaks at 24h (Lee et al. 1997). In a variety of cell types
induction was delayed when compared to TGF-P induction of other ECM proteins (at 3-
5h) (Lee et al. 1997; Massague 1990). Ovarian cell cultures in these studies showed an
upwards trend for BMP-1 and PCPE mRNA expression in the presence of TGF-P at 48h,
suggesting that accumulation of pro-LOX was followed by activation (BMP-1) and
substrate cleavage (BMP-1/PCPE). This suggests that the time-scale of TGF-|3 induction
of collagen pathway genes in the ovary is shifted relative to other cell types studied, or
that cells require a period of adjustment to the culture environment.
It is well documented that TGF-|3 improves wound healing by exerting effects on cell
proliferation, differentiation and migration through regulating deposition of ECM
constituents. To date, about 60 ECM-related genes have been identified as downstream
targets of TGF-P (Verrecchia et al. 2001). Figure 7.3 indicates the effects TGF-P may
have in the ovarian follicles on a small number of these downstream targets, and suggests
that the effects of the LH surge possibly target TGF-P to reduce ECM accumulation and
remodelling at ovulation. TGF-P itself has not been demonstrated to effect the expression
of lipHSD isoforms, but activin, a TGF-p superfamily member, has been shown to up-
regulate 11PHSD2 in luteinised granulosa cells (Myers et al 2007, in preparation). This
may suggest a role for other TGF-P superfamily members such as TGF-P itself in
lipHSD isoform regulation.

















Figure 7.3. Proposed influences of TGF-f3 in the ovarian follicle before and after the LH surge. Before the LH surge, TGFp is
central to the accumulation and stabilistaion of the ECM and basement membrane. In the ovary TGFP is produced by the theca
cells where it will increase the production of furin, which will activate BMP-1 (1). BMP-1 will increase the cleavage of latent
TGFp, therefore the actions of TGFps actually increase it own activation (2). TGFp increases PCPE production which enhances
BMP-1 effects on procollagen cleavage (3), therefore producing more collagen. TGFp increases LOX expression (4) and BMP-1
activates LOX by cleaving it propeptide (5). BMP-1 also cleaves the proforms of other ECM components such as laminin and
biglycan (6). Other acions of TGFp on ECM include up-regulation of fibronectin which has been shown to increase LOX
activation. At this time no direct evidence exists demonstrating TGFp action on glucocorticoid activation. However unpublished
data from Myers et al shows that the TGFp superfamily member activin up-regulates 1IPHSD2, indicating that TGFp may have
a similar effect and will therefore inactivate glucocorticoids subsequently allowing active remodelling. It is predicted that the
LH surge initiates a decrease in ovarian TGFp (9). This decline in the central driving force of ECM accumulation will
subsequently cease and existing ECM structures such as basement membrane are degraded by MMPs (10). I lpHSDl is now the
predominant regulator of ovarian glucocorticoids driving the production of corticosterone which down-regulates BMP-1 and
PCPE and up-regulates LOX that will accrue as a pool ofpro-LOX as BMP-1 is lacking in the system (II).
Chapter 7 General Discussion 209
pathway biology which have not yet been identified. Recent work by Forelgren et al
(2005) suggests that fibronectin could provide a specific microenvironment that would
regulate LOX activity. Using solid-phase binding assays, it was shown that fibronectin
binds LOX, with cellular fibronectin having a higher affinity than plasma fibronectin
(Fogelgren et al. 2005). Fibronectin also binds collagen (Johansson & Hook 1980)
thereby localising LOX substrate to areas where LOX is present. In the fibronectin-null
mouse, active LOX was decreased by 90% and pro-LOX increased (Fogelgren et al.
2005). There were also marked decreases in measurable LOX activity but BMP-1 levels
were unchanged (Fogelgren et al. 2005), indicating that fibronectin is needed for the
activation of LOX enzyme and that LOX enzyme activity can be regulated by its
microenvironment. Studies in the ovary have shown that fibronectin in preantral/early
antral follicles is localised to granulosa cells, but in larger follicles it is more strongly
associated with the theca/stroma (Berkholtz et al. 2006). In the bovine corpus luteum,
fibronectin is initially abundant but decreases as the corpus luteum is formed and the
same pattern of expression has been shown for collagen type I (Silvester & Luck 1999).
Hence, fibronectin seems to be available in the ovary at times when pools of pro-LOX are
formed.
In conclusion, these studies have shown that the collagen pathway components are
regulated throughout rat ovarian follicle development and ECM remodelling changes as
the follicle matures, influenced by endocrine, paracrine and intracrine signalling.
Future work
Tissue remodelling during follicle development and post-ovulation is essential for normal
function of the ovary. This work has established a basis for further detailed investigations
into collagen pathway biology in the ovary.
Even though LOX was observed to be present throughout the ovary, other LOX family
members should be considered. Immunohistochemistry and in situ hybridisation for
LOX, LOXL and LOXL2 in human fetal membranes and placentae show that LOXL and
LOXL-2 have both overlapping and distinct areas of protein expression compared to
LOX (Hein et al. 2001; Saux et al. 1999). LOX and LOXL have been co-localised to
skin, aorta, heart, lung, liver and cartilage but are seen in different localities in kidney,
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stomach, small intestine, colon, retina, ovary, testis and brain (Hayashi et al. 2004). In
the mouse ovary, LOX protein was principally seen in the theca cells of primary follicles
and LOXL protein was expressed in the granulosa cells of these follicles (Hayashi et al.
2004). Therefore these proteins may have different functions in different ovarian cell
types and would be prime candidates for future investigations.
Similar to LOX, BMP-1 has other family-associated members with similar proteolytic
actions. These include mTLD, mTLL-1 and mTLL-2, which are all astacin family
members (Uzel et al. 2001). In situ hybridisation of embryonic mouse hind limb shows
that mTLL-1 and mTLL-2 are expressed more discretely than BMP-1 (Scott et al. 1999).
Perhaps these BMP-1 related proteins provide a fine level of control within tissues. To
date, these astacin family members have not been reported in the ovary, so it is not
known whether they contribute to the actions of BMP-1 in this tissue.
It has been shown herein that the growth factor TGF-P regulates collagen pathway genes
during follicle maturation. As the primary development of the ovarian follicle is
dependant on growth factors, these may also influence collagen pathway gene expression.
Possible regulators include other members of the TGF-P superfamily. It has been shown
previously that GDF-9 and activin A, both members of the TGF-P superfamily, increase
LOX mRNA and activity in immature rat granulosa cells. Contrary to positive effects on
collagen synthesis during early follicle development, many pro-inflammatory cytokines
are up-regulated at ovulation and may negatively regulate collagen pathway gene
expression. Such effects have been shown in lung fibroblast cultures, where TGF-p
effects on LOX are lost in the presence of the pro-inflammatory prostanoid, PGE2 (Roy
et al. 1996).
The studies described in this thesis have begun to determine the locations and activities of
collagen pathway components. However, due to technical difficulties with the LOX
enzyme activity assay and the lack of a PCPE antibody, complete profiles for all the
involved proteins have still to be established. Potential use of the LOX western could be
utilised in future investigations to quantify the relative amounts of inactive and active
LOX in isolated cell types. Similary western analysis could be performed for BMP-1
protein to determine activity of this protein and therefore the potential for activating
LOX.
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Comparisons between the qRT-PCR results from freshly isolated follicle cells (Chapter
3) and follicle cells cultured for 48h (Chapter 5) can begin to provide evidence for the
regulators that influence collagen pathway biology at difference stages of follicle growth.
The results from chapter 3 show the overall state of gene expression in maturing follicles.
Whereas the results from chapter 5 show the influences of individual regulators, therefore
influences that reflect the gene expression in freshly isolated cells may be more
prominent in collagen pathway gene regulation at these points in follicle development.
However, it should be remember that many hormones, growth factors and cytokines
interact and regulate gene expression in vivo. This comparison has highlighted that LOX
can be influenced by TGFp at all stages of follicle development, but is probably most
important in immature follicles when LOX expression is highest. The gene expression
BMP-1 and PCPE in cultured cell experiments showed general down-regulation or no
change implying that other factors up-regulate the expression of these genes during
follicle maturation. These studies provide a basis for the regulation of collagen pathway
biology in the ovary, and there are many other potential regulators that justify further
investigation for example the influences of other mediators of ovarian inflammation
could be examined such as TNFa, which in other tissue has been shown to influence
LOX. Further investigations into the transgenic animal models studied in this thesis are
required to build upon preliminarily investigations, additional studies will be insightful
with respect to the animal model, as well as to the genes of interest being examined. Of
particular interest in the models of interrupted glucocorticoid regulation (CYP11B1 v~ and
11PHSD1~/_) would be the examination of inflammatory markers to determine the degree
of inflammation to be resolved in these models.
A further interesting observation between results chapters showed that qRT-PCR studies
for BMP-1 and PCPE mRNA expression in isolated follicle cells (Chapter 3) showed an
increasing trend as follicles matured, whereas the in situ hybridization studies (Chapter 4)
showed a qualative decline in mRNA as follicles matured. Possible reasons for these
differences include the sensitivies of these two techniques. qRT-PCR directly measures
the amount of gene expression quantitatively from RNA extracted from cells and
provides a highly sensitive method for measuring gene expression. In situ hybridization
is performed on fixed tissue sections which require permeablisation and protein digestion
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to allow cDNA probes to penetrate tissue to bind to sites of gene expression. All these
steps can be optimised but can also limit the sensitivity of this technique. When in situ
hybridsation was performed for these studies it was decided to use the same conditions
for all tissues so comparisons could be drawn between stages of follicle maturation. If
these studies were to be repeated it could be considered to look at the differently staged
ovary tissue separately as they may require different optimal in situ hybridisation
conditions to allow a clearer view of mRNA expression within these tissue.
In addition to further investigations into ovarian LOX function, it will be important to
establish the relationship between LOX and collagen IV cross-linking, as the literature is
still unclear as to whether LOX does cause cross-linking of the collagen network (Section
1.3.2.2.2). The importance of LOX in collagen cross-linking was observed in animals
feed lathyrongenic agents such as legume plant family members or BAPN, these animals
had weakened bones, skin, tendon and ligament attachments as well as impaired wound
healing (Levene & Gross 1959). Subsequently it was shown that BAPN inhibited the
activity of LOX extracted from chick cartilage (Siegel & Martin 1970). Collagen extracts
from chick bone were further used to demonstrate that the addition of LOX stabilised
collagen (reduced amounts of soluble collagen were recovered from cultures) and this
effect decreased in the presents of BAPN (Siegel & Martin 1970). By re-visiting these
original studies but substituting fibrillar collagens for collagen IV could confirm or refute
the role of LOX in stabilising collagen IV structure.
Finally, as patterns of normal regulation and localisation are established, the role of LOX
in ovarian pathology can be investigated. LOX has been shown to have a role in cancer
(Section 1.3.2.1.3.). The incidence of ovarian cancer is ranked the fourth most common
type of cancer and cause of death in women (NHS, Cancer in Scotland Statistics, 2003).
Ovarian cancer arises from the OSE cells, which have been shown to produce LOX (Rae
et al 2007, in preparation). Therefore, the role of LOX in these cells may be a fruitful
avenue of investigation in ongoing investigations into ovarian cancer. Another ovarian
disorder is polycystic ovary syndrome (PCOS). This is the most common
endocrinopathy in women of reproductive age (Diamanti-Kandarakis & Economou
2006). The ovaries of these women are characterised by a thickened and fibrotic
interstitial tissue containing cystic follicles in various phases of growth and atresia
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(Henmi et al. 2001). Previous work using a rat model has shown that LOX is up-
regulated and MMP-2 down-regulated in PCOS ovaries (Henmi et al. 2001). This
indicates that LOX, and other collagen pathway components could be targets for
endocrine inducers of this syndrome, perhaps offering markers of disease status and
novel treatment strategies.
Finally, the ovary provides a model of scar-free remodelling and repair that can be used
more widely as a model for wound repair mechanisms where scarring occurs and disrupts
normal function elsewhere in the body.
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(3-mercapethanol Sigma-Aldrich (Poole, Dorset, UK)
1,5-diaminopentane Sigma-Aldrich (Poole, Dorset, UK)
100 bp ladder Promega (Chilworth, Southampton,
UK)
18s primer/probe mix Applied Biosystems (Warrington, UK)




DAKO (Ely, Cambs. UK)
35S-UTP (1.48 MBq/pl) Amersham (Chalfont St. Giles, Bucks
UK).
ABC Elite Vector Laboratories (Orton Southgate,
Peterborough UK)
Acetic anhydride Sigma-Aldrich (Poole, Dorset, UK)
Adivin/biotin block Vector Laboratories (Orton Southgate,
Peterborough UK)
Agarose Sigma-Aldrich (Poole, Dorset, UK)
Agilent 2100 Bioanalyser Agilent Technologies (Wokingham,
UK)
Ampiex red Sigma-Aldrich (Poole, Dorset, UK)
Aqueous picric acid Sigma-Aldrich (Poole, Dorset, UK)
Assay-On-Demand assays Applied Biosystems (Warrington, UK)
ATP, CTP and GPT Ambion (Huntingdon, Cambs, UK)
BAPN Sigma-Aldrich (Poole, Dorset, UK)
Borax Sigma-Aldrich (Poole, Dorset, UK)
Bovine serum albumin Sigma-Aldrich (Poole, Dorset, UK)
Bromophenol blue Sigma-Aldrich (Poole, Dorset, UK)
CNBr Sigma-Aldrich (Poole, Dorset, UK)
Coat-a-count direct androstenedione
kits
DPC (Llanberis, Gwynedd, UK)
Collagenase Sigma-Aldrich (Poole, Dorset, UK)
Denhardt's solution Sigma-Aldrich (Poole, Dorset, UK)
DEPC Sigma-Aldrich (Poole, Dorset, UK)
Dextran sulphate Sigma-Aldrich (Poole, Dorset, UK)
Dithionthreitol Sigma-Aldrich (Poole, Dorset, UK)
DNase I Sigma-Aldrich (Poole, Dorset, UK)
Donor calf serum Invitrogen (Paisley, UK)
dPBS Invitrogen (Paisley, UK)
DPX mounting medium VWR (Lutterworth, Leics, UK)
Appendix 242
Duolite VWR (Lutterworth, Leics, UK)
ECL PlusIMWestern Blotting Detection
Reagents
Amersham (Chalfont St. Giles, Bucks
UK)
EDTA Sigma-Aldrich (Poole, Dorset, UK)
Eosin Sigma-Aldrich (Poole, Dorset, UK)
Ethidium bromide Sigma-Aldrich (Poole, Dorset, UK)
EtOH Fisher Scientific Ltd (Loughbough,
Leics, UK)
First strand superscript III synthesis
reagents
Invitrogen (Paisley, UK)
Formamide Sigma-Aldrich (Poole, Dorset, UK)
Formic Acid Sigma-Aldrich (Poole, Dorset, UK)
G.5 Nuclear emulsion llford Imaging Ltd (Mobberley,
Cheshire. UK)
Glacial acetic acid Sigma-Aldrich (Poole, Dorset, UK)
Glycerol VWR (Lutterworth, Leics, UK)
Glycine Sigma-Aldrich (Poole, Dorset, UK)
Goat serum Diagnostics Scotland (Glenrothes, UK)
Gold chloride Sigma-Aldrich (Poole, Dorset, UK)
Haematoxylin Sigma-Aldrich (Poole, Dorset, UK)
hCG Sigma-Aldrich (Poole, Dorset, UK)
Horseradish peroxidase Sigma-Aldrich (Poole, Dorset, UK)
Hydrogen peroxide Sigma-Aldrich (Poole, Dorset, UK)
Immobilon-P transfer membrane Fisher Scientific Ltd (Loughbough,
Leics, UK)
Industrial methylated spirit Fisher Scientific Ltd (Loughbough,
Leics, UK)
Kodak BioMax MR VWR (Lutterworth, Leics, UK)
Kodak BioMax XAR Sigma-Aldrich (Poole, Dorset, UK)
Kodak D-19 developer Calumet Photographic (Milton Keynes.
UK)
Kodak GBH fixer Sigma-Aldrich (Poole, Dorset, UK)
L-Glutamine Sigma-Aldrich (Poole, Dorset, UK)
Lysine free medium Promo Cell, SickingstraBe, Heidelberg,
DE
Lysozyme Sigma-Aldrich (Poole, Dorset, UK)
Medium 199 Invitrogen (Paisley, UK)
MeOH Fisher Scientific Ltd (Loughbough,
Leics, UK)
Methenamine VWR (Lutterworth, Leics, UK)
Milk powder Tesco (Dundee, UK)
Na citrate Sigma-Aldrich (Poole, Dorset, UK)
NaCI Sigma-Aldrich (Poole, Dorset, UK)
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NaCI Sigma-Aldrich (Poole, Dorset, UK)
Nalidixic acid Sigma-Aldrich (Poole, Dorset, UK)
NICK columns Amersham (Chaifont St. Giles, Bucks
UK)
Optical reaction plates Applied Biosystems (Warrington, UK)
Paraformaldehyde Sigma-Aldrich (Poole, Dorset, UK)
PBS tablets Sigma-Aldrich (Poole, Dorset, UK)
Penicillin Sigma-Aldrich (Poole, Dorset, UK)
Percoll Sigma-Aldrich (Poole, Dorset, UK)
Periodic acid Sigma-Aldrich (Poole, Dorset, UK)
Permafluor Beckman Coulter (High Wycombe, UK)
Phenylmethylsulfonyl fluoride Sigma-Aldrich (Poole, Dorset, UK)
Pregant Mare Serum Gonadotrophin Sigma-Aldrich (Poole, Dorset, UK)
Promega mastermix Promega (Chilworth, Southampton,
UK)
Protease cocktail Sigma-Aldrich (Poole, Dorset, UK)
Proteinase K Sigma-Aldrich (Poole, Dorset, UK)
QIAquick gel extraction kit Qiagen (Crawley, UK)
Rabbit serum Diagnostics Scotland (Glenrothes, UK)
RLT buffer Qiagen (Crawley, UK)
RNA polyermase (T3,17 or SP6) Promega (Chilworth, Southampton,
UK)
RNase free water Sigma-Aldrich (Poole, Dorset, UK)
RNase inhibitor Promega (Chilworth, Southampton,
UK)
RNase inhibitor Promega (Chilworth, Southampton,
UK)
RNasy Kit Qiagen (Crawley, UK)
RNAzap (Ambion Ambion (Huntingdon, Cambs, UK)
S35 UTP Amersham (Chaifont St. Giles, Bucks
UK)
Salmon Sperm DNA Sigma-Aldrich (Poole, Dorset, UK)
Saran Wrap™ VWR (Lutterworth, Leics, UK)
Scintillation fluid VWR (Lutterworth, Leics, UK)
Scott's tap water Sigma-Aldrich (Poole, Dorset, UK)
SDS Sigma-Aldrich (Poole, Dorset, UK)
Silver nitrate Sigma-Aldrich (Poole, Dorset, UK)
Sirius red Sigma-Aldrich (Poole, Dorset, UK)
Sodium borate Sigma-Aldrich (Poole, Dorset, UK)
Sodium deoxycholate Sigma-Aldrich (Poole, Dorset, UK)
Sodium thiosulphate VWR (Lutterworth, Leics, UK)
Streptadivin 463 Molecular Probes (Paisley, UK)
Streptomycin Sigma-Aldrich (Poole, Dorset, UK)
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Sytox green Molecular Probes (Paisley, UK)
Taqman reversre transcriptase
regeants
Applied Biosystems (Warrington, UK)
Taqman Universal mastermix Applied Biosystems (Warrington, UK)^
Topro Molecular Probes (Paisley, UK)
Triethanolamine Sigma-Aldrich (Poole, Dorset, UK)
Tris-base Sigma-Aldrich (Poole, Dorset, UK)
Tris-HCI Sigma-Aldrich (Poole, Dorset, UK)
Trisodium citrate Sigma-Aldrich (Poole, Dorset, UK)
Trypan Blue Sigma-Aldrich (Poole, Dorset, UK)
Trypsin Sigma-Aldrich (Poole, Dorset, UK)
TSA™ Tiramide Cy3nine 3 system Perkin Elmer (Beaconsfield, Bucks,
UK)
Tween-20 VWR (Lutterworth, Leics, UK)
Urea Sigma-Aldrich (Poole, Dorset, UK)
Xylene Fisher Scientific Ltd (Loughbough,
Leics, UK)
Yeast tRNA Invitrogen (Paisley, UK)
Antibodies Source
113HSD1 Cayman/IDS Ltd (Bolton, UK)
Collagen IV Chemicon (Chandlers Ford, Hamps,
UK)
Goat anti-rabbit Vector Laboratories (Orton Southgate,
Peterborough UK)
GR ABR (Golden, CO, USA)
Laminin Abeam (Cambridge, UK)
MMP-2 Nova-castra (Newcastle, UK)
Rabbit anti-sheep Vector Laboratories (Orton Southgate,
Peterborough UK)
Rat anti-mouse Vector Laboratories (Orton Southgate,
Peterborough UK)
Product Source
24-well culture plates (tissue culture
grade)
Fisher Scientific Ltd (Loughbough,
Leics, UK)
Eppendorfs Fisher Scientific Ltd (Loughbough,
Leics, UK)
Syringe needles Fisher Scientific Ltd (Loughbough,
Leics, UK)
Syringes Fisher Scientific Ltd (Loughbough,
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Leics, UK)
Hybridisation boxes Fisher Scientific Ltd (Loughbough,
Leics, UK)
Rohen tubes Sarstedt, Germany
Whatman 3MM chromatography paper VWR (Lutterworth, Leics, UK)
Falcon tubes Fisher Scientific Ltd (Loughbough,
Leics, UK)
Glassware Fisher Scientific Ltd (Loughbough,
Leics, UK)
Plasticware Fisher Scientific Ltd (Loughbough,
Leics, UK)
Superfrost microscope slides VWR (Lutterworth, Leics, UK)
